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Genomic instability and aneuploidy, which are ubiquitous hallmarks of cancer cells, 
encompass both structural and numerical chromosome aberrations. Strikingly, 
cancer cells often display recurrent patterns of aneuploidy which are thought to be 
contingent on selection pressures within the tumour microenvironment maintaining 
advantageous karyotypes. However, it is currently unknown if individual 
chromosomes are intrinsically vulnerable to missegregation, and therefore whether 
chromosome bias may also contribute to pathological aneuploidy patterns. 
Moreover, the earliest responses to chromosome missegregation in non-
transformed cells, and how these are overcome in cancer, has remained elusive due 
to the difficult nature of isolating nascent aneuploid cells.  
 
Results. 
Individual chromosomes displayed recurrent patterns of biased missegregation in 
response to a variety of cellular stresses across cell lines. Likewise, a small subset 
of chromosomes accounted for a large fraction of segregation errors following one 
specific mechanism driving aneuploidy. This was supported by the discovery that 
chromosomes 1 and 2 are strikingly susceptible to the premature loss of sister 
chromatid cohesion during prolonged prometaphase arrest.  Additionally, I have 
elucidated the arrangement of individual metaphase human chromosomes, 
highlighting missegregation vulnerabilities occurring at the metaphase plate 
periphery following nocodazole wash-out. Finally, I have developed a novel system 
for isolating nascent aneuploid cells, suggesting the earliest transcriptome 
responses to chromosome missegregation in non-transformed human cells involve 
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The complement of genetic material in eukaryotic cells is usually diploid – 
possessing pairs of homologous chromosomes. The diploid state appears to be 
advantageous because it is permissive for the balanced genetic exchange which 
occurs during recombination in the gametes, thereby enabling sexual reproduction. 
Surprisingly, there are notable exceptions in which the diploid state is perturbed 
without catastrophic cellular consequences. Numerous plant species are tetraploid 
(containing a multiple of the diploid chromosome number) and many species of fungi 
are haploid (half the diploid chromosome number) for a majority of their life cycle. 
Additionally, there is the phenomenon of aneuploidy – the gain or loss of whole 
chromosomes – which usually has deleterious consequences on cell fitness but is 
surprisingly well-tolerated by cancer cells. 
The large variety of chromosome states observed, even between cells from a single 
organism, is still poorly defined and mechanistically unclear. Moreover, stably-
maintained aneuploidies for particular chromosomes are likely an interplay of both 
selection and recurrent chromosome missegregation. Both possibilities are 
contingent on subverting the mechanisms which act to maintain a stable 
chromosome number between generations. Aneuploid cells may therefore, in-effect, 
bypass or dysregulate a putative ‘aneuploidy sensing’ pathway which is as-yet 
undefined. 
In this introductory chapter I describe the structure and function of chromosomes, 
drawing particular attention to their molecular regulation, organisation and 
segregation which impacts upon aneuploidy mechanisms and responses in 






Figure 1.0. Spectral karyotyping of aneuploid cells. RGB display of hybridised 
metaphase spreads can be used to detect aberrant chromosome structure and 
number. Cancer cells often display recurrent patterns of aneuploidy and structural 















In eukaryotes, linear deoxyribonucleic acid (DNA) is tightly packaged into a higher-
order structure known as chromatin, a DNA-protein composite containing histones 
and non-histone proteins. Hierarchical compaction of this nature allows a large 
amount of DNA to exist as discreet entities known as chromosomes which reside in 
the comparatively small volume of the nucleus of each cell2. Here I describe the 
molecular pathways concerning chromosome function, regulation and segregation 
during cell division.  
1.1.1. Chromosome structure and function 
 
The DNA comprising the human genome is divided unequally into 22 chromosome 
pairs, known as the autosomes, and two sex-determining chromosomes – XX in 
females and XY in males. The structure and organisation of chromosomes are 
governed by several requirements including gene expression control3. As such, 
human cells have evolved chromatin remodelling strategies that are capable of 
enormous plasticity under the control of complex, regulatory signalling networks4.  
Two structural features common to all chromosomes are the centromeric and 
telomeric regions, occurring at the central constriction and capping the ends of 
chromosomes, respectively. These regions contain highly-repetitive DNA 
sequences that serve several important functions. Although they are present in each 
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1.1.1.1. Chromatin architecture and remodelling 
 
The basic repeating subunit of chromatin, known as the nucleosome, is highly 
conserved across species5. It is comprised of a 147bp segment of DNA wrapped 
around homodimers of each of the four histone proteins (H2A, H2B, H3 and H4) 
which assembles to form the histone octamer. The tight association between DNA 
and the octameric core afford protection from nuclease digestion and permit an initial 
compaction of linear genomic DNA of approximately 7-fold6,7. Nucleosomes serve to 
package the genome, but in doing so they also restrict the access of DNA-binding 
transcription factors, meaning there is a fine balance between DNA accessibility and 
packaging efficiency8. Gene expression in transcriptionally active areas of the 
genome is controlled by a number of regulators. Firstly, there is dynamic competition 
between transcription factors and nucleosomes for elements in gene promoters 
known as the cis-regulatory sequences9. Competition of this nature is regulated by 
enzymes known as ‘chromatin modifiers’ which covalently alter nucleosomes, and 
‘chromatin remodellers’ which eject or reconfigure nucleosomes. Studies in yeast 
suggest that the chromatin architecture at promoters exists in two broad states – 
constitutive and highly regulated – with protein complexes for specific genes blurring 
the distinction in special cases10,11.  
Constitutive (open promoter) genes are spatially organised to allow the binding of 
transcription factors at the expense of nucleosomes, therefore promoting gene 
expression. The chromatin immediately upstream of the transcription start site of 
these genes typically contains a large nucleosome-depleted region (NDR) that is 
densely populated with poly(dA:dT) tracts12–14. These sequences are rigid in 
structure, thereby promoting nucleosome instability and inhibiting chromatin 
spooling15. Conversely, AA/TT dinucleotide repeats induce a chromatin curvature 
which promotes nucleosome assembly16,17. Regions of this nature which extend for 
more than 150bp are known as nucleosome positioning sequences (NPS). Notably, 
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transcriptional activator binding sites often reside in the NDR, increasing 
transcription factor binding efficiency and gene expression. 
At regulated (closed promoter) genes, transcription factors compete with 
nucleosomes for occupancy of the cis-regulatory binding sites. These promoters are 
littered with NPS sequences of varying length, which dictate the nucleosome-
transcription factor balance by altering the rigidity of promoter chromatin18. In most 
cases, there is at least one exposed binding site, between adjacent nucleosomes, 
on the linker DNA that permits a ‘pioneer’ access to the promoter which can then 
initiate chromatin remodelling in a controlled manner to expose further sites 
concealed by the nucleosome19,20. Transcription initiation can also vary between 
open and closed promoters. The transcription initiation binding protein (TBP) is an 
absolute requirement for TATA-less and TATA-containing promoters21. Whereas 
very few open genes contain TATA boxes, almost all closed promoters contain 
TATA boxes inside the proximal nucleosome edge, enhancing the requirement for 
chromatin remodelling and nucleosome displacement before TBP access and gene 
expression can occur22. 
The transition between chromatin states can also be achieved through the hydrolysis 
of adenosine triphosphate (ATP) by chromatin remodellers. These are specialised 
protein complexes that are classified by their mechanism of action. The imitation 
switch (ISWI) and sucrose non-fermentable (SNF) remodelling families assemble 
and organise chromatin by the deposition of nucleosomes23; the SWI/SNF family 
facilitate nucleosome ejection or movement, and the SWR1 family insert specialised 
histones into nucleosomes for reconstruction24,25. By cooperating the expression and 
localisation of remodelling complexes with environmental changes, chromatin 







The repetitive sequence which specifies the centromere, known as α-satellite DNA, 
is organised into functional subdomains and is flanked by regions of 
heterochromatin. The centromere serves as more than a junction point between the 
two chromatid arms – it also coordinates the movement of chromosomes during 
mitosis and meiosis, regulates sister chromatid cohesion and helps synchronise 
chromatin condensation26,27. Most of the available data concerning centromere 
function describe its important role in mitosis, where it serves as the assembly site 
for microtubules through its interaction with a multi-protein complex, known as the 
kinetochore28. 
The centromeric α-satellite DNA is host to a specialised histone H3 variant, CENP-
A, which is important, but not essential for, kinetochore assembly on the centromere 
(figure 1.1a)29. It has been shown that the octamer of histone proteins that form the 
nucleosome can assemble in vitro with purified CENP-A, suggesting that CENP-A 
is sufficient to replace endogenous H3 dimers at centromeric regions30. Unlike other 
histone proteins which are removed and reincorporated into chromatin during early 
S-phase, CENP-A nucleosomes are inherited in a semi-conservative manner with 
nascent-synthesised CENP-A loading occurring at the centromere during G131. This 
explains how CENP-A specificition at α-satellite DNA is faithfully maintained 
between generations32,33. It is now known that CENP-A does not completely replace 
histone H3 at centromeric sequences. Instead, H3-containing nucleosomes are 
interspersed with CENP-A-containing nucleosomes. These H3 histones are tagged 
with a dimethyl modification on lysine 4 (H3K4me2) which is essential for the 
specification and maintenance of CENP-A at centromeres. Interestingly, it has been 
shown that CENP-A contributes to the rigidity of the centromere through its 
interaction with H4, which is less flexible than the common H3-H4 interaction, 
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thereby providing a stable platform for downstream assembly of kinetochore 
components34. 
Centromeres are also distinguished from the rest of the genome by higher-order 
packaging. This relies on two other members of the CENP family – CENP-B and 
CENP-C. Targeting of CENP-B to the centromere is achieved through its interaction 
with the CENP-B protein binding motifs, the CENP-B boxes, which are deposited at 
alternating 171bp monomers (figure 1.1b)35. Functionally, this allows dimerization 
of conserved domains on adjacent CENP-B proteins so that the CENP-B boxes are 
brought in close proximity36. This looping of α-satellite DNA induces non-random 
phasing of CENP-A nucleosomes throughout the centromere37. Likewise, CENP-C 
has several targeting domains specifying it to centromeric DNA, where it is important 
for the dimerization of CENP-B and promoting other protein-protein interactions. 
During mitosis, CENP-C functions as a scaffolding protein, remodelling the 
centromeric architecture to create a chromatin environment which is permissive for 
the assembly of the inner kinetochore at metaphase38. 
Given that most centromeres are flanked by heterochromatin – transcriptionally 
silenced regions of the genome characterised by dense histone methylation – it is 
likely that the epigenetic environment surrounding the centromere plays an 
important role in either specifying the centromere, or aiding its function39. More 
recently, it has been suggested that heterochromatin might be important to limit 
kinetochore assembly to centromeric DNA40. Experimentally, this has been shown 
by heterochromatin restriction of CENP-A to the centromere, even in conditions 
when CENP-A is overexpressed41. Conversely, the removal of pericentromeric 
heterochromatin is permissive for the spread of CENP-A into flanking sequences, 







Figure 1.1. The structure and function of the centromere. (a) The inner and outer 
kinetochore (KT) components assemble on the repetitive α-satellite DNA of the 
centromere (CEN). (b) A specialised histone H3 variant, CENP-A, is incorporated 
into centromeric nucleosomes and facilitates kinetochore assembly in collaboration 










As the name suggests – from the Greek nouns telos (‘end’) and meros (‘part’) – 
telomeres are found at the extremities of each chromosome arm. Much like 
centromeres, telomeres are specialised chromatin environments consisting of 
repetitive DNA sequences which are essential for chromosome function. Without 
telomeres, each round of genome duplication would lead to progressive 
chromosome attrition. Of equal importance is their ability to mask the ends of 
chromosomes which would otherwise be recognised as DNA breaks leading to cell-
cycle arrest43.  
Human telomeres are characterised by multiple tandem repeats of the sequence 
TTAGGG proceeded by G-rich single-stranded overhangs at the 3’ terminus. 
Telomeric DNA adopts an unusual conformation known as ‘T-loop’ where the 
telomeric ends fold back and invade the adjacent double-stranded DNA (dsDNA)44. 
These repeat regions are generated and maintained by a specialised reverse 
transcriptase, known as telomerase, which is unusual in that it carries its own RNA 
template. 
The precise molecular mechanisms which recruit telomerase to the telomeres are 
still unclear; however it is known that Cdc13, a G-rich-specific DNA-binding protein 
which is necessary to protect telomeres against double-strand breaks (DSBs), is 
involved in telomerase recruitment45–47. These G-rich overhangs are also able to 
quadruplex with themselves, by virtue of the fact that each base serves as both an 
acceptor and donor for hydrogen bonds. This quaternary structure limits telomerase 
activity (preventing promiscuous telomere extension), suppresses recombination 
events and acts to protect the chromosome ends from exogenous DNA damage47. 
It has been shown that the length of the 3’ G-overhang is essential for telomerase 
regulation and end processing, with the shortest telomeres eliciting the strongest 
telomerase recruitment at S-phase48–50.  
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The transition between the repetitive regions of telomeres to transcriptionally-active 
euchromatin is not abrupt. Instead most, but not all, telomeres are underpinned by 
a dynamic and variable region known as the subtelomere, which may traverse up to 
300kb51,52. The precise evolutionary origin of subtelomeric regions are unknown, but 
are likely to have arisen by many translocation and recombination events. 
Functionally, subtelomeres may provide enhanced protection for telomeres; 
however it has recently been demonstrated that they are also able to rescue genes 
located at the ends of chromosomes from telomeric methylation, which would 
otherwise disrupt their expression53,54. Additionally, subtelomeres play an important 
role in meiosis, where they inhibit crossover events. This is important as it has been 
shown that meiotic recombination events near the ends of chromosomes could 














1.1.2. The nuclear organisation of chromosomes 
 
The nucleus is an organelle which is spatially separated from the cytoplasm by two 
membrane bilayers – the outer nuclear membrane and the inner nuclear membrane. 
The non-random arrangement of chromosome within the nucleus is important for 
many of their functions including transcriptional regulation, DNA stability and 
chromosome segregation during mitosis. 
1.1.2.1. Radial chromosome positioning 
 
Individual chromosomes can be stained with fluorescent probes by Fluorescence in 
situ Hybridisation (FISH). This technique revolutionised my understanding of the 
spatial organisation of DNA, as it allowed the sub-nuclear location of genetic loci to 
be mapped along an axis extending from the nuclear core to the inner nuclear 
membrane56,57. By mapping the radial positions of chromosomes, it is now known 
that many cell types have a preference for gene-dense chromosomes locating in the 
nuclear core and gene-poor chromosomes occupying the nuclear periphery; this is 
known to be conserved among primates and a similar phenomenon for chromosome 
size has been reported (figure 1.2)57–59. Confusingly, despite this general density 
phenomenon, there is little evidence that each chromosome has a defined ‘3D 
neighbourhood’ of chromosome with which it resides60.  
The mobility of chromatin in the interphase nucleus is limited61–63. This has important 
implications for human disease, as the proximity of chromosomes becomes the 
limiting factor for the variety of chromosome translocations which can occur; only 
chromosomes which are sufficiently close may exchange genetic material by 
double-strand break repair64. This has been shown in both mouse and human 
lymphocytes65. It has also been reported that reciprocal translocations involving 
chromosomes with stochastic arrangements can disrupt nuclear organisation. This 
is most pronounced in the example of the recurrent t(11;22)(q23;q11) translocation 
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where chromosome 22, usually positioned in the nuclear core, is shifted towards the 
periphery when chromosome 11 is located more centrally than expected56. The 
radial positioning of chromosomes, given the consequences for translocations and 
other structural DNA aberrations, may have important implications for chromosome 
evolution66. 
Each chromosome, regardless of its position in the nucleus, occupies a well-defined 
territory67. At the boundary between adjacent territories, there are regions where 
chromatin is able to loop into the no-mans-land and form cis and trans associations 
between chromosomes68. Interestingly, it has been shown that the centromere is 
important for attenuating the association of looped sequences present on opposite 
arms of the same chromosome, preventing intra-chromosome translocations, 
although the mechanistic basis for this is still unclear69. Functionally, the looping of 
DNA may aid transcription of these regions. Recent data suggest that most of these 
looping regions are gene-dense and hyper-sensitive to DNase I treatment, indicative 
of highly-active promoter regulatory elements70. It has also been suggested that 
DNA looping may allow actively-expressed regions of the genome to explore a larger 













Figure 1.2. The radial positioning of chromosomes. Human chromosomes can 
be mapped radially within a nuclear sphere. Larger, gene-sparse chromosomes 
reside at the nuclear periphery while smaller, gene-dense chromosomes occupy the 
nuclear core (illustrative data points). Chromosomes occupy distinct territories which 








1.1.2.3. Chromatin domains 
 
Within each chromosome territory, there is further clustering of active and inactive 
gene regions, known as chromatin domains72. The interaction of inactive domains 
occurs in two broad categories – centromere proximal and centromere distal – which 
is likely to reflect their reduced freedom of movement and are usually found within 
their own chromosome territory73. Conversely, active regions are able to associate 
over long distances, which may reflect their requirement to cluster around shared 
gene splicing machinery. Local chromatin domains form unique structures which 
correspond with replication timing during S-phase. Regions of the genome with 
active genes, the ‘replication (R) bands’, are known as early replicating and inactive 
genomic regions, the ‘Giemsa (G)-bands’, are late-replicating74. It has also been 
shown that late-replicating domains tend to cluster at the nuclear periphery and that 
replication timing can significantly affect chromosome translocations75. This is 
important as it suggests that aberrant S-phase execution may predispose to the 
structural rearrangement of chromosomes.  
1.1.2.4. Nuclear membrane-associated chromatin 
 
The inner nuclear membrane (INM), aside from being the physical boundary of the 
nucleoplasm, is important for cooperating gene expression, genome stability and 
initiating DNA repair76. The INM is traversed by filamentous lamin proteins and 
nuclear pore complexes which interact with perinuclear chromatin and play an 
important role in maintaining the structural and functional integrity of the genome77. 
It is now possible to detect loci which interact with the INM by fusing DAM 
methyltransferases to INM proteins and identifying de novo DNA methylation by 
sequencing78. Using this approach, it is now known that transcriptionally silent 
chromatin regions associate with perinuclear membrane proteins in both humans 
and flies79. Interestingly, treatment with histone deacetylases causes the release of 
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lamin-associated sequences from lamins, suggesting that gene silencing by 
methylation is sufficient to promote association with the nuclear membrane79. This 
further supports the view that heterochromatic regions of the genome preferentially 
occupy the nuclear periphery80. It is important to highlight that the nuclear periphery 
is not always associated with gene silencing. It has been shown in yeast that genes 
associated with nuclear pore complexes (NPCs) can promote transcription, and that 
treatment with histone deacetylases inhibitors can promote the reactivation of silent 
chromatin to active domains at the NPC81,82. The precise mechanisms governing 
expression at the nuclear periphery are blurred further by activation, or silencing, of 
some genes at the INM in a regulatory element-dependent nature. These data 
highlight the complex interplay between perinuclear compartments, genetic 
elements and the nuclear envelope. 
In yeast cells, the nucleolus is comprised largely of repetitive ribosomal DNA (rDNA), 
abuts the inner nuclear membrane and is prone to homologous recombination 
events, which cause genomic instability83. Affinity purification and proteomic analyse 
have revealed two key proteins, Heh1 and Nur1, which form the CLIP (chromosome 
linkage INM proteins) complex which bridges the rDNA repeats to the INM. It has 
recently been shown that disruption of the CLIP complex releases rDNA repeats 
from the nuclear membrane leading to recombination events and the accumulation 
of genetic lesions – a phenotype which was rescued by reintroducing artificial 
tethering to the INM84,85.  
Additionally, it is known that other repetitive sequences can associate with 
perinuclear proteins – one of which is telomeres. Early work identified at least one 
protein, Mps3, which is able to promote clustering of the 32 yeast telomeres into 4-
8 foci at the nuclear envelope86. This discovery led to the study of INM chromatin 
silencing at telomeres and it was shown that several telomere-binding proteins are 
important for perinuclear anchoring87. More recently, it has been shown that Mps3-
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dependent telomere clustering is important to sequester transcription inhibitors 
which can otherwise erroneously silence non-subtelomeric genes88. 
Surprisingly, DNA insulted with double-strand breaks (DSBs) is actively relocated to 
the nuclear membrane, where it interacts with nuclear pore complexes89. This 
recruitment to the INM is dependent on Mec1, a kinase that delays cell-cycle 
progression in response to DSBs. Importantly, damaged loci do not cluster with 
telomeric attachment sites, and damaged telomeric sequences promote co-
localisation of telomeres with the NPC, suggesting that damaged DNA may be 
targeted to the NPC regardless of its nuclear envelope attachment status. The role 
of NPCs and lamins in genome stability and maintenance of chromatin organisation 
is reinforced by a number of important studies. For example, mutations in lamin 
proteins are linked with chromatin architecture abnormalities and loss of nuclear 
structural integrity; and lamins have also been linked to transcriptional regulation by 
modulating the availability of transcription factors at the nuclear envelope90,91.  
It is possible that the inner nuclear membrane helps stabilise DNA by acting as a 
large support platform enabling cells to control the distribution of repetitive loci 
relative to each other. The INM may also limit long-range recombination events 
between susceptible loci, by keeping sister chromatids spatially separated during S-
phase. The clustering of repetitive domains at the nuclear periphery may also permit 
genetic co-regulation, which can promote beneficial recombination diversity under 
stress. Together, the above data demonstrate that the nuclear periphery is an 
important organisational region, where transmembrane proteins act to minimise 





1.1.3. Mitotic chromosome assembly 
 
Profound changes in chromatin structure occur during mitosis, when the duplicated 
genome is equally partitioned into two daughter cells. Disassembly of the nuclear 
envelope, at mitotic onset, occurs concurrently with the rearrangement of an 
amorphous chromatin mass, resolving as sister chromatid pairs which line up on the 
equatorial spindle. This sequence of carefully-coordinated events is known as 
chromosome condensation, or assembly, and is an absolute requirement for the 
faithful segregation of genetic material92,93. 
1.1.3.1. The structure and composition of SMC complexes 
 
Mechanisms of chromosome condensation, DNA repair and sister chromatid 
cohesion rely on a families of proteins known as the structural maintenance of 
chromosomes (SMC) complexes. These essential genomic functions are carried out 
by the three SMC complexes: condensin, Smc5/6 and cohesin94. These complexes 
assemble around heterodimers of SMC proteins (named SMC1-5), which are 
obligatory for DNA binding activity and the hydrolysis of ATP. 
Smc1 and Smc3 create a ring-like structure, which is important for entrapping sister 
chromatids until proteolytic cleavage of Ssc1 at anaphase onset95,96. The 
entrapment of DNA is also known to hold condensins in close association with their 
target site. However, whereas cohesion is bound at physiological ionic strength, the 
interaction of condensins has been shown to dissociate only at high salt 
concentrations, suggesting that condensins are also able to bind DNA directly97. It 
is currently unknown whether Smc5/6 is able to bind DNA directly, or if it forms a 
similar ring-like structure. Given the structural similarity with condensins and 






The primary function of condensins is to establish proper mitotic chromosome 
structure and promote faithful chromosome segregation during meiosis and mitosis. 
There are two condensin complexes, referred to as condensin I and condensin II, 
that share two core subunits, which are independently coordinated by distinct 
regulatory subunits. The two core protein subunits belong to a larger family of 
ATPases called the structural maintenance of chromosomes complex. Condensins 
are able to hydrolyse ATP to promote both superhelical rigidity and DNA 
compaction98,99. Despite data suggesting that condensins are crucial for 
chromosome assembly, there is an abundance of conflicting literature on their 
precise mechanism of action. 
The earliest stages of chromosome condensation are characterised by the 
hierarchical supercoiling of chromatin fibres. One of the SMC subunit of condensins, 
Smc2, first associates with chromatin fibres at the periphery of the nucleus and 
subsequently accumulates at prometaphase along the central axis of each 
chromosome. Importantly, NEBD is coincident with the relocalisation of Smc2 and 
condensin I recruitment to chromatin arms, suggesting that chromosome structural 
changes observed before and after NEBD may be mechanistically distinct. More 
recently, it has been suggested that topoisomerase II is important for the axial 
formation of chromosome arms and recruitment of condensin I subunits; however 
this cannot explain the activities of condensin II100. 
Chromosome bridges, DNA spanning between dividing chromosome masses at 
anaphase, are one of the most prominent segregation defects observed in 
condensin-deficient cells101–103. Segregation defects of this kind are thought to be 
linked to improper chromosome condensation in the preceding metaphase. 
Condensin depletion in human cells and Xenopus embryos has been shown to 
increase the formation of merotelic chromosome attachments, single kinetochores 
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attached to microtubules emanating from both spindle poles, raising the possibility 
that condensins are also important for bipolar orientation of chromosomes104. 
Chromosome assembly defects have also been observed in condensin-depleted C. 
elegans models. Unlike vertebrate chromosomes which have one kinetochore per 
sister chromatid, C. elegans have many kinetochores which assemble along the 
length of each sister chromatid pair, known as holocentric chromosomes105,106. 
1.1.3.3. Sister chromatid cohesion 
 
The dissolution of sister chromatid cohesion is coordinated in a two-step process. 
The first, occurring during prophase, does not affect centromeric cohesion, which 
gives mitotic chromosomes their single constriction107,108. The activity of separase at 
the onset of anaphase is responsible for the cleavage of the SMC protein Scc1, 
triggering disjunction of sister chromatids109,110. Cohesin exists as different 
populations which are loaded onto chromatin at various stages of the cell cycle. In 
human cells, >90 % the cohesin bound on chromosomes becomes dissociated 
during early prophase, leading to soluble mitotic cohesin complexes in the cytoplasm 
which are spared separase cleavage111. Cohesin subunits tagged with a green 
fluorescence protein (GFP) suggests that the residence time of some chromosomal 
cohesin is shorter than 25 minutes, in both G1 and G2 cells112. However, a distinct 
population engages with chromatin for significantly longer and may represent the 
pool responsible for holding sister chromatids together113.  
The loading of cohesin onto chromatin requires ATP hydrolysis at all stages and is 
facilitated by the ATPase domain of Smc1 and Smc3 of the cohesin complex. This 
was first shown using mutated Smc1 and Smc3 proteins which could bind, but not 
hydrolyse, ATP which were able to form cohesin ring-like structures but failed to 
stably associate with DNA114,115. The DNA binding capacity of cohesin varies at 
different parts of the genome, with some requiring the presence of additional factors 
or proteins before a stable association can be formed. At every known site, the 
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Ssc2/4 complex is essential for binding in mammals, Xenopus and yeast116–119. 
Unsurprisingly, defects in either Ssc2 or Ssc4 precipitate as global failure of sister 
chromatid cohesion120. It is unlikely that Ssc2/4 functions solely in cohesin loading, 
given that ssc2 mutation is also known to compromise Smc5/6 onto chromatin 
concurrently with defects in condensin121,122. 
Chromatin association of cohesin in Xenopus requires, in addition to Ssc2/4, the 
formation of the pre-replication complex (RC)123. Purified extracts from Xenopus 
larvae display associations between Ssc2/4 and Cdc7/Drf1-dependent kinase 
(DDK), which is an essential member of the pre-RC124. The sequential binding of 
various cofactors in this assembly have revealed the possibility that Ssc2/4-DDK 
may act prior to DNA replication, suggesting that Ssc2/4’s functions include 
chromatin fibre trapping in addition to cohesin recruitment to chromatin. 
The two phase process of cohesin removal from sister chromatids is under tight 
temporal control. Unlike the metaphase-to-anaphase transition, in which the 
separase-mediated cleavage is well characterised, the prophase pathway of 
cohesin dissolution is separase-independent and has yet to be fully elucidated. It is 
known that, during the prophase pathway, moderate dissociation is mediated by 
polo-like kinase (PLK) and Aurora B phosphorylation on the C-terminal domains of 
Scc3125. Given that cohesin removal can still occur in the absence of these proteins, 
they are unlikely to be requisite. Recent data suggests that the master regulator of 
prophase cohesin removal is Wapl, a protein which binds to the SMC scaffolding 
subunit Pds5. This was demonstrated in Wapl-depleted cells, resulting in the 
majority of cohesin remaining on chromatin arms126,127. The prophase pathway 
removes most, but not all, chromatin-bound cohesin. Centromeric cohesin is 
protected from this pathway because of a centromere-specific Sgo1128,129.  
The metaphase-to-anaphase transition is characterised by separase cleavage of 
Ssc1, the α-kleisin subunit of the cohesin complex96. A non-cleavable mutant Ssc1 
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in HeLa cells disrupts sister chromatid disjunction and blocks Rec8’s removal from 
bivalent chromosomes110.  The activity of separase is further regulated, in a cell-
cycle-dependent manner, by the chaperone protein inhibitor, securin130. The 
phosphorylation of separase by Cdk1 on serine 1121 promotes the stable interaction 
with cyclin-B/Cdk1, rendering the protease domain catalytically null131. This function 
is of paramount importance, especially in pre-implantation mouse embryos and 
primordial germ cells, where securin levels are known to be lower than in other cell 
types132,133. 
Crucially, the activity of separase is prevented until all sister chromatid pairs are 
bioriented. Once all kinetochores are attached to microtubules the APC/C 
ubiquitinates securin and cyclin B, leading to their proteolysis 134. This signalling 
cascades culminates with the cleavage of Ssc1 subunit of cohesin complexes at 
centromeric DNA, triggering sister chromatid disjunction110. 
An important emerging role for cohesin is in double-strand break repair in meiotic 
and mitotic cells122,135. Two distinct cohesin population engage in repairing DSBs in 
mitotic cells – cohesin recruited to the break point and cohesin already holding sister 
chromatids together when the break occurred136,137. Cohesin in meiotic cells is 
involved in generating reciprocal translocation events by DSB repair and generates 
the chiasmata, which secures bivalent chromosomes to each other until meiosis I138. 
It is known from yeast studies that the α-kleisin subunits Ssc1 and Rad21 present in 
mitosis are replaced by Rec8, which is specific to the meiotic cohesin complex139. 
Functionally, this may permit the repairing of DSBs by non-sister chromatid 
recombination and therefore promote genetic diversity. Human cells also swap these 
subunits for meiotic-specific variants, namely STAG3 replacing Scc3 and Smc1B 
(replacing Smc1), which are important for generating heterogeneity during 




1.2. Mechanisms driving aneuploidy 
 
1.2.1. DNA damage 
 
The DNA of human cells is under continual assault by a barrage of exogenous DNA 
damage-inducing agents and cellular metabolites. These insults may alter the 
primary nucleotide sequence, which is a leading cause of many of human diseases. 
Unperturbed cells have the capacity to sense errors arising from DNA damage and 
have evolved regulatory networks which correct damage below a threshold, 
removing cells with damage which cannot be corrected by programmed cell 
death140,141. Aneuploid cells often display high rates of protein mis-folding due to 
protein stoichiometry imbalances142,143. It is also known that DNA damage is a major 
driver of chromosome instability and cause of aneuploidy144–147. This section 
describes the foundations of DNA damage phenotypes with examples of 
perturbations which give rise to aneuploid progeny. 
1.2.1.1. DNA damage repair 
 
Repair pathways which maintain the integrity of DNA are broadly divided into sub-
categories, depending on their mechanism of action: base excision repair, 
nucleotide excision repair, double-strand break repair, direct repair and repair of 
cross-linked DNA. 
The repair of DNA by base excision is initiated by the removal of the base by a DNA 
glycosylase to form an abasic site. This class of glycosylase enzymes are capable 
of recognising a wide range of aberrant nucleotides including deaminated, oxidised, 
reduced, alkylated and mismatched bases.  In most cases, the removal of the base 
occurs by a process known as the abasic lyase reaction in which the 1’-aldehyde 
from the deoxyribose is reduced by a β-elimination reaction, leaving the 3’-sugar 
phosphate residue unsaturated148. This is proceeded by removal of the sugar 5’ to 
the abasic site and the gap is filled by DNA polymerase and subsequently nick 
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ligated149. In human cells, this process is known simply as the short-patch base 
excision repair as the reaction only involves three enzymes: APE1, DNA ligase III 
and DNA Polβ. Glycosylases use simple diffusion and Brownian motion to detect 
distortions created by the formation of hydrogen bonds in the DNA backbone caused 
by base damage150. Careful analysis of their crystal structure has revealed that some 
glycosylases compress DNA helices on either side of the damaged base, which 
permits rotational movement, thereby exposing the glycosylic bond which can be 
hydrolysed by specialised domains151. These act as a proof-reading mechanism to 
ensure base repair specificity. The dysregulation of Polβ is a frequent occurrence in 
human cancers. 
Of particular interest is the centrosome-associated abnormal localisation of gamma-
tubulin during mitosis in nude mice with aberrant Polβ expression. These changes 
were shown to promote numerical aneuploidy and increase malignancy aggression, 
possibly as a result of mitotic checkpoint deficiency152. Therefore, it is likely that 
defects in base excision repair could manifest as stochastic errors which promote 
chromosomal instability (CIN) and tumour progression. 
Lesions formed on DNA after exposure to chemicals, irradiation or proteins cross-
linked to DNA are repaired by the process of nucleotide excision repair (NER). 
Insults of this nature are repaired by the enzymatic removal of the offending base by 
multi-protein complexes which envelope the damaged strand153. Excision repair is 
known to recognise a wide range of substrates; consequently, it is thought that rather 
than identifying chemical variation in the lesions, it is structural changes in the 
phosphodiester backbone which are the point of engagement153.  
Once identified, lesions are subject to incision and removal of an oligomer of 24-
32nt in length, which can be filled in by template-strand complementarity. An 
assembly of 6 repair factors form a multi-protein complex responsible for all the 
activity associated with NER154. In humans, it is the nuclease activity of XPC, XPA 
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and RPA which confer the initial DNA binding specificity, although there is still some 
uncertainty over their preferences for damaged DNA. It was demonstrated that these 
three nucleases have different DNA binding affinities and are present in different 
abundances154. It is likely that a combination of all of these play an important role in 
the final excision nuclease complex assembly. DNA unwinding and kinetic 
proofreading during NER is devolved to a specialised protein complex, the TFIIH, 
consisting of 6 subunits with both 3'-5' and 5'-3' helicase activity154. The helicase 
subunit unwinds DNA 20bp downstream of the assembly site; if this happens to be 
a non-damaged site then disassembly of the complex is promoted by hydrolysis of 
ATP. 
Conversely, sites of DNA damage provide a high-affinity binding site for other 
subunits which recruit the nuclease domains in to contact with the damaged 
nucleotide155. Excision, polymerase activity and nick ligation complete the nucleotide 
replacement. Of interest, the proof-reading activity of TFIIH to detect only damaged 
nucleotides is not absolute, and gratuitous repair of undamaged bases does occur 
in human cells and may be mutagenic156. 
In yeast models it has been shown that NER is a requirement for faithful 
chromosome disjunction. In the absence of the repair factors, Rad1, Rad2 and 
Rad4, there was a significantly elevated rate of spontaneous gain of chromosome 
XV in both diploid and haploid mutant strains157. Emerging data also suggest that 
the nuclease activity of XPA is required for the maintenance of proper centrosome 
number (2 centrosomes per cell) 188. This in vitro work has shown that the loss of 
Xpa is associated with centrosome amplification and micronuclei formation. 
Interestingly, the concurrent loss of p53 showed a more severe phenotype than 
haploinsufficiency of either alone, suggesting that there is cross-talk between NER 
and p53 pathways to supress chromosomal instability in response to DNA damage.  
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Double-stranded DNA breaks are unusual in that they occur by exogenous damage, 
by ionising radiation and ROS, but also occur naturally as a mechanism for 
generating genetic variation (such as in V[D]J recombination) and meiotic cross-over 
events158–160. DSBs are repaired by either homologous recombination (HR) or non-
homologous end-joining (NHEJ). The process of HR is a multi-step process which 
requires the damaged strand to invade its homologous template, mediated by 
Rad51, BRCA1 and BRCA2161. The resulting structure, known as a Holliday junction, 
is resolved in such a way that the ‘lost base’ information is retrieved from the 
homologous duplex. NHEJ involves the heterodimer of Ku proteins which recruit 
ligase4-XRCC4, ligating two ends of a double strand break irrespective of whether 
the arms are from the same chromosome162. 
Defective HR pathways are prevalent in a number of cancers with heterogeneous 
chromosome content. These are typified by BRCA1 and BRCA2-deficient breast 
cancers. The loss of either of these genes is coincident with loss of genome 
stability163. This is most likely due to defects in HR-mediated repair which gives rise 
to cells with translocations and large-region deletions. Additionally, BRCA1/2 act in 
a tumour-suppressive manner as they regulate the cell cycle by signalling to 
checkpoint complexes164. It is by these mechanisms that BRCA1/2 likely act to 
simultaneously supress tumour initiation and maintain genome stability.  
A number of anti-cancer drugs cause cell death by inducing the formation of inter-
strand DNA cross-links. During replication, cross-linked DNA impairs polymerase 
activity and leads to the formation of DSBs both in vivo and in vitro as a result of 
replication fork collapse165. At replication-induced DSBs there is nuclease digestion 
which degrades the cross-link in a 3’ to 5’ direction. The combined actions of Rad51 
and Rad52 with RPA form a Holliday junction which can then be resolved by 




1.2.1.2. Cell cycle checkpoints 
 
The eukaryotic cell cycle is characterised by four distinct phases: G1, S, G2 and M. 
Transition between these states is carefully controlled to ensure that deleterious 
events in one stage are not left uncorrected before the next stage commences167. 
Human cells possess many inter-connected pathways, known as checkpoints, which 
inspect the integrity of DNA before permitting the cell to proceed to the next phase 
of the cell cycle (figure 1.3)168. The term 'checkpoint' has been expanded to include 
the execution of more ambiguous responses such as apoptosis, DNA repair and 
arrest of cell-cycle progression as a general phenomenon, independent of DNA 
damage. For this reason, I reserve the use of ‘DNA-damage checkpoint’ exclusively 
for signalling cascades which arrest, or slow, the cell cycle as a direct result of DNA 
damage. In this context, checkpoints which monitor DNA damage are not uniquely 
activated by such an event. Rather, they are continually operative pathways whose 
members are upregulated during a damage response. 
In most human cancers, aneuploid cells are often deficient in proteins which execute 
various stages of the cell cycle checkpoints169–172. Often, multiple key checkpoint 
proteins are mutated in a single cell, allowing the uncontrolled proliferation of 
aneuploid cells with accumulating DNA damage and increased karyotypic 
complexity. The underlying cause of this chromosomal instability (CIN) phenotype is 
complex, but some studies suggest that the primary cause is due to improper mitotic 
checkpoint signalling, allowing cells to proceed to anaphase with misaligned 
chromosomes173.  
The G1/S checkpoint, also known as the restriction point in human cells, prevents 
entry into S-phase in response to DNA damage by preventing the initiation of 
replication. Ionising radiation leading to double-strand breaks activates ATM which 
phosphorylates Chk2 and p53. Chk2 initiates Cdc25a degradation or exclusion from 
the nucleus resulting in p-Chk2 (inactive) accumulation, thereby preventing Cdc45 
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phosphorylation and hence preventing replication initiation174,175. UV light, and UV-
mimetic compounds, cause DNA damage which is recognised by ATR, leading to 
Chk1 and Cdc25 phosphorylation-mediated arrest in G1. Regardless of which 
pathway initiates the arrest, p53 is crucial for the maintenance of the G1/S arrest 
which occurs several hours after DNA damage detection175. During this period, p53 
becomes phosphorylated on ser15 and ser20, by Chk2 and Chk1 respectively, 
preventing its export from the nucleus and activating target genes including p21 
(inhibiting Cdk2-cyclin E S-phase progression)176,177. Inhibition of transition to S-
phase is also prevented by p21 binding to Cdk4-cyclin D, preventing Rb 
phosphorylation which in turn inhibits E2F transcription factor-activation of S-phase 
genes178. 
Importantly, the G1/S checkpoint is activated precipitously in response to excision 
repair processing cascades. In yeast, this has been shown in cells which are 
deficient in excision repair exhibiting no S-phase entry delay following UV 
radiation178. Interestingly, checkpoint activation occurs in these cells once they are 
in S-phase, perhaps as a result of UV-induced photoproducts causing replication 
blockade. The G1/S checkpoint is therefore critical for limiting the proliferation of 
aneuploid cells. 
The main signal transducers which promote this response are ATM and p53 – ATM 
activates p53 leading to cell-cycle arrest and subsequently p53-mediated apoptosis. 
This has been validated in vivo with p53 and ataxia-telangiectasia mutated kinase 
(ATM) -null mice which develop thymic lymphomas with high levels of aneuploidy179. 
Importantly these tumours exhibited elevated ROS, characteristic of aneuploid cells. 
In these cells, ROS-induced oxidative DNA damage is thought to contribute to the 
activation of ATM which prompted the speculation of an ‘aneuploidy checkpoint’180. 
It is known that p53 is one of the most commonly mutated genes in cancer, with p53-
/- tumours exhibiting high levels of aneuploidy and chromosomal instability181. It is 
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still controversial whether p53 loss is required for the proliferation of aneuploid cells. 
For example, in aneuploid embryonic kidney cells, many rounds of cell division occur 
before embryonic lethality despite wild-type p53 and some tumours exhibit 
aneuploidy before p53 loss182. It is possible that these tumours have impaired 
signalling either upstream or downstream of p53 which may impair the G1/S 
checkpoint. This is seen is some tumours where overexpression of MDM2 (a p53 
antagonist) or down-regulation of p53 activators (such as the hyper-methylation of 
the p14ARF promoter) proceeds tumourigenesis183.   
Damage which is left unrepaired and manages to evade the G1/S checkpoint, or 
encountered during S-phase, leads to activation of the S-phase checkpoint184. The 
mechanisms underlying this checkpoint are still not fully resolved, however it is 
known that ubiquitinylation or sequestration (by p21) of PCNA may significantly slow 
the speed of replication fork progression185. The main body of data so far suggests 
that the predominant mechanism of the S-phase checkpoint is late origin of 
replication (LOR) firing suppression186. Unsurprisingly for such an essential 
checkpoint, it involves the cooperation of a large number of sensor and effector 
proteins. 
When the insult is a double-strand break, BRCA1 and ATM initiate a kinase signal 
cascade which can proceed by either of two mechanisms – the classical ATM-Chk2 
described above, and the phosphorylation of SMC1187,188. DNA insults by UV 
radiation activate the ATR-ATRIP heterodimer. Functionally, ATR is able to bind to 
RPA-coated single-stranded DNA, UV-induced lesions and directly to 
chromatin189,190. Recent data from work in Xenopus egg extracts has shown that 
Cdc7-Dbf4 kinase activity, required for Cdc25a licensing on to DNA, is 
downregulated following Chk1 phosphorylation by ATR191. 
Similarly to the ATM pathway, the ATR pathway is also able to promote replication 
fork recovery after DNA correction mechanisms by phospho-activation of BRCA1. 
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Work in yeast has demonstrated that replication fork arrest can be initiated by the 
presence of lesions in replicating DNA192. The recovery of such regions is dependent 
on the activity of the recombination proteins MUS81 and Rad51193. Mutant yeast 
strains in which these genes have been knocked out, or disrupted, accumulate lethal 
double-stranded DNA breaks with long single-stranded intermediates194,195. The 
occurrence of these breaks is not random in the genome, certain areas are more 
susceptible than others. For example, in human cells, ATR depletion is known to 
cause breaks in regions of the genome that replicate slower than others – known as 
fragile sites196. 
The G2/M boundary is the final fail-safe guarding cells from entering mitosis with 
damaged DNA. If damage is detected, either ATR-Chk1 or ATM-Chk2 signalling 
cascades arrest cells in G2, however the maintenance of arrest is predominantly by 
ATM-Chk2197. Cells are prevented from entering mitosis by the down-regulation of 
Cdc25 which modulates Cdc2-Cyclin B activity164.  Early experiments interrogated 
Cdc25C-knockout mutant mice strains, revealing that Cdc25C is not essential for 
checkpoint activation. Rather, the phosphatase activity of Cdc25A was shown to be 
essential for G2/M checkpoint activation following ionising radiation (IR)198. In 









Figure 1.3. Cell cycle checkpoints and regulation. The cell cycle is regulated by 
a network of signalling cascades, which maintains genome fidelity. Progression 
through each of the four phases (G1, S, G2 and M) is controlled by cyclins and cyclin-
dependent kinases (CDKs). Errors occurring during DNA replication at S-phase, or 
exogenous DNA damage accumulating throughout the cell cycle, restrict entry into 








1.2.2. Replication stress 
 
Replication of eukaryotic DNA is initiated from many origins, which are each 
'licensed' by proteins which signal the start of S-phase201–204. The timing of 
replication at each origin is carefully orchestrated to ensure that nucleic acid 
resources, the accuracy and the speed are replication are balanced appropriately. 
There are many factors which can impede DNA synthesis, leading to the slowing, 
stalling and collapsing of replication forks – this is known as replication stress205–
207. Replication stress can be thought of as a specialised form of DNA damage which 
has profound implication for genomic stability and cell survival. Unsurprisingly then, 
there are effector kinases that are shared between both replication stress and DNA 
damage pathways; the main sensors and effectors of replication stress being ATM 
and ATR208–210. Replication stress is rather unusual, compared to direct DNA 
damage, in the sense that the major underlying causes appear to be endogenous. 
 
1.2.2.1. Replication-transcription collisions  
 
The machinery for both transcription and replication operate on 
DNA simultaneously. Recent data has identified regions of the genome which are 
highly transcribed, particularly susceptible to double-strand breaks 
and replicated during early S-phase211. These are known as 'early replication fragile 
sites', and highlight the importance of collisions between protein complexes on DNA 
with separate agendas. It has been shown that, in some cases, DSBs can occur 
even before the convergence of the replication-transcription machinery at the 
nuclear periphery. This phenotype is surprising at it reveals that replication stress 
might be increased by the tethering of actively-transcribed genes to nuclear pore 
complexes212. The sequence of DNA itself may also determine its fragility to 
replication stress. For example: nascent RNA transcripts with particular AT/GC 
content have a propensity to form R-loop structures by re-hybridising with DNA 
emerging from behind the transcription complex, leading to polymerase stalling and 
50 
 
the replication fork collapsing213. Alternatively, if there is insufficient RNA-processing 
capacity at certain sites then this may inhibit dissociation of the replication complex 
from DNA, indirectly causing replication stress. To avoid these situations, human 
cells have the capacity to resolve R-loops by helicase and topoisomerase activity 
together with RNA-processing complexes that serve to prevent RNA from re-
annealing with DNA214,215.  
 
1.2.2.2. Restarting at collapsed forks 
 
If replication stress persists, or replication stress response pathways are abrogated, 
the fork may collapse. Recent data in mice and yeast suggest that ATR is crucial in 
restarting collapsed forks by recruiting and stabilising replication machinery in 
addition to preventing 'replisome' disengagement216,217. It has been shown that DNA 
breaks can occur following the collapse of a replication fork. Interestingly, treatment 
of human cells with fork-stalling agents leads to the presence of detectable breaks 
as early as four hours after fork collapse218. If the ATR pathway is abrogated in these 
cells, activation of DNA-PK and ATM are rapidly recruited to DSBs which may 
functionally compensate for ATR’s absence219. 
It is thought that double strand breaks occur at collapsed forks as a result of 
endonuclease attack on persistent ssDNA or nucleotide gaps behind the fork194. 
Alternatively, the cell may be in a futile effort to correct stalled fork structures by 
initiating recombination or endonucleolytic cleavage repair pathways218. Curiously, 
fork structure resolution occurs significantly more frequently in the absence of 
signalling by ATR. One possibility is that HR-mediated processing of cleaved 
nucleotides in the absence of ATR permits fork restart without a checkpoint 
response, which may lead to permanent stalling of the replication fork220. If a fork 
reverses inappropriately, nascent-synthesised DNA is prone to degradation; 
although more recent data also suggest that reversal may, paradoxically, promote 
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1.2.2.3. Replication stress in cancer 
 
The timing of DNA polymerase activity at replication origins is crucial. It has been 
shown that re-replication and unscheduled initiation at these origins in human cells 
is controlled by Cdt1221,222. Overexpression of Cdt1 is associated with epithelial 
cancers with high-incidence of replication fork collisions and DNA breaks; an 
observation which can be recapitulated by injection of premalignant CDT1-
overexpressing human cells into mice, generating genetically heterogeneous 
tumours223–225. Importantly, it has been shown that replication stress and impaired 
replication fork progression are present in human colorectal cancers (CRC) and are 
sufficient to promote chromosome missegregation, leading to aneuploidy226. 
Interestingly, this phenotype could be alleviated by supplementing chromosomally 
unstable colorectal cancer cells with nucleosides to suppress replication stress, 
suggesting that this mechanism plays a central role in maintaining the fidelity of the 
genome. This worked also demonstrated the existence of CIN-suppressor genes 
located on chromosome 18q which are subject to recurrent loss in CRC. Taken 
together these data provide evidence for a causal link between CIN and aneuploidy 
in vivo and show that there may be selective pressures for the generation and 
maintenance of discreet aneuploid karyotypes between tumour types. 
It has been shown that the ATR pathway is upregulated in several cancer types, and 
that overexpression of ATR can lead to aneuploidy227,228. This is important as it 
known that loss of ATR in p53 null cells, or cells with oncogene-induced replication 
stress undergo senescence or apoptosis229–231. Together these data suggest that 
cancer cells depend on ATR for the maintenance of a CIN phenotype, and that 
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targeting ATR therapeutically may provide a mechanism for selective cell death in 
CIN+ tumour cells232. 
 
1.2.3. The spindle assembly checkpoint 
 
The spindle assembly checkpoint (SAC) detects unattached kinetochores, and 
delays anaphase onset until all chromosomes are attached on the spindle233. The 
Achilles heel of this molecular switch is that merotelic attachments, single 
kinetochores attached to microtubules from both spindle poles, are not detected by 
the SAC and these chromosomes can become trapped at the spindle equator during 
anaphase. Some data show that most of these ‘lagging’ chromosomes are 
eventually segregated to the correct cell; however, a proportion do not and result in 
aneuploid progeny234,235.  There are many ways in which merotelic attachments can 
occur, and an elevated rate of merotelic attachments is a hallmark of CIN cancer 
cells236. The mitotic checkpoint complex (MCC) is responsible for this ‘wait 
anaphase’ signal and is comprised of a number of key proteins and signalling 
effector kinases including Mps1, MAD2, Bub1 and BUBR1. In mouse models of 
mosaic variegated aneuploidy, it has been shown that there is inactivation of 
BUBR1, demonstrating that disruption of MCC signalling is sufficient to disrupt 
faithful chromosome segregation237. However, the presence of MCC gene mutation 
in human cancers is rare and some data suggests that MCC gene methylation is a 
more common route to SAC disruption leading to CIN238,239.  
During the wait anaphase signal by the SAC/MCC, microtubule-kinetochore 
attachments are dynamically regulated by Aurora-B kinase which regulates 
microtubule turnover allowing merotelically attached kinetochores to be resolved 
before anaphase240. Aurora-B is also directly involved in the separation of duplicated 
centrosomes and, when overexpressed, centrosome amplification240. It has been 
shown that cancer cells cluster their extra centrosomes to form a pseudo-bipolar 
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spindle which permits bipolar cell division with an increased incidence of merotelic 
attachments and chromosome missegregation241,242.  Together with Aurora-B kinase 
there are two main microtubule depolymerising proteins, MCAK and KIF2B, which 
reside at the kinetochore and are involved with the correction of erroneous 
attachments. Experimental knockdown of MCAK has been shown to increase the 
frequency of lagging chromosomes, and it has been reported that MCAK inactivating 
mutations are present in CIN colorectal cancer243,244. Taken together, these data 
suggest that merotelic attachments can lead to aneuploid daughter cells and provide 
a mechanism for the continual karyotype shuffling observed in many cancers. 
 
1.2.4. Chromosome cohesion abnormalities 
 
The cohesin complex is a ring-like structure which holds sister chromatids together 
until the onset of anaphase. At the metaphase-anaphase transition, this complex 
must be removed allowing the separation of genetic material134,245. STAG2, the main 
structural subunit of the cohesin complex, has been shown to play a fundamental 
role in maintaining the stability of the genome272. The relationship between STAG2 
and chromosomal instability is complicated; in vitro knockdown of STAG2 in non-
CIN cancer cell lines is correlated with increased aneuploidy and decreased 
cohesin, while genome sequencing of acute myeloid leukaemia (AML) samples 
revealed that very few STAG2 mutations are coincident with CIN246. The disparity 
between these results may be explained by recent work demonstrating that STAG2-
dependent aneuploidy may be tissue specific, and likely to be linked to its secondary 






1.3. Cellular consequences of aneuploidy 
 
In general, the loss and gain of chromosomes has a detrimental effect on cellular 
fitness248,249. Studying the consequences of aneuploidy at the cellular level has 
remained challenging, in-part due to the lack of appropriate tools to study nascent 
aneuploid populations. Despite these challenges, important model systems have 
aided the understanding of the consequences of aneuploidy in yeast and 
mammalian cells; describing the impact of aneuploidy on: cell fitness, transcription, 
proteomic changes and genome stability250–254.  
 
1.3.1. Cell fitness and cell cycle changes 
 
It has been suggested that CIN may allow chromosomal combinations to arise in 
cancer cells which impact on drug sensitivity both in vitro and in vivo255,256. There are 
also reports that some complex karyotypes increase the drug-efflux capacity of 
cancer cells, providing such sub-clones with a proliferative advantage under strong 
chemotherapy pressure and a poor clinical prognosis257. On the other hand, 
stratifying breast cancer patients based on CIN status may help to predict sensitivity 
to taxane therapy, a mitotic spindle stabilising agent that pushes CIN+ cells towards 
cell death in mitosis or multinucleate apoptosis258. Paradoxically, these data 
demonstrate how CIN can both increase and decrease cellular fitness in a context-
dependent manner. 
The rates of cellular metabolism and timings of the cell cycle have been investigated 
in aneuploid cells. Using a chromosome transfer strategy, with selectable resistance 
markers, has allowed the study of single-chromosome aneuploidies in yeast259,260. It 
was found that all aneuploid cells proliferated significantly slower than isogenic 
euploid controls, with cell-cycle delays in G1 and increased sensitivity to drugs 
targeting protein folding. Interestingly, although G1 was delayed, only 2 out of 20 
55 
 
strains had a delayed metaphase-anaphase transition and 7 out of 20 had a delayed 
entry into mitosis. This may reflect the individual properties of each chromosome to 
illicit a particular phenotype, as G1 delay time largely correlated with the amount of 
extra DNA260. It was also found that Cln2, responsible for promoting entry into the 
cell cycle, was significantly delayed in aneuploid strains, suggesting that aneuploidy 
interferes with the G1-S transition upstream of Cln2 transcription.  
 
1.3.2. Genome stability 
 
Defining the relationship between genome stability, aneuploidy and their combined 
effect on tumourigenesis has remained challenging. This is because these states 
are difficult to test experimentally and, as such, there is an abundance of conflicting 
data in cell culture models, animal models and how these may explain clinical 
data236,261. Some human cells may have stable aneuploidies which result from a 
transient lapse in genome stability, resulting in daughter cells with an abnormal 
karyotype which are faithfully inherited over time262. It is more likely however, 
especially in cancer, that aneuploidy results from an underlying CIN phenotype 
where whole chromosomes, chromosome fragments, and chromosome 
recombination events frequently occur263. One of the greatest technical challenges 
is to test whether spontaneously arising aneuploidies in-turn generate progeny with 
an increased likelihood of further missegregating chromosomes, or if an underlying 
CIN phenotype was the cause of the initial missegregation event. 
It was first reported that cells with chromosomal instability were able to escape 
mitotic arrest following treatment with microtubule spindle poisons, leading to the 
suggestion that mitotic checkpoint attenuation was the underlying mechanistic basis 
of the CIN phenotype264,265. It was revealed a few years later however (by live-cell 
imaging) that spindle toxins increase the duration of mitosis in CIN cells; and they 
do not enter anaphase with misaligned chromosomes suggesting that a weakened 
56 
 
mitotic checkpoint is not the primary driving force of CIN266,267. It was also found that 
CIN+ cells have elevated rates of lagging chromosomes at anaphase, indicating that 
unresolved mitotic spindle defects might by an important mechanism by which CIN 
and aneuploidy occur in human tumour cells. 
To address whether aneuploid human cells are more vulnerable to further 
chromosome missegregation and genomic instability, lymphocytes from individuals 
with trisomies 13, 18 and 21 were isolated and chemically stimulated to proliferate 
ex vivo268. By analysing chromosome copy number using fluorescent centromere 
probes, it was found that trisomic individuals had a two-fold higher incidence of 
chromosome copy number alterations (CNA) than diploid individuals. Similar 
analysis of cells from patients with Turner syndrome (monosomy X) revealed that 
established monosomic cells are more than two-fold more likely to missegregate any 
of the autosomes investigated269. This suggests that spontaneous chromosome 
missegregation in human cells may be sufficient to generate CIN in cells with an 
otherwise stable karyotype. 
These results have important implications for cancer initiation, as the loss of a 
tumour suppressor-rich chromosome, or gain of a chromosome harbouring 
oncogenes, may be sufficient to alter the mechanisms which regulate proliferation 
and induce CIN, simultaneously.  
 
1.3.3. Transcriptional and proteomic reprogramming 
 
From work in yeast it has been shown that expression of genes on aneuploid 
chromosomes is largely proportional to gene copy number260. Interestingly, 
aneuploid yeast strains also share a common gene expression signature, originally 
identified as a possible ‘environmental stress response’ which upregulates genes 
related to nucleic acid metabolism and ribosomal biogenesis270. This response 
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appears to be evolutionarily conserved across plants, yeast mice and humans, 
although the cause, nature and mechanism remain unclear254. In human cells, the 
presence of an extra chromosome has been shown to upregulate pathways involved 
with energy metabolism and autophagy, and causes down-regulation of DNA and 
RNA synthesis pathways251. Recent work has used a novel strategy to silence the 
extra copy of chromosome 21 in cells from Down syndrome patients271. It was 
demonstrated that genetic insertion of the X-inactivation gene on chromosome 21 
could promote transcription repression through similar mechanisms as for the 
inactive X chromosomes in females. Silencing of the one extra copy of chromosome 
21 by this method resulted in an 18-34 % increase in cell growth rate, suggesting 
that transcription is partly responsible for the compromised proliferation rate of 
aneuploid human cells. Importantly, chromosome silencing did not rescue 
proliferation to wild type levels, reflecting the multifactorial response to trisomy and 
that extra DNA alone, regardless of transcriptional state, may be sufficient to slow 
cellular growth. If there is an aneuploidy-sensing mechanism hard-wired into cells 
that regulates transcription, it raises the exciting possibility that it can be exploited 
therapeutically to target tumour cells whilst sparing healthy diploid cells. 
The correlation between transcription and the proteome in aneuploid cells is unclear. 
Although gene expression is proportional to gene copy number, it has been shown 
that many proteins encoded by additional chromosomes do not scale in the same 
manner260. Importantly, many of the proteins that do not are part of larger multi-
protein complexes, suggesting that protein stoichiometry imbalances may be 
influencing the proteolytic pathways in aneuploid cells251. This is an attractive 
hypothesis as it fits with the data demonstrating that aneuploid cells have a higher 
energetic demand, possibly due to the synthesis and degradation of superfluous 




More recently, proteomic dosage compensation has been observed in human cells 
in response to trisomy and tetrasomy, and post-translational mechanisms have been 
shown to further self-attenuate protein expression when the genes encoding them 
are present in excess250,251. This proteomic analysis further revealed the existence 
of a novel aneuploidy-related proteomic signature which is characteristic of redox 
homeostasis and altered metabolism, which could be alleviated by increasing 
protein turnover. 
These results demonstrate that aneuploidy is sufficient to alter the metabolism and 
redox state of human cells which is subject to a negative feedback loop by both post-
transcriptional and post-translational mechanisms. Both of these are important 
factors which increase the energetic burden in cells with abnormal karyotypes. 
 
1.3.4. Aneuploidy tolerance 
 
Human neurons and hepatocytes are known to harbour non-diploid chromosome 
complements271,273. Surprisingly, where they do arise, these aneuploidies do not 
appear to be deleterious to cellular function, and are not thought to predispose to 
tumourigenesis274. The mechanisms which allow some cell types to tolerate 
aneuploidy are currently unknown, and careful comparison with non-quiescent cells 
may reveal important transcriptional/proteomic reprogramming which occurs during 
cancer development and confers similar tolerance to a non-diploid genome.  
There are thought to be numerous ways that cells can buffer the deleterious effects 
of aneuploidy. One hypothesis is that polyploidy, the entire genome present in 
multiple copies, may dilute the protein stoichiometric imbalances of a single extra 
chromosome302. It has been shown that there may be a strong selective pressure 
for this phenotype during tumour evolution, as many cancer types have a near 
tetraploid karyotype275,276. Further evidence of the need for superfluous-protein 
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regulation as a prerequisite to aneuploidy tolerance has been demonstrated by 
inactivation of UBP6305. UBP6 is a deubiquitinylating enzyme which regulates the 
activity of the proteasome. When UBP6 is inactivated, proteasomal turnover of 
proteins is accelerated and provides aneuploid yeast strains with a mechanism for 
reducing the proteotoxic effect of uncomplexed cytosolic proteins277,278. Upregulation 
of the proteasome by this mechanism was shown to be strongly correlated with 
increased aneuploid yeast proliferation rates. It has yet to be determined whether 
phenotypically-equivalent mutations are present in human cancers cells, and the 
subsequent impact this may have on proliferative capacity. 
The integrity of DNA and progression of the cell cycle are tightly controlled by 
regulatory pathways which provide feedback to p53, a key cell cycle regulator. 
Aberrations which compromise any part of these processes ultimately lead to p53-
dependent cell cycle arrest or delays, and it has been shown that this is also true for 
aneuploid cells180,267,279,280. Accordingly, it is unsurprising that p53 inactivation is a 
common occurrence in human cancers, acting as a driver of tumourigenesis and 
strongly correlated with a poor clinical outcome279. Interestingly, it has been shown 
that p53 mutations can act synergistically with progesterone, but not estrogen, 
stimulation to significantally increase chromosomal instability and aneuploidy in 
mammary epithelial cells281. Importantly, this reveals the existence of tumour 
microenvironment-specific differences in tumour suppressor inactivation and extent 







1.4. The Aneuploidy-CIN relationship in cancer  
 
Despite widespread aneuploidy in human cancers, there is little consensus on the 
exact role aneuploidy and chromosomal instability play in tumour development and 
progression. Much of the in vivo work to study chromosomal abnormalities has relied 
on mouse models with a spectrum of abnormalities in the key cell cycle checkpoints 
described above. The reliability and similarity to human carcinogenesis in these 
models is a topic of debate but have revealed that, somewhat paradoxically, 
aneuploidy and chromosomal instability can both promote and inhibit 
tumourigenesis256,282–284. The ubiquitous nature of aneuploidy across almost all 
cancer types is starting to be recognised as an important therapeutic target and is 
an active area of research. 
 
1.4.1. Promoting tumourigenesis 
 
It has been shown that mitotic checkpoint dysfunction, by overexpression of genes 
regulating the checkpoint, can lead to aneuploidy. Importantly, this is also true in 
human cancers, where overexpression of spindle assembly checkpoint genes 
occurs more frequently than their inactivation285. Experimentally, it has been shown 
that overexpression of mitotic check-point complex (MCC) protein MAD2 produces 
aneuploid tumours in various tissues including hepatomas, adenomas and, in some 
cases, intestinal tumours286,287. Interestingly, transient MAD2 overexpression is 
sufficient to promote tumour formation, suggesting that sustained mitotic checkpoint 
abnormalities are not a prerequisite for this phenotype314. Importantly, this may 
reflect the nature of aneuploid cells to perpetuate their own transformation through 
increased chromosomal instability. It has also been observed that the degree of 
overexpression of the outer-kinetochore protein HEC1 is correlated with the 
formation of aneuploid tumours in mice, and is a poor prognostic indicator in human 
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cancers288. These data suggest that there is a strong mechanistic relationship 
between cells with abnormal microtubule-kinetochore attachments, CIN and 
aneuploidy in vivo.  
It has been demonstrated, through the analysis of array-based comparative genomic 
hybridisation (aCGH) and cytogenetics, that solid tumours show preferential loss of 
small chromosomes289. It is also reported that patients with chronic myeloid 
leukaemia have a significantly elevated rate of small chromosome gain; raising the 
possibility that the tumour microenvironment plays an important role in the 
propensity for different aneuploidies between malignancy types290. The most 
common aneuploidies in human gametes include chromosomes 21, 22, X and Y in 
sperm cells and chromosomes 16, 21 and 22 in oocytes291–293. Interestingly these 
also occur most frequently during early-stage astrocytomagenesis, potentially 
reflecting the nature of solid tumour cells to spontaneously lose small chromosomes, 
independent of oncogenic potential289. 
The recurrent gain of specific chromosomes in tumour cells supports the hypothesis 
that the loss of tumour suppressor genes, or the gain of oncogenes, through CIN 
mechanisms facilitates oncogenesis. For example, individuals with Down’s 
syndrome (trisomy 21) are at a significantly higher risk of developing acute myeloid 
leukaemia and acute lymphoblastic leukaemia294,295. This is compounded by the 
observation that an extra copy of chromosome 21 is often present in haematological 
cancers, suggesting there may be a context-dependent selective pressure for 
cancer cells with discrete karyotypes235. Additionally it has also been shown that 
chromosomal instability, as a result of replication stress, can lead to the recurrent 
loss of three tumour suppressors on chromosome 18q, providing a putative 
mechanism which could drive CIN in colorectal cancers226. Taken together these 




1.4.2. Inhibiting tumourigenesis 
 
Having established that the majority of aneuploidy and CIN phenotypes are 
tumorigenic, it is important to highlight that they can also inhibit tumour formation in 
a highly context-dependent manner256,296,297. It has been shown that inducing 
excessive CIN by treatment with spindle poisons leads to cell death following a gross 
aneuploidy phenotype, but the presence of CIN in cancer suggests there may be an 
optimal level of genome instability which is sufficient for tumour progression, without 
catastrophic genomic dysfunction298. 
Accordingly, it has recently been shown that the stratification of breast cancer 
patients on their ‘CIN score’ correlated with a poor prognosis; that is until a threshold 
of CIN was reached after which increasing genome instability correlated with 
increased survival outcome255. This suggests that aneuploidy and chromosomal 
instability are only tumourigenic within given limits, and raises the possibility that 
raising CIN beyond this threshold could be a novel therapeutic approach.  
Returning to the example of trisomy 21, it is important to note that although there is 
a significant increased risk of leukemias, the incidence of solid tumours is markedly 
decreased299. These inhibitory effects have been investigated and reported linked to 
two key genes encoded on chromosome 21: DYRK1A and DSCR1. Although the 
underlying mechanism has not been fully elucidated, it is known that these genes 
are involved with the inhibition of the calci-neurin pathway of tumour 
angiogenesis300.  
It has also been reported that aneuploidy can inhibit tumourigenesis in tissues which 
are already prone to tumour formation, such as the liver301. By heterozygous deletion 
of one allele of CENP-E, a centromere protein important for chromosome 
congression, it was observed that the formation of spontaneous liver tumours was 
decreased by 50%301. Additionally it was also observed that when liver tumours did 
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occur in CENP-E+/- mice they were significantly reduced in volume, suggesting that 
mitotic dysfunction in cells with an inherent propensity to missegregate 
chromosomes can act as a tumour suppressive mechanism.  
 
1.4.3. Aneuploidy as a therapeutic target 
 
Therapeutic targeting of aneuploid human cells, whilst sparing diploid cells, is a very 
active research area with high impact potential. Many of the current compounds 
exploit the perturbed processes of metabolism and protein production in aneuploid 
cells ultimately leading to cell death and arrest through uncharacterised 
mechanisms. One such molecule is 17-AAG, an inhibitor of the protein-folding 
chaperone Hsp90 which associates with the endoplasmic reticulum272. Reducing the 
protein folding capacity of aneuploid cells that are already under proteotoxic stress 
is hypothesised to lead to AMP-mediated cell death. Further supporting this model, 
combination therapy of 17-AAG and AICAR, an energy stress-inducing compound, 
in trisomic mouse embryonic fibroblasts and human cell lines significantly reduced 
their proliferation compared to diploid control cells272. However it has been shown 
recently that these compounds are associated with unacceptably high side-effects 
in phase II clinical trials, but provide preliminary evidence that it is possible to target 
aneuploid cells specifically with small molecules302,303.  
More recently, the idea of targeting CIN cells specifically has been suggested. 
Cancer cells have been shown to cluster extra centrosomes to allow a pseudobipolar 
mitosis with increased incidence of merotelic attachments241. In the absence of a 
pseudobipolar spindle, cells proceed through mitosis with multipolar spindles 
leading to cell death304. An RNAi screen identified HSET, a kinesin motor protein 
involved in microtubule trafficking, as an important effector protein for extra 
centrosome clustering. Importantly, it has been shown that HSET is expendable in 
normal cells, possibly because there is some functional overlap with other kinesin 
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motor proteins, suggesting it may be possible to induce cell death in cells with extra 

































1.5. Methods for detecting aneuploidy   
 
Experimental technologies for investigating aneuploidy can be broadly grouped into 
those which measure aneuploidy on a population-wide basis and those which give 
single-cell resolution. One critical consideration for any technique is the over or 
under estimation of aneuploidy rates due to the introduction of experimental 
artefacts during sample preparation and analysis.  More recent approaches have 
tried to improve on legacy techniques by coupling high-throughput, population-
based analysis with single-cell resolution. Here I discuss the advantages and 
disadvantages of the most widely used karyotype analysis techniques to detect 
aneuploidies in human cells.  
 
1.5.1. Comparative genomic hybridisation 
 
Comparative genomic hybridisation (CGH) technologies are microarray-based 
sequencing platforms which were developed to assess genomic aberrations in 
cancer307,308. The development of array-CGH (αCGH) permitted, for the first time, 
DNA copy number alterations to be correlated with population-wide chromosome 
abnormalities thus transforming clinical cytogenetics. In traditional αCGH, genomic 
DNA from a reference genome and the sample of interest are differentially 
hybridised with two fluorescent probes which competitively bind to nucleic acid 
targets immobilised on a solid support309. The amount of DNA hybridised to each 
array position, expressed as a log2 ratio of fluorescent signal relative to the reference 
genome, correlates with the ploidy of that particular genetic locus. There are two 
main factors which determine the resolution of αCGH array – the density of genome 
coverage and the size of the nucleic acid target. The most apparent benefit to using 
αCGH over traditional FISH is that one is able to detect multiple DNA copy number 
alterations simultaneously across the genome. These changes include 
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amplifications, deletions and duplications at any locus represented on the array. In 
this way, αCGH can be thought of as a concurrent and coordinated FISH experiment 
over thousands of loci, compared to traditional FISH which is limited by the 
availability of fluorophores which can visualised simultaneously310.   
Aneuploidy, in the broadest sense, encompasses both structural and numerical 
chromosome aberrations. Therefore, as αCGH is based exclusively on DNA 
hybridisation, it is unable to detect structural abnormalities such as inversions or 
reciprocal translocations as these are not reflected by chromosomal content. 
Additionally, only copy number changes which are present in the majority of the 
population, and therefore above the intrinsic noise of the analysis, will be detectable 
with αCGH311.  These make αCGH unsuitable where subtle structural and numerical 
aneuploidies are to be detected. 
 
1.5.3. Single-cell sequencing 
 
The rapid development of next-generation sequencing has significantally reduced 
the cost and time to obtain a complete genome DNA sequence. This has realised 
the possibility of sequencing individual cells and detecting aneuploidies on a cell-by-
cell basis. This has already been demonstrated for both mouse and human tissue 
samples from the brain, liver and skin312. A critical step in single-cell sequencing 
(SGS) is isolating and amplifying target DNA from individual cells. The isolation of 
single cells can be achieved through FACS, cell pickers or, more crudely, serial 
dilution. Preparation of the genomic library for sequencing begins with whole-
genome amplification (WGA), where DNA is fragmented and end-ligated to be 
amplified by PCR. Libraries from individual sequencing lanes can subsequently be 




The copy number variation (CNV) can be determined using a Hidden Markov model 
which determines the read copy number for each genomic loci in turn, generating a 
resolution that is equal to, or greater than, αCGH314. Importantly, determining faithful 
chromosome copy number does not depend on high resolution sequencing data, as 
only 0.5-1% DNA sequence coverage per cell is necessary. 
Single-cell sequencing is less subject to artefacts than traditional FISH as thousands 
of sequencing reads are analysed for each chromosome simultaneously, compared 
to a small number of loci by FISH315,316. Additionally, the preparation of the library 
and robotic fluidic systems can automate a large proportion of the wet lab work, 
further reducing costs. Unfortunately, although next-generation sequencing (NGS) 
is only a fraction of the former cost, it is still considered relatively expensive to 
sequence enough individual cells to obtain representative population aneuploidy 
rates, as a large number of single cells are required. Furthermore, it is not yet 
possible, at low coverage, to detect inversions and balanced translocations which 
precludes some usages, such as the study of chromothripsis317. It is also difficult to 
amplify and sequence such small quantities of DNA without significant risk of 
sequencing artefacts including GC bias during PCR amplification; although these 
can be mitigated using well-designed bioinformatic tools318. As NGS costs continue 
to drop precipitously, it is likely SCS will become a viable option for investigating 
clinical aneuploidy.  
 
1.5.4. Flow cytometry 
 
The use of flow cytometry to detect chromosome copy number has increased 
significantally in resolution in recent years and encompasses three broad 
applications: DNA profiling, population chromosome copy number and single cell 
chromosome copy number319–322.  
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DNA profiling is a term used to describe the intensity of fluorescent staining of DNA 
intercalating dyes, where the intensity of DNA staining is proportional to the DNA 
content of each cell (figure 1.4a). Its most common application is to determine the 
cell cycle profile of a population, where cells in G2/M have approximately double the 
fluorescence intensity of G1 cells. Cells in S-phase have a spectrum of DNA 
intercalation between these two peaks. It is therefore possible to determine an 
approximate value of the ploidy for a population of cells by comparing the DNA 
profile of a sample population to a known diploid population – cells with aberrant 
ploidy are shifted towards the higher end of the fluorescence spectrum. The data 
from these experiments only provide a rough approximation of ploidy for two 
reasons; firstly, the intercalation of DNA dye may be incomplete or dependent on 
the cell type, which could cloak or distort subpopulation of cells. Secondly, aneuploid 
cell populations may not be homogenous which gives rise to noisy DNA profiles with 
less sharp peaks, particularly in cycling cells where there are a large number of 
karyotype states or polyploidy which makes analysis difficult. 
The variation between chromosomes, with respect to size and base pair content 
ratio, lends favourably to interrogation with bivariate flow cytometry. Principally, 
chromosomes are stained with chromomycin A3, which specifically binds GC-rich 
DNA, and Hoechst 33258, with specificity for AT-rich DNA. These two dyes can be 
resolved by flow cytometry on naked human chromosome DNA, not only by DNA 
content, but by base pair ratio, which varies between each chromosome. 
Chromomycin and Hoechst have excitation maxima which are sufficiently separated 
that they can be excited by different lasers, however there is a considerable degree 
of overlap in emission spectra. It is for this reason that the only flow cytometry 
instruments capable of bivariate chromosome analysis have two spatially separated 
lasers required to obtain spatially separated emissions from each dye. 
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The primary drawback of flow cytometry is that a consequence of the specialised 
optical arrangement is a linear time delay between signals at the two detectors 
requires highly sensitive compensation electronics to correct the elliptical laser 
optics. Data output can be interpreted using a bivariate cluster algorithm, where 
aneuploidies in single chromosomes can be detected as an increase in dot-plot 
density in a given region (figure 1.4b)323. Chromosomes 9-12 are similar enough in 
their AT and GC ratios that they are not resolved using this method, which obscures 
aneuploidies of these chromosomes. Furthermore, bivariate chromosome analysis 
is not sensitive enough to determine small translocations and deletions324. However, 
larger structural chromosomal abnormalities may be visualised as a shift or 
separation in two dimensions on the plot.  
It has recently been shown that, using specialised image cytometry technologies 
coupled with FISH, it is possible to visualise chromosome copy number alterations 
in a high-throughput, single cell approach325. This is able to couple the high-
throughput requirements for population-based analysis with the resolution of single 
cell sequencing. I discuss the precise application of this technology in chapter 6 and 













Figure 1.4. DNA analysis by flow cytometry. (a) DAPI-stained populations of fixed 
cells fluoresce proportional to their DNA content. Cell cycle profiles can determine 
the proportion of cells at each stage of the cell cycle and detect polyploidy by 
comparison to diploid population. (b) Staining chromosomes with chromomycin and 
Hoechst can detect aneuploidy using bivariate chromosome flow analysis 
(illustrative data points). Aneuploidy can be detected as an increase in the staining 











1.5.5. Fluorescence in situ hybridisation 
 
Population-based studies of aneuploidy can be analysed in both dividing and non-
dividing cells by decorating the DNA with fluorescent probes and/or DNA 
intercalating agents. In simple metaphase preparations, stained only with 
intercalating agents such as Giemsa, it is possible to detect a number of large 
chromosome abnormalities including translocations, deletions, inversions, 
insertions, amplifications as well as whole chromosome copy number variations327–
329. Coupling DNA banding staining with fluorescent probes against individual 
genomic loci can help establish cytogenetic abnormalities with clinical phenotypes 
such as the BCR-ABL translocation t(9;22)(q34;q11)330.The use of a single probes 
to measure aneuploidy rates can introduce false positive and negative results if there 
are duplication or deletions events at the probe-binding region which necessitates, 
in some cases, the use of dual probes against subtly different regions of the same 
chromosome, which can be expensive.  
Additionally, the FISH procedure can introduce artefacts itself due to failure of probe 
hybridisation, probe clustering, or incomplete metaphase spreading331,332. FISH on 
interphase cells has the advantage of providing single cell copy number state and it 
is possible to couple this information with immunofluorescence to determine to 
down-stream spatial and temporal responses of aneuploidy with exquisite 
resolution.  
Whole-chromosome FISH paints permit spectral karyotyping analysis which reveal 
whole chromosome copy number changes and gross genome translocation 
events333–335. The process is moderately expensive as it requires the use of 
chromosome-specific chromosome paint sets with five fluorescent dyes, which 
barcode each chromosome in metaphase preparations. Importantly, both structural 
and numerical aberrations can be detected using this method, which lends itself to 
clinical applications where there are known disease drivers caused by chromosome 
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abnormalities. One important consideration for clinical oncology applications is the 
process of aneuploidy speciation over time, as heterogeneous sub-populations 
evolve in response to subtle microenvironmental pressures. 
The very nature of sampling size in populations of genetically diverse tumour 
samples therefore limits the probability that true aneuploidies are represented 


























2. Aims and objectives 
 
Develop a novel system to isolate nascent aneuploid cells 
The earliest responses to chromosome missegregation in non-transformed cells are 
largely unknown. In-part, this is due to technical limitations preventing the isolation 
of cells within the few hours following chromosome loss. The first aim of this PhD 
was to generate a novel, fluorescence-based aneuploidy reporter cell line to isolate 
nascent aneuploid cells. Analysis of monosomic populations isolated using this 
approach aimed to expose changes at the level of the transcriptome in response to 
aneuploidy, within 12 hours of chromosome loss. 
Determine the missegregation rates of individual chromosomes 
A ubiquitous feature of cancer cells is elevated chromosome missegregation and 
recurrent patterns of aneuploidy. The second aim of this PhD was to undertake the 
first high-throughput and systematic approach to elucidate the missegregation rates 
of individual human chromosomes in response to different cellular stresses. Further, 
this PhD aimed to characterise the mechanisms underlying the most striking 
differences between individual chromosome segregation error rates. 
 
Elucidate the arrangement of metaphase chromosomes 
The well-defined territories of interphase chromatin are intimately linked with 
ordinary function. At present, the only data for metaphase territories are derived from 
radial measurements in metaphase spreads, which are subject to significant 
artefacts. The final aim of this PhD was therefore to develop an image analysis tool 






















3.1. Tissue Culture Assays 
 
3.1.1. Reagents and cell culture 
 
All cells were maintained in sterile conditions at 37 ºC with 5% atmospheric CO2. 
Cell culture media was supplemented with 10% (v/v) foetal bovine serum (FBS; 
Gibco) and 1% (v/v) penicillin-streptomycin (Sigma). Cell lines were selected which 
had previously been characterised as chromosomally stable (table 3.1). 
Cell lines were grown as adherent monolayers and passaged through trypsinisation. 
To trypsinise cells, media was removed by aspiration and cells were carefully 
washed twice in phosphate-buffered saline solution (PBS) at room temperature for 
30 seconds. PBS was removed and 1x trypsin-EDTA (Sigma) was incubated with 
cells at 37ºC until cells had detached from the surface of the culture vessel. Cells 
were fully resuspended in at least five times the volume of trypsin in appropriate 
media supplemented with FBS - to inhibit the trypsin enzyme. Cells taken from this 
suspension were used to seed new culture vessels, containing fresh media, at the 












Table 3.1. A panel of transformed and non-transformed human cell lines. The 
panel of human cell lines used for the experiments in this thesis covered both 
transformed and non-transformed cell types from a range of tissues of origin. The 












Cell line Media Cell type CIN status 
RPE-1 hTERT DMEM – F12 retinal pigment epithelial negative336,337 
RPE-1 hTERT 
12/3 
DMEM – F12 retinal pigment epithelial positive336 
HCT116 DMEM colorectal carcinoma negative336,337 
DLD1 DMEM colorectal adenocarcinoma negative338 
BJ hTERT DMEM foreskin fibroblast negative339 
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3.1.2. Plasmid transfections 
 
Adherent cell monolayers in 6-well dishes were grown to approximately 60 % 
confluence for transfection. 6 µL Lipofectamine 2000 reagent (Life Technologies) 
was diluted in 150 µL Opti-MEM reagent (Life Technologies) and added in a 1:1 ratio 
with the required amount of plasmid DNA diluted in 700 µL Opti-MEM reagent. 
Following incubation for five minutes at room temperature, 250 µL of the DNA-lipid 
complex solution was added, drop-wise, to the surface of the media in each 
transfection well. After 24 hours, the media was replaced and cells grown for a 
further 24 hours. For stable cell line generation, transfected cells were passaged at 
low density into culture vessels supplemented with media containing G418 at a final 
concentration of 500 µg/mL (Sigma) to select for drug-resistant clones. The selection 
media in each well was replaced every three days for two weeks, after which time 
drug-resistant colonies had formed and were harvested for down-stream 
applications. 
 
3.1.3. Small-molecule perturbation of the cell cycle 
 
Nocodazole is a microtubule depolymerising drug which arrests cells in mitosis as 
they are unable to form a functional mitotic spindle. To arrest cells in mitosis, and to 
induce chromosome missegregation, cells were treated with 100 nM nocodazole 
(Sigma) dissolved in dimethyl sulfoxide (DMSO) for between 2 hours and 16 hours. 
To allow microtubule re-polymerisation, nocodazole was washed out of cells by 
completely replacing the media three times with PBS pre-warmed to 37 ºC for two 
minutes each, followed by fresh media pre-warmed to 37 ºC, twice. Cells were 
released from nocodazole for up to 24 hours to allow cells to proceed through 
mitosis. A variation of this protocol includes the physical removal of mitotic cells from 
the culture vessel by mitotic shake-off. Dislodgement of mitotic cells into suspension 
is achieved by gentle shaking of the culture vessel. To release mitotic cells from 
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nocodazole, mitotic cells in suspension following shake-off were harvested by 
centrifugation at 1,200 rpm for three minutes. The supernatant was aspirated and 
cells were resuspended in the appropriate media pre-warmed to 37 ºC, twice. 
To synchronise cells at the G2/M check-point, cells were treated with the CDK1 
inhibitor RO-3306, dissolved in deionised water, for 14 hours at a final concentration 
of 9 µM.  To allow cells to proceed through the mitotic checkpoint, RO-3306 was 
washed out of cells by completely replacing the media three times with PBS pre-
warmed to 37 ºC for two minutes each, followed by fresh media pre-warmed to 37 
ºC, twice.  In experiments requiring cells synchronisation prior to nocodazole 
treatment, the final media wash contained 100 µM nocodazole. 
 
3.1.4. Colony formation assay 
 
Single cells sorted by FACS were counted in experimental triplicate using a 
haemocytometer (BioRad) and 100 cells from each condition were seeded into 6-
well dishes from triplicate experiments and allowed to form colonies over a period of 
10 days. After 10 days the number of colonies in each well were counted as follows. 
Colonies were stained with 5 mL 0.01 % (w/v) Crystal Violet in deionised water for 
one hour at room temperature on a rocker. Excess dye was removed and colonies 
were dissolved in 1 mL 2 % (w/v) Triton X-100 for a minimum of 16 hours with 
agitation. The optical density (OD) of 200 µL crystal violet-stained cell suspension 







3.2. Fluorescence Microscopy 
 
3.2.1. Live-cell imaging 
 
Cells expressing a fluorescent histone H2B variant (H2B-RFP/GFP) were seeded 
into live-cell imaging dishes at low density at least two days prior to filming, mounted 
on an Olympus DeltaVision microscope (Applied Precision) and maintained at 37 ºC 
in CO2-independent medium (L15, Sigma) for the duration of the experiment. 
Additionally, the DeltaVision stage environment was maintained at 5 % CO2. 
Proliferating cells were imaged by acquiring seven 2.0µm optical sections in the Z-
axis, with TRITC laser line band-pass filter (488/532 nm), at three-minute intervals 
for three hours, followed by 15-minute intervals for between 24 and 72 hours. Movies 
were analysed in the softWoRx Explorer 1.3 (Applied Precision). The timing of 
mitotic events was determined by analysis of cells going through mitosis during the 
three-minute time-lapse filming, to allow precise timings to be obtained. Nuclear 
envelope break-down, congression of the last chromosome and anaphase onset 
were easily identifiable at this temporal resolution. The fate of daughter cells was 




Cells were seeded onto microscopy coverslips were treated with 9 µM RO-3306 
(Santa-Cruz) and/or 100 µM nocodazole (Sigma). After treatment, cells were 
washed once with 1x PBS, fixed and permeabilised with PTEMF solution (20 mM 
PIPES pH 6.8, 0.2 %, Triton X-100, 10 mM EGTA, 1 mM MgCl2 and 4 % 
formaldehyde) for 10 minutes at room temperature. Fixed cells were blocked for 30 
minutes in PBS + 3 % BSA, washed twice in 1x PBS (5 minutes, room temperature) 
and stored in 1x PBS at 4 ºC for at least two hours and up to two weeks before 
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immunostaining. For immunostaining, cells were incubated for one hour at room 
temperature in the appropriate primary antibody diluted in 1x PBS. 
Following primary antibody staining, cells were washed three times with 1x PBS for 
five minutes each. Primary antibodies were detected by appropriate FITC/ TRITC/ 
Cy5-conjugated secondary antibodies (Life Technologies) for 30 minutes at room 
temperature, diluted in 1x PBS containing 1 µg/mL DAPI, followed by three five-
minute washes with 1x PBS. Coverslips were mounted on glass microscopy slides 
in Vectashield (Vector laboratories). 3D fluorescent image stacks were acquired on 
an Olympus DeltaVision microscope in 0.2 µm steps, using the Olympus 20x, 40x, 
















3.3. Construction of a mammalian dsEGFP expression 
vector  
 
3.3.1. Amplification of pEGFP-C1 vector 
 
A pEGFP-C1-containing vector was obtained from a commercially available source 
(Addgene), as it had a suitable backbone for cloning into mammalian cell lines. The 
vector DNA was first amplified, for downs-stream applications, by transforming α-
Select Gold Efficiency competent cells (Bioline Reagents). Competent cells stored 
at -80 ºC were thawed on ice for 15 minutes before addition of 10 ng plasmid DNA 
was added to 50 µL of cells. Cells were incubated with plasmid DNA, on ice, for a 
further 15 minutes prior to heat-shock. Competent cells were heat-shocked by 
incubating at 42 ºC in a water bath, without agitation, for two minutes before being 
immediately plunged into ice for five minutes. For one hour, cells were incubated at 
37 ºC in a shaking incubator at a rate of 220 rpm in 350 µL of S.O.C medium to 
supressed catabolite production. Bacteria colonies were left to grow overnight at 37 
ºC on Luria-Bertani (LB)-agar plates containing 50 µg/mL kanamycin. Single 
colonies were picked, used to inoculate 50 mL LB broth plates containing 50 µg/mL 
kanamycin, and grown overnight in a shaking incubator at 37 ºC, 220 rpm. DNA of 
the correct size was confirmed by running approximately 200 ng of plasmid DNA, 
recovered from overnight bacterial cultures by the QIAprep Spin Miniprep (Qiagen), 
on a 1 % (w/v) agarose gel stained with gel red (Biotium), with a 1 kb ladder (NEB), 







Figure 3.1. Diagrammatic representation of the pEGFP-C1 plasmid. The 
pEGFP-C1 plasmid contains a regular EGFP report gene at the C-terminus of a 
multiple cloning site (MCS). NheI and NotI were used to remove EGFP and 
dephosphorylated to prevent plasmid self-ligation. An origin of replication (pBR322) 
and kanamycin resistance cassette (NTPII) enabled E.coli amplification, selection 








3.3.2. Cloning the dsEGFP gene into the pEGFP-C1 vector 
 
The dsEGFP gene donor (Addgene #56474) and pEGFP-C1 backbone plasmid 
DNA were digested with the restriction enzymes NheI-HF and NotI-HF in CutSmart-
4 buffer (NEB) for 1 hour to generate fragments with compatible ‘sticky’ ends. To 
prevent self-ligation, and therefore increase cloning efficiency, the pEGFP-C1 vector 
backbone was dephosphorylated with shrimp alkaline phosphatase in the supplied 
buffer (rSAP, NEB) for 30 minutes at 37 ºC, followed by enzyme inactivation at 65 
ºC for five minutes. A sample of the digested vector DNA, and the total volume of 
dsEGFP-donor DNA, were separated on a 1 % (w/v) agarose gel stained with gel 
red (Biotium), with a 1 kb ladder (NEB), for one hour in TBE at 80 volts. The vector 
digestion was confirmed by the presence of a linear DNA band at the expected size 
(3879 bp). The dsEGFP fragment (843 bp) was excised from the gel using a sharp 
blade over a UV box and purified using a Zymoclean Gel DNA Recovery kit (Zymo 
Research) and the recovered DNA concentration assessed by spectrophotometry 
(Nanodrop ND-1000). 
The vector backbone and dsEGFP plasmid DNA were incubated, at a molar ratio of 
3:1, in the presence of T4 DNA ligase in the appropriate buffer (NEB) overnight at 
16 ºC to allow the fragments to anneal and ligate. The resultant plasmid, pSMC50, 
was recovered following E.coli amplification, as described above, in bacterial media 







Figure 3.2. Diagrammatic representation of the dsEGFP-C1 plasmid. The 
dsEGFP-C1 plasmid contains an EGFP report gene with a mouse ornithine 
decarboxylase (MODC) domain at the C-terminus. An origin of replication (pBR322) 
and neomycin resistance cassette (NTPII) enabled transfected plasmid DNA 
expression and selection in human cells. High levels of expression were maintained 








3.4. Fluorescence in situ hybridisation 
 
3.4.1. Traditional fluorescence in situ hybridisation 
 
Cells were cultured on sterile glass microscopy slides until log-phase growth and 
fixed using freshly-prepared Carnoy’s fixative solution (3:1 methanol-glacial acetic 
acid) for 10 minutes at room temperature. For cells sorted by fluorescence-activated 
cell sorting, samples were harvested by centrifugation at 1,200rpm for three minutes 
and fixed with Carnoy’s fixative, in suspension for 10 minutes at room temperature, 
followed by settling onto glass slides. The fixative was allowed to evaporate and air-
dried slides were immersed in 2x SSC for two minutes, without agitation, at room 
temperature. Samples were dehydrated through an ethanol series for two minutes 
each (70 %, 80 % and 100 %) and allowed to dry. 
Each centromere enumeration probe (CEP, CytoCell) was equilibrated to room 
temperature for five minutes and uniformly mixed with a nuclease-free pipette tip. 
Solutions of complete hybridisation mixture consisted of 2µL of each probe and 
made up to a final volume of 10 µL with hybridisation solution B (CytoCell), briefly 
vortexed to mix, and pulsed in a microcentrifuge for 10 seconds. The probe mixture 
and sample slide were pre-warmed on a hotplate at 37 ºC for five minutes prior to 
hybridisation.  
The probe mixture was spotted onto the sample slides and carefully covered with a 
nuclease-free coverslip. The probe and sample were denatured simultaneously for 
two minutes 75 ºC. After two minutes, the samples were placed in a light-proof, 
humid container at 37 ºC for at least eight hours. Post-hybridisation, the coverslip 
was carefully removed and the samples immersed in 0.2x SSC at 72 ºC for one 
minute without agitation. The sample slide was drained and submerged in PBS with 
DAPI (1 µg/mL) for two minutes. Sample slides were allowed to air dry at room 
temperature. Slides were prepared for fluorescence microscopy by addition 10 µL 
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of anti-fade reagent (Vectashield, Vector Laboratories) and sealed with a nuclease-
free coverslip and non-aqueous fixative. 
 
3.4.2. Fluorescence in situ hybridisation in-suspension 
 
Cells in log-phase growth were treated with 100 µM nocodazole for eight hours and 
released following mitotic shake-off into fresh medium for 12 hours before analysis. 
Replication stress was induced by treatment with 0.2 µM aphidicolin for 24 hours. 
Cells from all experimental conditions were harvested, as previously described, and 
fixed by adding freshly-prepared 3:1 methanol-glacial acetic acid drop-wise to a 
pellet of PBS-washed cells. For hybridisation, cells were washed with 1x PBS with 
3% BSA twice for five minutes, pelleted, and resuspended in 0.05% Tween20 and 
2x Saline-sodium Citrate (SSC) in PBS. 1 x106 cells from this suspension were 
pelleted and the supernatant removed by pipetting. Cells were then resuspended in 
40µL of complete hybridisation mixture containing 28 µL hybridisation buffer, 10µL 
nuclease-free H2O and 2 µL CEP probe. Denaturing and probe hybridisation were 
performed in a thermocycler under the following conditions: 80 ºC (five minutes), 42 
ºC (9 to 16 hours) and an optional storage step of 4 ºC. Following hybridisation, 200 
µL of 2x SSC was added to each reaction mixture. Cells were pelleted and 
resuspended in 50 to 100 µL of 1x PBS before analysis (optional: DAPI, 1 µg/mL). 
All samples were analysed on the ImageStreamX cytometer by excitation with the 







3.4.3. Mitosis fluorescence in situ hybridisation 
 
3.4.3.1. Anaphase fluorescence in situ hybridisation 
 
Cells were treated with 100 µM nocodazole for eight hours. Following mitotic shake-
off, cells were pelleted and seeded onto glass microscopy slides pre-coated with 
poly-L-lysine. After 60 minutes, cells were incubated for 10 minutes at room 
temperature with freshly prepared fixative solution (3:1 methanol-glacial acetic acid). 
Fixed cells were hybridised with centromere-specific probes with, and without, all-
centromere probe according to manufacturer instructions (Cytocell), as previously 
described, and counter-stained with DAPI (1 µg/mL). For chromosome laggard 
rates, anaphase cells with lagging chromosomes were analysed from three 
independent experiments. Chromosome lagging rates were determined from the 
absolute number of CEP signals for specific chromosomes and the total number of 
chromosomes lagging in each anaphase judged by the all-centromere probe. 
 
3.4.3.2. Late prometaphase fluorescence in situ hybridisation 
 
Late prometaphase were identified by the presence of five or less uncongressed 
chromosomes 45 minutes post-nocodazole wash-out. Cells were analysed to 
determine the percentage of uncongressed chromosomes, split centromere rates 
and chromosome positioning in the metaphase plate. Uncongressed chromosome 
rates were determined from the total number of chromosomes uncongressed and 
the absolute number of CEP signals for specific chromosomes. The centromeres of 
individually stained sister-chromatid pairs were deemed to be ‘separated’ or ‘split’ if 
the centre of the two signals for each chromatid were greater than 2 µm apart, or 
were on opposing sides of the metaphase plate. The metaphase plate territory for 
individual chromosomes were interrogated by determining the distance of each 
sister chromatid pair from one end of the metaphase plate. Data were transformed 
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as a ratio of the distance from one end of the metaphase plate, to normalise for 
variation in metaphase plate length as a result of sample preparation.  Chromosome 
territories at metaphase were analysed by generating frequency histograms of each 




















3.5. Flow and Image Cytometry 
 
3.5.1. Fluorescence-activated cell sorting 
 
To sort RPE-1-4 cells by flow cytometry, a hierarchical gating strategy that measures 
parameters of each cell as it passes through the capillary-flow chamber was utilised. 
The first parameter identifies all cells, and is a readout of the total cell area, based 
on how much light is scattered from two lasers in the ‘forward’ (FSC) area and ‘side’ 
(SSC) area directions. Material below a threshold scatter of ~30,000-50,000 in both 
axes is determined to be debris and is excluded from the subsequent analysis and 
sorting. Of the ‘all cells’ population, doublet cells can be eliminated by plotting FSC-
A (area) against FSC-H (height). Cells with a high ratio of their total area against 
height are likely to be two cells together and are excluded. Single cells are identified 
from clumps of cells, which still satisfy the area to height ratio, by gating those with 
a low total area side-scatter (SCA-A) and a low total width side-scatter (SCA-W). 
 
3.5.2. Cell cycle analysis 
 
The DNA content of single cells was used to determine population-wide changes in 
progression through the cell cycle. The cell cycle phases can be determined by 
plotting a frequency histogram of the relative amount of DNA in each cell. In 
proliferating cells, the majority of the population will be in G1 and have a 2n DNA 
content that is visualised as the largest peak. Cells at various stages of S-phase, as 
the genome is being duplicated, will have an intermediate DNA content between 2n 
and 4n. Cells in G2 and mitosis, following S-phase, can be distinguished as a DNA 
content with a fluorescence value roughly twice that of the G1 peak. To prepare cells 
for cell cycle analysis, cells were fixed using 4% paraformaldehyde (PFA) at room 
temperature for seven minutes. Fixed cells were centrifuged out of the fixative 
solution at 1200 rpm for three minutes, and resuspended in a PBS + 0.2 % Triton X-
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100 for three minutes to permeabilise the cell membrane. Permeabilised cells 
harvested by centrifugation at 1200 rpm for three minutes and resuspended in 500 
– 1000 µL PBS containing DAPI at a final concentration of 1µ/mL and incubated for 
a minimum of five minutes at room temperature prior to analysis. Samples were 
analysed on a BD LSR Fortessa flow cytometer (BD Biosciences) by excitation of 
DAPI-stained cells with a 350nm laser and data recorded after a band-pass 
450/50nm emission filter. For each sample, the DNA content of a minimum of 10,000 
cells was acquired and the percentage of the population in each phase of the cell 





In living cells, phosphatidyl serine (PS) is on the plasma membrane leaflet facing the 
cytoplasm. When cells are undergoing apoptosis, PS is transported to the outer 
plasma membrane where it binds, with high affinity, to the calcium-dependent lipid-
binding protein, annexin V. The percentage of cells in early and late apoptosis, as 
well as dead cells, was determined by immunofluorescent staining of annexin V and 
the incorporation of DAPI by flow cytometry. Cells that are negative for both stains 
are living cells. Early apoptotic cells are identified by the presence of annexin V on 
the outer membrane, but are still impermeable to DAPI. Late apoptotic cells are 
positive for both DAPI and annexin V staining. Dead cells remove annexin V from 
the cell membrane by proteolysis, and are therefore only positive for DAPI. 
Samples were harvested as previously described, washed once with PBS for three 
minutes, and stained for annexin V. Annexin V was stained using an anti-annexin V 
antibody conjugated to a far-red fluorophore (AlexaFluor 647, Thermo Fischer). 
Annexin binding buffer (1X, 140 mM NaCl, 10 mM HEPES, 2.5 mM CaCL2, pH 7.4) 
was added in a ratio of 25:1 with the conjugated antibody and incubated with the 
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sample for 15 minutes at room temperature. DAPI, diluted to a final concentration of 
1 mg/mL in 200 µL of annexin binding buffer, was added to the samples and 
incubated for five minutes at room temperature prior to analysis. Reference voltages 
for each laser on the flow cytometer were set using stained and unstained control 
cells. Cells were excitated simultaneously with light of wavelength 450 nm and 647 
nm. Annexin V and DAPI staining was recorded through the 450/50 and 670/14 
band-pass filters, respectively. A minimum of 10,000 cells were recorded for each 
experiment. 
 
3.5.4. Image cytometry analysis 
 
Data obtained by the ImageStreamX were analysed in IDEAS 6.2 (Merck Millipore). 
Samples for each chromosome and experimental condition were obtained 
separately and contained within a single data file. For each sample between 500 
and 40,000 individual cells were analysed.  
Raw data files were opened in the IDEAS software package and the built-in 
compensation matrix applied. This correction is necessary to remove fluorescent 
noise introduced from the spatial alignment between channels, the flow speed, 
camera background normalisation and the level of brightfield gain. During 
acquisition, the EDF element was used to increase the focus range from 4 µm to 16 
µm, allowing close to 100% of cells to be focused. Single cells are distinguished 
from cell aggregates by low area and high aspect ratio. 
The gating of single cells was manually verified by visual observation of brightfield 
images in the selected region. Plotting the Gradient Root Mean Squared (RMS) 
value of the brightfield channel allowed only cells that were in-focus to be analysed. 
In-focus cells have a high Gradient RMS value. For some samples, where the 
hybridisation efficiency was weaker, a further gate was applied to select for only cells 
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in the sample above a threshold of probe signal intensity. This was achieved by 
plotting the total intensity of fluorescence in each cell, versus the Raw Max Pixel 
intensity within the cell. Cells with hybridised probe have an average total 
fluorescence, and a high Raw Max Pixel intensity.  Single, in-focus, hybridised cells 
were then analysed for the chromosomal content of a particular chromosome by 
applying a ‘spot mask’ and ‘spot counting’ feature to the centromere probe signals 
for each image. The masking parameters were determined on user-defined 
variables: the radius of the spot and the spot-to-background ratio (STBR). The STBR 
is the spot pixel value divided by the background fluorescence of the bright detail 
image.  The spot mask therefore denotes a region that is of appropriate area to be 
considered a centromeric signal, and the boundary at which the signal diminishes. 
Where the radius value is x, this suggests that the denoted area of a single spot 
should have a minimum value of 2x+1 pixels. Regions that satisfy the spot mask 
criteria in single cells are enumerated by the spot-counting wizard. For the wizard to 
accurately determine chromosome ploidy, true populations were denoted for both 
2n-1 and 2n+1 cells for a minimum of 25 images. The wizard then compiles the 
common features for over 250 elements and assigns each image a spot count. 
The images obtained of CEP spots are 2D projections of 3D images, to encompass 
the entire volume of the nucleus. If a cell is aligned so that the two centromere 
signals are in the same x, y position, but different z positions, they sometimes appear 
as a single focus, because they overlap following image projection. To correct for 
this, CEP signal intensity was plotted as a histogram from the original spot count 
data which correlates with the amount of probe hybridised, rather than the spot 
count. Disomic cells had a medium (M) intensity of hybridisation signal intensity, 
representing two spots. Cells with one spot that had lost a chromosome will fall 
below the value represented by two standard deviations above the mean fluorescent 
intensity; cells that had gained a chromosome will fall above two standard deviations 
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of the mean of the hybridisation signal intensity. Events that are classified as one 
spot by the software usually fell into the medium range for intensity in the majority 
of cases. This suggests that, for the reasons stated above, they are disomic cells 
with aberrant ploidy-spot relationship. Cells designated as one spot that fell outside 
the 2 standard deviation window were deemed to be true monosomies. Cells 
designated as 2n+1 by the spot-counting wizard were manually verified by visual 
inspection of each image and correlating it with the 2 standard deviation cut-off 

















3.6. DNA analysis 
 
3.6.1. Genomic DNA extraction 
 
Genomic DNA was extracted from cell lines using the DNeasy Mini kit (Qiagen). For 
control experiments, where starting material was not limiting, DNA was extracted 
from 1 x106 cells. For all experimental conditions sorted by FACS, genomic DNA 
was extracted from at least 50,000 cells. To extract genomic DNA, harvested cells 
were centrifuged and resuspended in 200 µL PBS and 20 µL proteinase K, to 
remove proteins from the sample. Following resuspension, 200 µL buffer AL was 
added and the sample thoroughly vortexed and incubated at 56 ºC for 10 minutes. 
200 µL of ethanol absolute was added to the sample and mixed by vortexing. The 
mixture was pipetted into a DNeasy Mini spin column and centrifuged at 6000 xg for 
one minute. DNA in the column was washed twice by addition of 500 µL buffer AW1 
and AW2 followed by centrifugation, at 6,000 xg for one minute and 20,000 xg for 
three minutes, respectively. DNA was eluted by centrifugation at 12,000 xg in a 
variable volume of nuclease-free PBS (60 to 200 µL), depending on the sample. For 
elution in a total volume of 60 µL, the DNeasy Mini column was washed with 2x 30 
µL PBS to increase the total yield. 
The absolute DNA concentration was determined by a spectrophotometer 
(Nanodrop ND-1000), where the ratio of absorbance at 260 nm and 280 nm was at 
least 1.8, and therefore considered to be DNA of sufficient quality for down-stream 
applications. 
 
3.6.2. Southern blot 
 
Cells from clone RPE-1-4F were harvested and resuspended in 200 µL PBS + 20 
µL proteinase K, to digest proteins. Genomic DNA was extracted as previously 
described. To fragment the genome, 1 µg of genomic DNA was restriction-digested 
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with XhoI and KpnI-HF in the supplied buffers (NEB), followed by heat-inactivation 
at 80 ºC for 10 minutes. Genome fragmentation was confirmed by imaging each 
sample on a 0.8 % (w/v) agarose gel, stained with gel red, after running for 100 
minutes at 65 volts in TBE.  
To transfer DNA to the membrane the following procedure was implemented: A 
nitrocellulose membrane and three sheets of blotting were wetted by brief immersion 
in 0.4 M NaOH. Two of the blotting papers served as wicks for the transfer, and the 
third was overlaid on the gel support stand to prevent direct contact with the acrylic. 
The gel was rinse briefly with de-ionised water and placed on top of the acrylic 
support surface. The nitrocellulose membrane was laid carefully across the top of 
the gel, ensuring no air bubbles were trapped which would prevent proper transfer 
of DNA to the membrane. To this, the two sheets of additional blotting paper were 
stacked, followed by dry paper towels, increasing the total thickness to 
approximately 7 cm. A further piece of acrylic was stacked on to the assembly to 
allow the stable balance of a 500 gram weight, to weight the entire assembly and 
promote capillary diffusion of the NaOH through the nitrocellulose membrane. The 
transfer assembly was allowed to stand and the DNA transferred to the membrane 
for a minimum of 16 hours at room temperature 
The membrane was carefully removed and washed in neutralisation buffer (Sigma). 
Before hybridisation with labelled probes, the membrane was blocked in salmon 
sperm DNA. To prepare the complete blocking agent, pre-hybridisation solution 
(Sigma) was incubated in a water bath at 42 ºC. Salmon sperm (Sigma) was 
denatured for 5 minutes at 95 ºC, immediately chilled on ice, and added to the pre-
warmed hybridisation solution to a final concentration of 50 µg/mL. The membrane 
was carefully rolled into a hybridisation tube, complete hybridisation blocking 
solution added, and placed in a revolving hybridisation oven for five hours at 42 ºC. 
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For hybridisation, fluorescently-labelled pSMC50 probe was added to 10 mL 
hybridisation solution (Sigma), pre-warmed to 49 ºC, up to a final concentration of 
10 ng/mL. The pre-hybridisation solution was discarded from the membrane and the 
hybridisation solution added, followed by incubation for 16 hours at 49 ºC. A 6X wash 
solution; consisting of 180 mL 20X SSPE (Sigma), 12 mL 10 % SDS and 408 mL 
deionised water; was pre-heated to 49 ºC and used to wash the blot on a shaking 
incubator for 15 minutes at 49 ºC. An aliquot of the 6X wash solution was diluted 
three times in deionised water, pre-heated to 49 ºC and used to wash the blot for 30 
seconds. Hybridised blots were visualised on an Odyssey CLx imaging system 
(Licor) with a one minute and three minute exposure time. 
3.6.3. Polymerase chain reaction and probe labelling 
 
3.6.3.1. Generating fluorescently-labelled dsEGFP probes 
 
The dsEGFP gene host plasmid, pSMC50, was digested with DNAse I – a restriction 
enzyme with no known sequence specificity – for 10 minutes at 37 ºC to generate a 
library of pSMC50 DNA molecules between ~100 bp and ~1,000 bp in length. DNA 
digestion was confirmed by running approximately 100 ng of the digestion mixture 
on a 1 % agarose gel for 30 minutes before down-stream applications. Precipitation 
of 1 µg of the fragment library was achieved by adding 1/10 volume of sodium 
acetate (pH 5.2, 3 M) and two volumes of ethanol absolute to the mixture, freezing 
at -70 ºC for 30 minutes then centrifuging at 12,000 rpm for 15 minutes. The 
supernatant was removed carefully by pipetting and the pellet washed with 70 % 
ethanol and allowed to air dry at room temperature. The pellet was resuspended in 
20 µL of labelling buffer (Ulysis), denatured at 95 ºC for 5 minutes, snap cooled on 
ice and briefly centrifuged to redeposit DNA to the bottom of the tube. To this mixture 
was added 1 µL of ULS Alexa Fluor® 488 labelling stock solution (Ulysis) and 
incubated at 80 ºC for 15 minutes. The reaction was stopped by plunging the sample 
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into ice. Labelled DNA was recovered from the reaction mixture by a gel filtration-
based spin column (BioRad) according to the manufacturer’s instructions. The 
labelling efficiency, quality and concentration of labelled DNA was determined by a 
spectrophotometer (Nandrop ND-100). 
 
3.6.3.2. Generating digoxygenin-labelled dsEGFP probes 
 
Digoxygenin-labelled probes were generated by amplifying the target sequence by 
polymerase chain reaction (PCR). To a microcentrifuge tube was added the 
following reagents: PCR buffer with MgCL2, PCR DIG-probe dNTP synthesis mix 
(Roche; 200 µM dATP, dCTP, dGTP, 130 µM dTTP, 70 µM DIG-dUTP), 0.5 µM 
forward PCR primer, 0.5 µM reverse PCR primer, 0.75 µL enzyme mix (Roche) and 
50 pg template plasmid DNA (or 50 ng genomic DNA, depending on the application; 
Table 3.2). The total reaction volume was brought to a total of 50 µL with PCR-grade 
water (Roche). For the PCR reaction, 0.2 µL microfuge tubes and DNA amplified by 
thermocycling (Table 3.2). The PCR amplification was confirmed by running 5 µL of 
the sample mix on a 1 % (w/v) agarose gel for one hour. Successful probe labelling 
was confirmed by comparing the gel shift of the DIG-labelled PCR products with the 
unlabelled control PCR reaction. 
 
3.6.4. Single-nucleotide polymorphism array 
 
The ploidy of each sample was determined by a Genome-Wide Human SNP Array 
6.0 (Affymetrix) and data analysed in the Chromosome Analysis Suite (CAS, 
Affymetrix). Data were transformed from global references obtained from signals in 
the CAS normalised reference library. Normalised signals were log2 transformed, 
and the copy number variation of a single SNP between samples was estimated 




Table 3.2. Polymerase chain reaction primers and thermocycling. Forward and 
reverse primers were used to amplify gene target sequences using the stated 
forward and reverse primers (5’ to 3’ sequences shown). DNA amplification was 





























   
Stage Temperature / Time  
Denaturing 90 ºC / 30 seconds  
Denaturing 90 ºC / 30 seconds  
Annealing 62 ºC / 90 seconds           X 25–35 cycles 
Extension 72 ºC / 120 seconds 
 
Storage ≤4 ºC / ∞  
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3.6.5. Metaphase spreads 
 
Cells were treated with colcemid for six hours, harvested and resuspended in pre-
warmed hypotonic solution (1:1; 0.4 % KCl 0.4 % Sodium citrate) at 37 ºC for seven 
minutes. Pelleted cells were resuspended by adding freshly-prepared fixative (3:1 
methanol-glacial acetic acid) in a drop-wise fashion to prevent clumping and 
incubated for 30 minutes at room temperature. Metaphase spreads were obtained 
by dropping the fixed cell suspension onto clean glass microscopy slides from a 
height of between 1.5 and 1.8 meters and allowed to air-dry before storage at 4 ºC 
for up to three months prior to analysis. 
 
3.6.6. Single-cell sequencing 
 
Samples from control and experimentally-induced aneuploid cells sorted by FACS 
were sent to a collaborator for single-cell sequencing analysis using AneuFinder as 
previously reported314. Briefly, sequence reads are determined as non-overlapping 
bins with an average length of 1 Mb, a GC correction is applied, and binned 
sequences are analysed using a Hidden Markov model to differentiate aneuploidies 
from zero (nullisomy) to 10 (decasomy) chromosome copies. To negate the inherent 
sample variation introduced by sequencing single cells, a stringent quality control 
step was included that uses multivariate clustering analysis to excluded samples of 
insufficient quality. Chromosome copy number is plotted as a genome-wide state 







3.7. Transcriptome Analysis 
 
3.7.1. RNA extraction 
 
EGFP-positive and negative cells were collected by FACS as previously described. 
Cells were pelleted by centrifugation at 1200 rpm for three minutes and 350 µL RLT 
lysis buffer (Qiagen) added drop-wise to a loosened cell pellet. Cells in lysis buffer 
were homogenised by passage through a P200 pipette tip and one volume of 70 % 
ethanol added and mixed by vortexing. The sample was transferred to an RNeasy 
Mini Spin column (Qiagen) and centrifuged for 15 seconds and 12,000 rpm to bind 
total RNA to the column. RNA was washed by addition of 700 µL buffer RW1 and 
15 second centrifugation at 12,000 rpm. To remove all traces of ethanol from the 
RNA sample, 500 µL Buffer RPE was added to the column and centrifuged at 12,000 
rpm for two minutes. Total RNA from each sample was eluted by applying 50 µL 
RNase-free water directly to the column and centrifuging for one minute at 12,000 
rpm. The total RNA concentration and RNA quality were analysed on a 
spectrophotometer (Nanodrop ND-1000). 
 
3.7.2. Determination of dsEGFP insertion frequency 
 
Total RNA from each sample was analysed using the GeneChip Human 
Transcriptome Array 2.0 (Affymetrix). Raw data from the array were transformed to 
normalise for quantile variation between samples, and correct for background noise, 
using the conservative RMA transformation function within the Affymetrix Power 
Tool software package (Affymetrix). RMA-transformed data were smoothed by 
plotting mRNA expression across the genome as a 1000-point moving average of 




3.7.3. Transcriptome responses to monosomy 6 
 
Raw transcriptomics data files were normalised by SST-RMA transformation within 
the Transcriptome Analysis Console software package (Affymetrix). Differences in 
expression for each probe between samples were determined by one-way, unpaired 
ANOVA where significance was p<0.05. The fold change for each gene was plotted 
on a linear scale from -4 to +4. Data were plotted as pathway maps using the built-
















3.8. Mathematical proofs 
 
3.8.1. Chromatid geometry 
 
The centre of a best-fit ellipse of metaphase DNA, stained with DAPI, was 
determined using ImageJ. The major and minor axis length were defined using built-
in analysis tools within ImageJ. Individual centromere signals were determined by 
thresholding fluorescent images to remove background and absolute x, y 
coordinates for individual signals were exported (figure 7.1a). 
The relative metaphase positions (figure 7.1b) were determined as follows:- 
o = x ,y 
oA = Δ x 
AB = Δ y 
∴ oB = √(Δ x2+Δ y2) 
θ2 = 180- θ or θ2 = ABS ((180-(tan-1(Δ y/Δ x))-θ) 
Relative metaphase position = oC  
cos θ2  = oC/oB 
∴ oC = oB cos θ2  
∴ oC = (√(Δ x2+Δ y2))cos(180-θ)  
             or 









The angular deviation between sister chromatids (figure 7.1c) was determined as 
follows:- 
o = x, y 
AE = Δ x 
AB = Δ y 
∴ BE = √(Δ x2+Δ y2) 
CD = ΔoCoD (see relative metaphase positioning proof) 
cosθ  = CD / BE 
∴ θ = cos-1(ΔoCoD / BE) 
θ2 = 90 - θ 
∴ θ2 = 90 - (cos-1(ΔoCoD / BE)) 
 
Raw data for ellipse centre coordinates (x, y), metaphase rotation angle (θ), major 
axis length, and sister chromatid coordinates (x, y) were extracted from each image 
by a custom ImageJ macro command (chapter 10.1.2). The mathematical 
calculations above were performed on extracted data using a Microsoft Excel 











3.9. Statistics  
 
Where required, data were normalised to the appropriate control before analysis. 
Statistical analyses of in vitro assays were performed in GraphPad Prism 5.4 
(GraphPad). Data with two experimental conditions were analysed using a two-tailed 
Student’s T-test assuming unequal variance. For two or more treatment groups, 
significance between mean values was determined by one-way ANOVA with 
Tukey’s post-hoc test to correct for family-wise errors. 
Chi-squared significance and p-values were calculated by comparing the observed 
and expected values for the independent variables (aneuploidy-vulnerability and 
metaphase plate region) from a 2x2 contingency table.   
Unless stated otherwise all graphs plot the mean, with error bars showing +/- one 
standard deviation of the mean, of triplicate biological repeats. Asterisks have been 
used to denote the significance value between experimental conditions, adhering to 

















4. Developing a novel 
system to isolate nascent 

















4.1. Optimising a drug-induced chromosome 
missegregation strategy 
Aneuploidy has detrimental consequences for cell fitness; therefore, the 
preservation of a diploid karyotype between generations is a fundamental priority of 
proliferating human cells260,341,342. Elucidation of the earliest responses to aneuploidy 
in human cells is severely limited by the lack of appropriate tools to isolate aneuploid 
cells in the few hours following chromosome missegregation, before cells undergo 
apoptosis145,180,259. To circumvent these issues, and investigate the early responses 
to chromosome missegregation, I devised an experimental strategy to isolate 
nascent populations of aneuploid cells using a fluorescence-based aneuploidy-
reporter cell line (figure 4.1). 
The insertion of an enhanced green fluorescent protein (EGFP) transgene into a 
single chromosome locus would enable the isolation of populations of cells which 
have lost this chromosome by fluorescence-activated cell sorting (FACS). I have 
chosen to create my initial aneuploidy-reporter cell line using retinal pigment 
epithelium cells (RPE-1-hTERT; RPE-1 herein); a chromosomally-stable, non-
transformed cell line which has been immortalised by constitutive expression of 
telomerase343. This cell line is well-suited for the outlined experimental strategy as it 
is has a low rate of spontaneous chromosome missegregation, and thus control and 
aneuploid (EGFP-negative) populations are biologically distinct and can be used for 
comparative analysis of the early responses to aneuploidy226,337.  
The analysis of the responses to aneuploidy requires enough cells to be able to 
utilise population-based approaches, such as gene expression arrays and 
transcriptomics, which require tens of thousands of cells344. Since the rate of 
spontaneous chromosome missegregation in RPE-1 cells is very low, chromosome 





Figure 4.1. Experimental strategy for isolating aneuploid cells using FACS. A 
chromosome reporter strategy, based on fluorescence-activated cell sorting 
(FACS), was devised. A de-stabilised green fluorescence protein (dsEGFP) gene 
would be inserted into a single chromosome. Elevating aneuploidy using small 
molecule inhibitors of mitosis (nocodazole) would, in some cells, lead to reporter 
chromosome missegregation. This would generate a pool of aneuploidies, a sub-
population of which would have missegregated the reporter chromosome and could 
be identified by EGFP fluorescence (lack thereof). Cells would be sorted by FACS 







4.1.1. The rate of micronuclei formation 
 
Nocodazole is a microtubule depolymerising agent which causes cells to arrest in 
mitosis due to a failure to assemble a mitotic spindle345. Upon wash-out of the drug, 
spindle assembly can resume but is prone to the formation of improper kinetochore-
microtubule attachments, leading to high rates of chromosome missegregation at 
anaphase (figure 4.2a)235,346,347. 
The primary cause of aneuploidy following nocodazole wash-out is thought to be 
mediated by merotelic chromosome orientation – individual kinetochore attachment 
to microtubules emanating from both spindle poles234. To determine the efficiency of 
nocodazole in inducing chromosome missegregation, I used a simple assay based 
on quantifying the percentage of cells with a micronucleus348. Micronuclei are a well-
established surrogate measure of aneuploidy, caused by lagging chromosomes at 
anaphase which become trapped outside the main nuclear body (figure 4.2b)349. 
It has been shown that prolonged treatment with nocodazole can cause DNA 
damage due to a long-term arrest in mitosis350–352. It will be important for down-
stream experiments that DNA damage caused by the chromosome missegregation 
strategy is minimised so aneuploidy-related, not DNA damage-related, phenotypes 
are elucidated. 
Anticipating that DNA damage would be elevated following a 16-hour nocodazole 
treatment, an additional experiment was included where cells had been pre-
synchronised at the G2/M checkpoint by 14-hour small-molecule inhibition of CDK1 
(using RO-3306) followed by a short 2-hour nocodazole treatment (referred to as 
14r+2n herein)353,354. Following arrest, cells were washed in fresh media to remove 




Basal levels of micronuclei in control cells were low (figure 4.2c). Treatment of RPE-
1 cells with nocodazole for 2 hours did not significantly increase aneuploidy 
compared to the untreated control. Following 16 hours nocodazole wash-out, 
chromosome missegregation was significantly elevated, in-line with the literature 
(***p<0.001)337. Pre-synchronising cells at G2/M followed by 2-hours nocodazole 
wash-out (14r+2n) significantly elevated chromosome missegregation above 2-hour 
treatment alone and to approximately similar rates as for 16-hour nocodazole 
treatment (***p<0.001). 
These data confirm that I are able to induce chromosome missegregation using 
small molecule inhibitors of the cell cycle. Importantly, it is possible to significantly 
elevate aneuploidy following a short (2-hour) nocodazole wash-out by pre-
synchronising cells at the G2/M boundary, which I anticipate to be important to 













Figure 4.2. Micronuclei formation rates following nocodazole wash-out. (a) 
Treatment with the microtubule spindle poison nocodazole leads to mitotic arrest 
due to a failure to assemble a mitotic spindle. Following nocodazole wash-out, 
chromosomes form merotelic attachments on the spindle. (b) Micronuclei are extra-
nuclear compartments containing whole chromosome or chromosome fragments 
which arise following a faulty mitosis. (c) Micronuclei rates are elevated following a 
faulty mitosis induced by 14r+2n and 16 hours nocodazole. One-way ANOVA with 






4.1.2. DNA damage in nocodazole-arrested cells 
 
As described above, DNA damage occurring during induction of chromosome 
missegregation is deleterious to my experimental strategy, resulting as a 
consequence of a prolonged mitotic arrest and should be therefore be minimised. 
To quantify DNA damage levels in each condition, the extent of DNA damage was 
determined by immunofluorescent staining of γ-H2AX, a phosphorylated histone H3 
variant that is incorporated at sites of DNA damage355–357. Cells were deemed to be 
positive for DNA damage if they contained three or more discreet γ-H2AX foci, as 
previously described226.  
Nocodazole treatment for two hours did not significantly elevate DNA damage in 
prometaphase RPE-1 cells above the untreated control (figure 4.3a and 4.3b). 
Extended treatment with nocodazole for 16 hours significantly increased unresolved 
DNA damage at prometaphase, in line with the literature (***p<0.001)350–352,358. 
Importantly, pre-synchronising cells at G2/M before a 2-hour nocodazole treatment 
did not elevate DNA damage; conversely, a small decrease was observed, although 
this did not reach significance. This slight decrease in DNA damage may reflect a 
longer time in G2 to correct errors that occurred during DNA replication359. 
Importantly, pre-synchronising cells before 2-hour nocodazole wash-out reduced 
DNA damage to levels comparable to that observed in the untreated control cells 
(figure 4.3a and 4.3b). This demonstrates that the induction of chromosome 
missegregation can be uncoupled from drug treatment-induced DNA damage in 
RPE-1 cells.  
In practise, despite the concomitant elevation of DNA damage, the 16-hour 
nocodazole treatment is a more cost effective and efficient means of elevating 
chromosome missegregation. Therefore, during some of the optimisation steps 
below, I continue to use this treatment. However, during isolation of aneuploid cells 
for further downstream analysis in future experiments I will pre-synchronise cells 
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before nocodazole treatment using RO-3306 to minimise DNA damage, ensuring I 
can analyse nascent responses specific to aneuploidy and not DNA damage. 
4.1.3. Centromere signal in the micronucleus 
 
DNA which is missegregated is broadly categorised into two groups: whole 
chromosomes and acentric chromosome fragments360–362. Micronuclei can therefore 
contain either whole chromosomes (positive for centromere staining) or partial 
chromosomes (lacking centromeric staining). Ideally, my experimental outline is to 
investigate the response to whole-chromosome aneuploidy. To determine the 
induction of whole-chromosome aneuploidy, untreated and nocodazole-treated 
RPE-1 cells were stained with an anti-CREST antibody, marking the kinetochore 
and therefore centromere of each chromosome, and percentage of CREST-positive 
micronucleI was quantified 24 hours after nocodazole wash-out. This allowed the 
percentage of whole chromosomes in the micronuclei to be quantified. 
In untreated cells, 42 % of micronuclei contained at least one CREST signal (figure 
4.3c and 4.3d). Following 2-hour nocodazole wash-out the percentage of whole-
chromosomes entrapped in a micronucleus was not significantly different (p=0.36). 
After an extended mitotic arrest with 16-hour nocodazole, all micronuclei contained 
at least one CREST signal (***p<0.001). Interestingly, 14r+2n was intermediate, with 
57.5 % of micronuclei containing whole chromosomes, potentially reflecting the 
increased likelihood of whole chromosomes being missegregated following DNA 
damage in 16 hours nocodazole rather than an artefact of synchronising cells363. 
Therefore, elevating missegregation using 14r+2n generates a mixed population of 
whole-chromosome and partial-chromosome aberrations and should be considered 





Figure 4.3. Prometaphase DNA damage and micronuclei characterisation 
following nocodazole wash-out. (a & b) DNA damage is increased in 
prometaphase cells arrested in mitosis by extended nocodazole (16 hours, 
***p<0.001) but not a 2-hour nocodazole arrest in synchronised cells (14r+2n). (c & 
d) Whole-chromosome missegregation was identified using a centromeric stain, 
CREST, at 24 hours following nocodazole wash-out. The percentage of CREST-
positive micronuclei (MN) was elevated following 16 hours nocodazole but not for 
any other treatment. Inset: CREST negative and positive micronuclei. Boxes: 
Micronucleus. One-way ANOVA with Tukey’s post-hoc multiple comparison; 





4.1.4. p21 and p53 nuclear stabilisation following chromosome 
missegregation 
It has been shown that, following chromosome missegregation, p21 and p53 are 
stabilised in the nucleus and limit the proliferation of aneuploid cells by inducing cell-
cycle arrest180,337,364,365. I hypothesised that populations of RPE-1 cells with an 
assortment of aneuploidies would stain positive for nuclear p21 and p53, and could 
therefore be isolated by fluorescent activated cell sorting – thereby providing an 
alternative strategy to that proposed in the primary experimental outline, should it 
prove difficult to execute (figure 4.4a cf. figure 4.1).  
The nuclear stabilisation of p21 and p53 in control and nocodazole-treated RPE-1 
cells was analysed 24 hours following drug wash-out. Cells were classified by the 
presence of a micronucleus (MN), indicating that chromosome missegregation had 
occurred in the preceding anaphase366. The sister of a cell that harboured a 
micronucleus was identified by proximity and classified as MN-positive, as it would 
have a high chance of aneuploidy, where an MN represents a change in 
chromosome number. 
To analyse every cell in the image set, a macro was written for ImageJ which would 
automatically quantify the p21 and p53 nuclear staining intensity, therefore reducing 
the requirement for time-intensive manual analysis (figure 4.4b & chapter 10.1.1). 
Chromosome missegregation induced by 16-hour nocodazole wash-out significantly 
increased nuclear p21 and p53 stabilisation in micronuclei-positive cells, as 
expected (figure 4.4c-e, ***p<0.001). Interestingly, micronuclei-positive (MN+) cells 
following 14r+2n did not show significantly elevated p21 or p53 stabilisation 
compared to the internal control cells without micronuclei (MN-). However, it is still 
unclear from this experiment whether p21 and p53 are stabilised in the nucleus as 
a response to aneuploidy or the DNA damage induced under these conditions. In 
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MN+ cells following 14r+2n, where DNA damage is abrogated, no p21 or p53 
stabilisation was observed which suggests that this approach cannot be used to 
differentiate between diploid and aneuploid cells, without significant DNA damage 
artefacts at this time point. Therefore, below I continue optimising the reporter 










Figure 4.4. p21 and p53 nuclear stabilisation following nocodazole wash-out. 
(a) Nascent aneuploid cells have been shown to stabilise p21 and p53 in the 
nucleus337. (b) An automated image analysis tool to quantify nuclear p21 and p53. 
(c, d and e) Micronuclei-positive cells were also positive for p21 and p53 following 
16-hour nocodazole arrest (***p<0.001). AU: arbitrary units. One-way ANOVA 
with Tukey’s post-hoc multiple comparison; ***p<0.001. Scale bars: 50 µm. 
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4.2. Generating RPE-1-hTERT cells expressing dsEGFP 
 
4.2.1. Construction of a mammalian expression vector 
harbouring dsEGFP  
 
To isolate aneuploid cells requires rapid EGFP turn-over following reporter 
chromosome loss.  However, EGFP is a very stable protein, with a half-life of over 
24 hours, therefore I have taken advantage of a destabilised-EGFP (dsEGFP) 
protein which has a C-terminal Mouse Ornithine Decarboxylase (ODC1) domain 
which targets EGFP for rapid proteasome-mediated degradation (figure 4.5a)367–369.  
A plasmid cassette harbouring dsEGFP, a kanamycin antibiotic resistance gene and 
a selectable Geneticin (G418) resistance gene was designed (chapter 3.3.1 and 
3.3.2). The identity of the resulting plasmid (pSMC50) was checked by restriction 
digestion using NheI and NotI that produced bands of the expected sizes (3879 bp 









Figure 4.5. Generating a destabilised EGFP expression cassette. (a) The mouse 
ornithine decarboxylase domains (mOCD1)-tagged green fluorescent protein 
(EGFP) should be rapidly degraded by proteasomal targeting. (b) Successful 
expression cassette plasmid generation was confirmed by agarose gel 
electrophoresis, producing bands at 3879 bp and 843 bp when digested with NotI 










4.2.2. Inserting the dsEGFP gene into RPE-1 cells 
 
To maximise the chances of integration into a single chromosome, RPE-1 cells were 
transfected with a dilution series (1µg, 500ng, 200ng and 100ng) of plasmid DNA. 
To isolate cells which had stably taken up the plasmid, cells were re-plated at low 
density and treated with Geneticin for 10 days. Geneticin is an antibiotic which is 
broken down by a selectable marker on the pSMC50 plasmid cassette – 
neomycin370. Following selection, the only plate with single-cell colonies arose from 
RPE-1 cells transfected with 1µg plasmid DNA, suggesting that these population 
had taken up the plasmid. A total of five clones were isolated, RPE-1-[1-5], 
expanded over 14 days, and characterised for expression of dsEGFP. 
By conventional fluorescence microscopy the EGFP signal was faint, but visible in 
RPE-1 clones. RPE-1 clones 1, 2, 4 and 5 expressed dsEGFP to similar degrees by 
fluorescence microscopy (control; figure 4.6a). No detectable EGFP signal was 
observed in clone 3.  
To confirm the proteasome dependency of EGFP degradation, and more easily 
visualise EGFP expression conclusively, each clone was treated with MG132, a 
small-molecule inhibitor of the proteasome, for 24 hours371. As expected, apart from 
clone 3 which remained negative, EGFP fluorescence intensity increased in each 
clone following proteasome inhibition, confirming the proteasome dependency of the 








Figure 4.6. Proteasome inhibition in RPE-1 clones. Five RPE-1 clones were 
isolated and expanded. (a & b) Following treatment with MG132 for 24 hours, to 
inhibit the proteasome, four out of five clones were positive for EGFP. Contrast for 
images are the same row-wise (not column-wise) for each clone. Two-tailed t-test 
assuming unequal variance; **p<0.01, ***p<0.001). AU: arbitrary units. Scale bars: 
50 µm.  
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4.2.3. Determining the half-life of dsEGFP in RPE-1 cells 
 
The half-life of dsEGFP in RPE-1 cells is an important parameter to determine, as 
rapid EGFP turnover is required to isolate aneuploid cells in the few hours following 
chromosome loss. RPE-1 clone 4 (RPE-1-4) was initially chosen for further analysis 
as the cellular morphology was the most consistent with the parental RPE-1 cells by 
phase-contrast and fluorescence visual inspection. To obtain a first estimation of 
EGFP half-life, RPE-1-4 was treated with a time-course of the proteasome inhibitor 
MG132 over 24 hours. As expected, EGFP fluorescence increased progressively 
with MG132 treatment time, doubling in intensity every ~ 4 to 6 hours (figure 4.7a 
and 4.7c). 
To confirm the half-life of dsEGFP, using a population-based assay in thousands of 
cells, RPE-1-4 cells were treated with a time-course cycloheximide. Cycloheximide 
is a small-molecule inhibitor of protein synthesis, which blocks translation elongation 
by interfering with a critical ribosomal mRNA-binding pocket372. Following 
cycloheximide treatment EGFP fluorescence decay was measured by flow 
cytometry. The half-life of dsEGFP was determined to be ~4.5 hours in RPE-1-4 
cells, compared to over 24 hours for regular EGFP (figure 4.7b and 4.7d)367–369. 
The rapid turnover of dsEGFP (and therefore fluorescence in cells which lose the 
reporter chromosome) should be permissive for the isolation of EGFP-negative cells 









Figure 4.7. Characterising the half-life of dsEGFP in RPE-1-4. RPE-1-4 was 
phenotypically the most similar to the parental RPE-1 cell line. (a and c) A time-
course of MG132 proteasome inhibition in RPE-1-4 increased EGFP fluorescence 
intensity (arbitrary units; AU). (b & d) Treatment with the protein synthesis inhibitor 
cycloheximide revealed the dsEGFP half-life to be ~ 4.5 hours in RPE-1-4 by flow 





4.2.4. Sorting RPE-1-4 cells by flow cytometry 
 
To enable a clear separation between the EGFP-negative and positive cells in 
subsequent experiments, RPE-1-4 cells expressing the highest 20 % EGFP 
fluorescence (named RPE-1-4F herein) were collected by fluorescence-activated 
cell sorting (FACS) and used for down-stream experiments (figure 4.8). 
To sort single RPE-1-4 cells by flow cytometry a hierarchical gating strategy, which 
measures parameters of each cell as it passes through the capillary-flow chamber, 
was used. Parental RPE-1 cells were used to set the reference voltage for the laser 
that excites EGFP (B530/30-A) so that, on a logarithmic scale of arbitrary 
fluorescence intensity, cells fluoresced with a maximum intensity of 103 EGFP 
arbitrary units (AU). This is important as cells from clones RPE-1-4 which fluoresced 
greater than this could be easily identified and represented at least a doubling in 
EGFP signal. Single, EGFP-positive cells were sorted using by FACS using a BD 













Figure 4.8. Sorting a pure population dsEGFP-expressing RPE-1-4 cells. A 
narrow window of RPE-1-4 cells were sorted by fluorescence-activated cell sorting 
(FACS) to ensure there were no EGFP-negative cells contaminating the cell line 
(subsequently: RPE-1-4F). Single, EGFP-positive RPE-1-4 cells were isolated by 
ensuring cellular debris, doublets and EGFP-negative cells were excluded by a 









4.3. dsEGFP is expressed from a single chromosome in 
RPE-1-4F cells  
 
To isolate nascent populations of cells which are aneuploid for a single chromosome 
necessitates the dsEGFP gene be exclusively expressed from a single 
chromosome. To determine if RPE-1-4F was expressing dsEGFP from a single 
chromosome, several approaches to interrogate the chromosome insertion 
frequency, as well as insertion locus/loci, of the dsEGFP gene were attempted 
(Southern blot, inverse-PCR, digoxygenin-labelled custom DNA probes). The only 
method with which I were able to successfully determine chromosome insertion 
frequency was fluorescence in situ hybridisation.  
 
4.3.1. Enumerating dsEGFP integration frequency by FISH 
 
Fluorescently-labelled DNA probes complementary to the original plasmid, 
harbouring the dsEGFP gene sequence, were generated which would hybridise to 
the dsEGFP gene when performing fluorescence in situ hybridisation (FISH) on 
interphase cells and metaphase spreads. By co-hybridising with known centromere 
enumeration probes (CEP), the number of chromosomes containing the dsEGFP 
gene in RPE-1-4F cells could be determined. The successful dsEGFP probe-
labelling reaction was confirmed by spectrophotometry (figure 4.9a).  
FISH was performed on interphase cells and metaphase spreads from RPE-1-4F 
cells, co-staining for unique centromeres and the dsEGFP gene. A clear fluorescent 
signal was observed, suggesting that the FISH procedure was working as expected. 
Importantly, the dsEGFP gene had integrated into a single chromosome, as evident 
by the presence a single dsEGFP focus in interphase cells and two foci on replicated 





Figure 4.9. The dsEGFP gene integrated into a single chromosome in RPE-1-
4F cells. (a) DNA probes conjugated with Alexa-488 dye were generated and the 
probe quality checked by spectrophotometry. (b) Fluorescence in situ hybridisation 
(FISH) with dsEGFP probes and known centromere enumeration probes (CEP; 
chromosomes 15, 13 and 21) revealed a single integration in interphase cells. (c) 
FISH on metaphase spreads confirmed the dsEGFP gene had integrated on the 
distal q-arm of an unidentified chromosome. (c, inset) One signal could be observed 






Here I have optimised a drug-induced chromosome missegregation strategy and 
generated a fluorescence-based aneuploidy reporter cell line. The main benefit of 
using the mitotic inhibitor drugs described (sequential RO-3306 synchronisation 
followed by a short nocodazole wash-out) is that I are able to significantly elevate 
chromosome missegregation, without generating DNA damage, in a cell line with 
otherwise low spontaneous aneuploidy rates. Moreover, the rapid loss of EGFP 
fluorescence in my single-chromosome aneuploidy-reporter cell line should enable 
the isolation of monosomic cells by FACS for down-stream experiments. 
It is important to highlight that it is still unclear whether there is the potential for EGFP 
loss by other transcriptional or post-translational mechanisms independent of 
aneuploidy; or if EGFP signal is lost during apoptosis. Therefore during my analysis 

















5. Isolation and 
characterisation of 




















5.1. Isolation of aneuploid cells by fluorescence-activated 
cell sorting 
 
To isolate populations of aneuploid cells by fluorescence-activated cell sorting 
(FACS),  RPE-1-4F cells were arrested in mitosis with nocodazole for either 2 hours 
alone, 2 hours in synchronised cells or 16 hours. Cells which had arrested in mitosis 
were clearly visible by traditional bright-field microscopy with a characteristic 
rounded morphology. Mitotic RPE-1-4F cells were harvested by shake-off and 
allowed to proceed through mitosis into G1 for 12 hours. This ensures that the vast 
majority of cells harvested for FACS have been arrested in mitosis by nocodazole, 
therefore aneuploid cells would not be diluted in a larger number of cells that had 
not reached mitosis before nocodazole wash-out. 
Control and nocodazole-treated RPE-1-4F cells were collected and counter-stained 
with DAPI, a fluorescent DNA-intercalating dye which does not stain living cells373. 
Counter-staining exclusion is crucial as dead cells no longer express dsEGFP, and 
would otherwise be erroneously counted and/or sorted as aneuploid. 
In control RPE-1-4F, dsEGFP-negative cells occurred in the population at a rate of 
0.32 %. This is higher than the expected value of 0.0002 % (the chance of the 
reporter chromosome missegregating in 1/100 cells) suggesting that a large 
proportion of untreated GFP-negative cells have lost GFP fluorescence via an 
aneuploidy-independent mechanism (figure 5.1a and 5.1b). Two hours treatment 
with nocodazole alone did not significantly elevate the rate of report-chromosome 
missegregation above the untreated control, as expected from observed micronuclei 
formation rates under these conditions (figure 4.3c; chapter 4.1.2). As expected, 
two hours treatment with nocodazole wash-out in pre-synchronised cells significantly 
increased the percentage of EGFP-negative cells in the population (***p<0.01). 
Likewise, the percentage of EGFP-negative cells in the population following 16-hour 
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nocodazole wash-out was significantly greater than the untreated control 
(***p<0.001).  
These data suggest that a prolonged (16-hour), or a short (2-hour in synchronised 
cells), nocodazole arrest is able to elevate the rate of reporter-chromosome loss in 
the EGFP-negative population. Due to a wide range of EGFP fluorescence, it was 
not possible to identify EGFP- double positive cells (with two copies of the reporter 
chromosome; 2n+1), which would be expected to exhibit approximately twice the 
EGFP fluorescence of diploid cells. Of note, EGFP-positive cells represent a 
population in which an assortment of aneuploidies (for unlabelled chromosomes) is 
likely, and should not be mistaken for completely diploid. 
EGFP-negative and EGFP-positive cells were sorted by FACS following both 16-
hour and 14r+2n wash-out in this way for the subsequent characterisation 










Figure 5.1. The loss of dsEGFP fluorescence following nocodazole wash-out. 
(a) Aneuploidy, as judged by the loss of dsEGFP expression by flow cytometry, was 
rare in untreated RPE-1-4F cells (control). The loss of dsEGFP was increased 
following nocodazole wash-out. (b) Treatment with nocodazole for two hours did not 
significantly elevate the rate of dsEGFP-negative cells in the population. Elevating 
aneuploidy by both 14r+2n and 16 hours nocodazole wash-out significantly 
increased the rate of dsEGFP loss in RPE-1-4F cells. AU: arbitrary units. One-way 






5.2. Determining the identity of the reporter chromosome 
 
Having isolated EGFP-negative cells, I wanted to identify the reporter chromosome. 
Given that I had preliminary data suggesting the dsEGFP gene was located on a 
single chromosome (see chapter 4.3.1), it is was likely that EGFP-negative cells 
were aneuploid for a single chromosome, and so I proceeded with down-stream 
analyses for confirmation. Unfortunately, temporary problems were encountered 
with dsEGFP FISH probe hybridisation efficiency. Therefore below, I characterise 
EGFP-negative cells, using alternative strategies, to determine the reporter 
chromosome identity. 
5.2.1. SNP array  
 
Changes in chromosome copy number can be determined by assessing the allelic 
frequency of single-nucleotide polymorphisms (SNP) – changes to a single base at 
many susceptible genomic loci374. EGFP-positive and negative RPE-1-4F cells 
sorted by FACS following 14r+2n and 16h nocodazole wash-out were sent for SNP 
array analysis (Affymetrix). Additionally, control samples from parental RPE-1, 
untreated RPE-1-4F, HCT116 and HCT116+3 cells were also analysed to calibrate 
the SNP array sensitivity.  
5.2.1.1. HCT116 SNP array 
 
HCT116 cells are a near-diploid, chromosomally-stable human colon carcinoma cell 
line of male origin that are known to have lost their Y chromosome in ~90% of 
cells338. Accordingly, the SNP array revealed the presence of a single X 
chromosome (Log2=-0.5) and complete loss of the Y chromosome (log2=<1). 
HCT116 cells are also known to harbour three stable-propagated chromosome 
translocations on one of each chromosomes 10, 16 and 18 allele (figure 5.2a)276,338. 
Comparison between the published karyogram and the SNP array revealed the 
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translocation on chromosome 10q is a result of short chromosome 10q duplication 
(log2=0.5, figure 5.2b). The translocated chromosome 16 allele is a large 
translocation and duplication involving chromosome 8q, visible by the G-banding 
pattern and amplification of chromosome 8q (log2=0.5,). Finally, the chromosome 
18p translocation results from a duplication of a region at the distal end of 
chromosome 17q (log2=0.5). HCT116+3 cells possess a known gene amplification 
site on chromosome 3q375. I were unable to detect the chromosome 3q amplification 
(log2<0.5, figure 5.2c). These data demonstrate that SNP array is sensitive to whole 
chromosome copy number alterations and population-wide translocations. However, 
gene amplifications cannot be detected due to the inherently low resolution of 

















Figure 5.2. HCT116 and HCT116+3 single nucleotide polymorphism array. (a) 
HCT116 cells are known to harbour three stably propagated translocated alleles276. 
(b) Single nucleotide polymorphism (SNP) array revealed the translocations to be 
t(10q:10q), t(18q:16p) and t(17q:18p). (c) A sub-clone of HCT116 with a 






5.2.1.1. RPE-1 SNP array 
 
Parental RPE-1 cells, of female origin, are ostensibly diploid however some isolates 
are known to display stably-propagated aberrations particularly of chromosomes 10 
and 12336,376. I were unaware of the additional chromosome 12 aberration in some 
RPE-1 isolates prior to generating my aneuploid reporter clone (RPE-1-4F) in RPE-
1 cells. 
SNP array analysis confirmed both gain of chromosome 12 (log2=0.25) and 
amplification of chromosome 10q in parental RPE-1 cells (log2=>0.5; figure 5.3a). 
Fortuitously, in RPE-1-4F cells, the trisomy of chromosome 12 was not observed, 
suggesting that this clone originated from the small percentage of cells not carrying 
trisomy 12 in my isolate of RPE-1 cells (figure 5.3b). This is important as trisomy 12 
in my aneuploidy reporter strategy would have been a direct conflict of the 
experimental aim – to induce aneuploidy. No other significant gross chromosomal 
changes were observed. 
EGFP-negative RPE-1-4F cells were sorted by FACS following both 14r+2n and 16 
hours nocodazole wash-out. The variability in DNA content induced by both 
treatments was similar (figure 5.3c and figure 5.3d). Unfortunately, I were unable 
to detect a significant change in chromosome copy number in EGFP-negative RPE- 
1-4F cells by SNP array following either drug treatment. This could reflect the 
sensitivity of the SNP array to detect changes in whole chromosome copy number 
where the aneuploidy is not present in every cell, suggesting that my EGFP-negative 
population is not sufficiently enriched for a specific monosomy above the noise for 
detection by SNP array. The enrichment of monosomy in the EGFP-negative 
population, and the level required for SNP array detection, are therefore unclear 





Figure 5.3. RPE-1 single nucleotide polymorphism array. RPE-1 cells were sent 
for SNP array analysis. (a) RPE-1 parental. (b) RPE-1-4F control. (c) RPE-1-4F, 





5.2.2. Transcriptome analysis 
 
Another approach to determine the elusive reporter chromosome was devised 
based on gene transcript levels. This approach would serve two purposes – to 
identify the reporter chromosome and additionally obtain population transcriptome 
data for EGFP-negative cells. The loss of one copy of a chromosome would be 
expected to reduce the global mRNA, for the genes encoded by that chromosome, 
by approximately 50%. This approach makes the assumption that transcription 
compensation mechanisms would not obscure the data within 12 hours following 
missegregation; for example by dosage compensation by the alleles from the 
remaining homologous chromosome, as previously reported in stable aneuploid 
populations377,378. 
Total RNA was extracted from parental RPE-1, untreated RPE-1-4F, and EGFP-
negative and positive RPE-1-4F cells sorted by FACS, to be sent for transcriptome 
analysis. Initially, RNA extracted from up to 20,000 EGFP-negative cells was 
insufficient in yield and quality to send for RNA sequencing. To overcome these 
limitations, the experiment was scaled to enable sorting of ~ 300,000 EGFP-
negative, aneuploid cells per experiment. Yields from these larger experiments were 
sufficient in RNA quality and RNA concentration to send for transcriptome analysis 
(Affymetrix GeneChip Human Transcriptome Array 2.0). 
Data from the transcriptome array were RMA-transformed to correct for background 
noise and normalise for quantile variation between samples. RMA-transformed data 
were smoothed by plotting a 1000-point moving average of Log2 mRNA expression 
across the genome. Between untreated RPE-1-4F and parental RPE-1 cells there 
was little variation in gene expression patterns for most chromosomes (figure 5.4a). 
Genes from chromosome 12, however, were significantly down-regulated compared 
to parental RPE-1 cells as a result of the known trisomy in this cell line, confirming 
the SNP array observation.  
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Significant changes in mRNA expression in EGFP-negative, aneuploid cells were 
observed (figure 5.4b). The variation of mRNA expression increased in comparison 
to untreated RPE-1-4F cells. Additionally, notable differences above this base-line 
were observed for chromosomes 1q, 5, 6 and 15. Chromosome 1q exhibited a 
marked drop in expression (up to -15.9 %), chromosome 5 increased (up to +40.39 
%), chromosome 6 expression had fallen (up to -28.37 %) and chromosome 15 
expression had significantly increased (up to 66.12 %). 
These data suggest that the EGFP-negative populations are enriched for monosomy 
6 cells, and thus chromosome 6 is a candidate to be harbouring the EGFP 
transgene. Although monosomy enrichment was sufficient to be observed by 
transcriptome analysis, monosomy 6 was not enriched enough to be seen by SNP 
array suggesting that some of the analysis down-stream applies to populations 
which are not 100 % monosomic. This could further be a consequence of sorting 
EGFP-negative cells which are not aneuploid, due to a transient loss of EGFP signal 










Figure 5.4. RPE-1-4F transcriptome analysis. RPE-1 cells sorted by FACS were 
sent for transcriptome analysis. (a) RPE-1-4F mRNA normalised to parental RPE-1 
global mRNA. No differences were observed for any chromosomes except 
chromosome 12. (b) RPE-1-4F, 14r+2n, GFP-negative. mRNA were normalised to 
parental RPE-1. Blue box: chromosome 6 gene down-regulation. 
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5.2.3. FISH analysis of chromosome 6 in EGFP-negative and 
positive cells 
 
To confirm the identity of the reporter chromosome, centromeric FISH was 
performed on EGFP-negative and positive cell sorted by FACS, post-nocodazole 
treatment. The signal to noise ratio for centromere probes specific to chromosome 
6 and a control, chromosome 11, were sufficient to score aneuploidy rates in 1000 
cells for each condition. 
Importantly, EGFP-positive cells remained largely diploid for both chromosome 6 
and chromosome 11 (figure 5.5 and 5.5b). Conversely, dsEGFP-negative cells 
were enriched for cells containing either nullisomy or monosomy 6 (74.9 %), 
whereas chromosome 11 monosomy remained comparable to the EGFP-positive, 
diploid cells.  
These data suggest that chromosome 6 is the identity of the dsEGFP reporter 
chromosome which is lost in EGFP-negative RPE-1-4F cells post-nocodazole wash-
out. However, I could not validate this with SNP array, suggesting EGFP-negative 
monosomy enrichment needs to be improved. Down-stream analysis of aneuploid 
cells isolated in this way may be a useful tool for assessing the early responses to 
aneuploidy in human cells. However, further optimisations of the methods used to 
induce missegregation (to induce greater whole-chromosome aneuploidy) and ways 
to enhance monosomy enrichment are required for extensive characterisation using 
this novel approach. The McClelland lab is currently developing more precise ways 
to isolate highly-enriched monosomy population for single chromosomes which will 






Figure 5.5. Fluorescence in situ hybridisation of cells RPE-1-4F cells sorted by 
flow cytometry. RPE-1 cells sorted by FACS were settled onto glass slides and 
hybridised with CEP probes. (a) RPE-1-4F dsEGFP positive and negative cells 
sorted by FACS were stained with chromosome 6 and 11 CEP probes. (b) 
Chromosomes 6 and 11, in EGFP-negative cells, were lost at a rate of 74.9 % and 





5.3. Characterisation of aneuploid cells 
 
In this section, I begin to characterise the phenotypic responses of non-transformed 
human cells to chromosome missegregation, albeit from a less than 100 % pure 
population of cells. Therefore, the data described below are likely to underrepresent 
the de facto responses to monosomy in human cells and form the preliminary basis 
for further experimentation to validate the data presented in this chapter. 
 
5.3.1. Cell cycle arrest and apoptosis 
 
It is known that non-transformed cells arrest in the subsequent G1 following 
chromosome missegregation337,379–382. To confirm this phenotype in my aneuploidy-
reporter cell line, EGFP-positive and negative RPE-1-4F cells were fixed and stained 
with DAPI, and the DNA content of single cells analysed by flow cytometry (figure 
5.6a). EGFP-positive cells showed a cell-cycle profile consistent with that expected 
for proliferating diploid cells 12 hours following release from mitotic arrest, with the 
emergence of S-phase and G2/M peaks (4.99 %). In contrast, EGFP-negative cells 
had arrested in G1, as expected, and were not observed at either S or G2/M (0.00 
%). 
To determine the survival rate of aneuploid human cells, EGFP-positive and 
negative cells were seeded at low density and allowed to form colonies over 10 days. 
The colony outgrowth of the EGFP-negative cells was significantly reduced, as 
determined by crystal violet staining and absolute colony counts (figure 5.6b; 
**p<0.01). One important consideration is that EGFP-positive cells are not strictly 
diploid, as a small fraction of cells will also have missegregated unlabelled 
chromosomes. Therefore these data are more reflective of enriched vs. non-
enriched aneuploid population survival. 
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To determine the mechanism(s) of reduced colony outgrowth, EGFP-positive and 
negative cells were interrogated for markers of apoptosis. Apoptotic cells were 
identified by the incorporation of DAPI, and the presence of annexinV on the cell 
membrane, of unfixed samples at 12 and 24 hours post-nocodazole wash-out by 
flow cytometry373. These preliminary data reveal that 36.9 % of EGFP-negative cells 
were in late apoptosis by 12 hours post-nocodazole wash-out, compared to 0.2 % 
for the untreated control (figure 5.6c and 5.6e). By 24 hours, the fraction of EGFP-
negative cells in late apoptosis had decreased to 3.1 % whilst the percentage of 
dead EGFP-negative cells had risen from 13.8 % to 61.6 %, compared to just 0.8 % 
for the untreated control (figure 5.6d and 5.6e). These data demonstrate that the 
majority of EGFP-negative cells die via apoptosis within 24 hours of nocodazole 
wash-out. 
Unfortunately, from this experiment alone, the distinction between two main 
possibilities is still unclear. Are EGFP-negative cells dying via apoptosis because 
they are aneuploid? Or, alternatively, are EGFP-negative cell arising independently 
of chromosome loss for reasons which are inducing apoptosis (possibly induced by 
unknown nocodazole-related effects)? 
I had already observed ~ 20 % of cells in the EGFP-negative population with a 
diploid chromosome 6 content, therefore it is not possible to determine the 
contribution of diploid vs. aneuploid cells to the overall apoptotic fraction. The 
McClelland lab has previously observed aneuploid cells surviving beyond 12 hours 
following missegregation by live-cell imaging, therefore it is likely that a proportion 
of the EGFP-negative cells are in late apoptosis (or dead) despite the absence of 
chromosome missegregation in the preceding anaphase. 
However, EGFP-negative cells (although diluted ~ 20 %) may still reveal interesting 
transcriptome changes occurring in the early response to chromosome 




Figure 5.6. The early responses to aneuploidy in RPE-1 cells post-nocodazole 
wash-out. (a) EGFP-negative populations arrest in G1 12 hours post-nocodazole 
wash-out. (b) EGFP-negative cells have significantly reduced colony outgrowth 10 
days post-nocodazole wash-out, normalised to post-FACS control RPE-1-4F cells 
(two-tailed t-test assuming unequal variance; **p<0.01). (c) EGFP-negative 
populations display apoptosis by 12 hours. (d) Cell death occurs in 61.6 % of EFP-
negative cells by 24 hours. (e) Apoptosis in untreated RPE-1-4F cells post-FACS is 





5.3.2. Transcriptome analysis of the early responses to 
aneuploidy 
 
5.3.2.1. Cell cycle regulators 
 
The transcription level of mRNAs encoding for proteins involved in cell-cycle 
progression were interrogated by comparison of global mRNA from EGFP-negative 
cells normalised to EGFP-positive cells (figure 5.7). The relative transcriptome 
changes were normalised on a scale ranging from -4 (red) to +4 (green), where a 
lower number reflects lower mRNA transcription. 
All cyclin-dependent kinases (CDK) associated with progression through the cell 
cycle were down-regulated, as were their binding targets, for all phases of the cell 
cycle. Of particular note, transcripts encoding CDK4 and E2F1, required for 
progression from G1 through to S-phase, were among those most significantly down-
regulated (***p<0.001). Additionally, three potent up-stream enhancers of p53 
activation namely MDM2, ATM and p300 were significantly elevated (p<0.01, p<0.01 
and ***p<0.001, respectively). 
These data suggest that the EGFP-negative population is arresting in G1 through 
the inhibition of cell cycle progression proteins and down-regulation of the E2F family 
of transcription factors, required to execute the initiation of S-phase. Moreover, it 
implies that the earliest responses to aneuploidy involve the upregulation of genes 
which promote p53 engagement and stabilisation in the nucleus, as previously 
reported294. Interestingly, the expression of p53 was not significantly different in 
EGFP-negative cells, suggesting that the p53 stabilisation in response to aneuploidy 
occurs prior to p53 expression changes. This is supported by the observation that 






Figure 5.7. Transcriptome analysis of cell cycle proteins in EGFP-negative 
RPE-1-4F cells. mRNA encoding for proteins involved in the cell cycle were down-
regulated in the EGFP-negative population. Increases were observed for EP300 
(p300; ***p<0.001), MDM2 (**p<0.01) and ATM (**p<0.01) suggesting the onset of 









5.3.2.2. G1/S checkpoint down-regulation 
 
Of particular interest is the level of transcripts encoding for regulators of the transition 
from G1 to S phase of the cell cycle. Strikingly, all transcripts coding for pro-cell 
cycle progression proteins, including E2F transcription factor family proteins and 
retinoblastoma proteins were significantly down-regulated (figure 5.8). Additionally, 
several proteins required for DNA replication and S-phase execution were 
significantly down-regulated, most notably POLƐ, MCM2 and RPA2 (***p<0.001). 
Additionally, there was an increase in transcripts for the cell cycle CDK regulators, 
CDKN2B (***p<0.001). All members of the origin recognition complex (ORC) family 
of proteins remained unchanged compared to the untreated control (data not 
shown). 
The effects of these changes are likely to promote a complete cessation of cell cycle 
progression and engaging the DNA damage response pathway. The upregulation of 
RPA2 suggests either that a short nocodazole wash-out in synchronised cells is 
inducing single-stranded DNA formation, or that the link between aneuploidy and the 
DNA damage response is mediated by RPA2. I propose that the latter is more likely, 
given that I did not observe significant unresolved DNA damage at prometaphase 
following a short nocodazole wash-out in synchronised cells (figure 4.3a and 4.3b; 
chapter 4). It is also unclear if some genes may be down-regulated due to 
haploinsufficiency of the reporter chromosome and it would be important to correct 







Figure 5.8. Transcriptome analysis of DNA damage-related proteins in EGFP-
negative RPE-1-4F cells. Gene expression profiles of proteins involved in the DNA 
damage repair demonstrated an increase in the upstream DNA damage pathway 
activation occurs in nascent aneuploid cells including MDM2 and RPA2. Data 










5.3.2.3. DNA damage response and apoptosis 
 
I had previously reported the activation of apoptosis in EGFP-negative cells (figure 
5.6c). The up-regulation of BCL6, and down-regulation of BCL2, mRNA therefore 
confirmed the induction of apoptosis already seen by AnnexinV staining in this 
population (figure 5.9; ***p<0.001). Although BCL2 was down-regulated, this did not 
correlate with an increase of the pro-apoptotic protein BAX or BAK1. Moreover, an 
increase in transcripts for the pro-apoptotic protein BCL2L11 was also observed 
(**p<0.01). 
These data suggest that the late apoptotic fraction of EGFP-negative cells at 12 
hours following nocodazole wash-out are dying through the intrinsic apoptosis 
response383. One important consideration is that the EGFP-negative population may 
be sensitised to stress arising during FACS following nocodazole wash-out. 
Therefore, although the induction of apoptosis was not observed in untreated RPE-











Figure 5.9. Transcriptome analysis of apoptotic signalling networks in EGFP-
negative RPE-1-4F cells. Gene expression profiles of proteins involved in the pro- 
and anti-apoptotic responses suggests a significant increase in pro-apoptotic factors 









In chapter 5, I have applied the chromosome missegregation strategy and 
aneuploidy reporter cell line from chapter 4 to enrich for EGFP-negative cells and 
sort this population by FACS. Using a combination of transcriptome analysis and 
traditional FISH, I have identified a ~75 % monosomy 6 enrichment in my EGFP-
negative population. Moreover, I have started to assess the validity of this system 
for isolating aneuploid cells as early as 12 hours following chromosome loss. 
Populations of cells isolated in this way behave similarly to the literature, arresting 
in G1 and undergoing apoptosis, although whether EGFP loss is a cause or 
consequence of these phenotypes is still being investigated. 
Furthermore, my preliminary transcriptome pathway analysis indicates that many of 
the expected consequences of chromosome loss are in agreement with my results, 
particularly the down-regulation of cell cycle progression proteins and increased 
transcription of pro-apoptotic proteins.  However, it is apparent that further 
optimisations of this system are required to improve the enrichment of monosomic 













6. The missegregation rates 




















Due to technical limitations, the rate of spontaneous chromosome 
missegregation in human tissues is currently unknown. Recent in vitro studies and 
mouse models estimate the rate of spontaneous chromosome gain or loss to be 
around once in every 100 cell divisions, and this is likely to vary between cell lines 
with different tissues of origin312,343. However, the rates of chromosome gain and 
loss for the majority of individual chromosomes have yet to be determined in a robust 
and systematic manner. 
Human chromosomes are very different to each other and this intrinsic variation may 
pre-dispose particular chromosomes to missegregation (figure 6.1a). This question 
is of fundamental interest to the fields of cell biology and medicine as it is currently 
unclear how patterns of aneuploidy in human disease arise, and if certain 
chromosomes are vulnerable to missegregation384,385. The available next-generation 
technologies, such as single-cell sequencing, are still expensive for routine analysis. 
Moreover, manual FISH scoring is artefact-prone and labour intensive, thus there is 
high demand for novel approaches to assess the rates of individual human 
chromosome missegregation386,387. 
Here, I implement a high-throughput image cytometry–based technology to detect 
whole-chromosome copy-number alterations (CNA) in response to a variety of 
cellular stresses, revealing striking difference in individual chromosome 
missegregation rates and patterns of aneuploidy across cell lines with different 






6.1. An image cytometry-based approach to detect 
aneuploidy 
 
A variety of methods for imaging cells in flow have been refined following the advent 
of traditional flow cytometry. Such approaches have included flying spot scanning, 
slit scanning, mirror tracking and strobed illumination cytometry388–390. One of the 
greatest challenges for analysing single cells by flow cytometry is achieving imagery 
with high enough spatial resolution, fluorescence sensitivity and accuracy to 
combine with brightfield images of each cell in the flow. Over the last 10 years, 
advances in computing and optical filtration have combined all of these important 
parameters, permitting the practical application of imaging flow cytometry. 
One such example is the ImageStreamX cytometer, a commercially available 
instrument which combines high resolution multispectral imaging with electronic cell 
tracking, producing images of comparable quality and resolution as a conventional 
60X fluorescent microscope391. With a maximum throughput of 300 cells per second, 
the ImageStreamX produces 60,000 images of 10,000 cells in 30 seconds. 
Combined with the data analysis software package – IDEAS – this system can 
quantify over 250 individual features per cell, opening up a realm of high-throughput 
fluorescent imaging and analysis possibilities391.  
It has previously been shown that the ImageStreamX can accurately detect 
monosomies and trisomies in clinical acute myeloid leukaemia samples, with a 
detection sensitivity and false discovery rate of ~ 1 %325. I wanted to test the 
ImageStreamX system in my own hands, to determine if I could also detect 
aneuploidy in a high-throughput manner. If possible, it was my intent to use this 
technology to determine the missegregation rates of individual human 
chromosomes, in response to a variety of cellular stresses, as outlined in the preface 
to this chapter.  
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6.1.1. Optimising aneuploidy detection by the ImageStreamX 
 
Individual chromosomes were labelled with fluorescent α-satellite centromere 
enumeration probes (CEP) by FISH in suspension (FISH-IS).  Fluorescent and 
bright-field images of single cells were then obtained using the ImageStreamX 
cytometer (figure 6.1b). Images were analysed, and the ploidy for each 
chromosome determined, using the IDEAS software package325. 
Single cells passing through the flow chamber are distinguished from cell 
aggregates by low area and high aspect ratio. The extended depth of field (EDF) 
element was used to increase the focus range from 4 µm to 16 µm, allowing close 
to 100% of cells to be focused. Single, in-focus cells were then analysed for the 
ploidy of individual chromosomes by applying a ‘spot mask’ and ‘spot counting’ 
feature to the centromere probe signals for each image (figure 6.1b). 
The images obtained of CEP spots are 2D projections of 3D images, to encompass 
the entire volume of the nucleus. If a cell is aligned so that the two centromere 
signals are in the same plane, they appear as a single focus, because they overlap 
following image deconvolution and projection (figure 6.1c). 
To correct for this discrepancy, CEP fluorescence signal intensity was plotted as a 
histogram which correlates with the amount of probe hybridised, as well as the spot 
count (figure 6.1d). Disomic chromosomes (e.g. RPE-1 chromosome 18) had a 
medium intensity of hybridisation signal, representing two spots. Cells with one spot 
(e.g. HCT116 chromosome X) will have approximately 50% of the hybridisation 
intensity and fall in the low range; cells which had gained a chromosome will have 
150% of the hybridisation signal intensity, falling in the high range (e.g. HCT116 
stained for both chromosome 18 and X). For the majority of cells with a single CEP 
spot, where disomy is anticipated (e.g. RPE-1 chromosome 18), the total 
fluorescence for that cell was observed in the medium range of intensity (>99 %). 
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This suggests that they are disomic cells with aberrant ploidy-spot relationship in 
which the two signals are eclipsed following image projection, appearing as a single 
focus. 
Given this, it is anticipated that there will be a small error margin of ploidy 
misclassification in my particular ImageStreamX configuration, of approximately 1 %, 
as previously reported325.  Therefore, complementary approaches such as traditional 


















6.1.2. An assessment of aneuploidy detection by the 
ImageStreamX 
 
To make a preliminary assessment of whether chromosome missegregation rates 
were accurately detected with the ImageStreamX, chromosome missegregation was 
elevated in an otherwise chromosomally-stable cell line – HCT116337,338. This cell 
line was exploited for the initial assessment of the ImageStreamX as it was 
fortuitously amenable to the FISH-IS optimisation, in addition to its biological 
relevance (see section 6.2.4). 
HCT116 cells were treated with an 8-hour nocodazole wash-out strategy, to elevate 
chromosome missegregation. Following a 12-hour wash-out, monosomy and 
trisomy rates were analysed by image cytometry and conventional fluorescence 
microscopy for a panel of chromosomes, covering a range of chromosome sizes and 
anticipated ploidy states (chromosomes 12, 16, 18 and X; monosomy X is 
anticipated because HCT116 are of male origin). The ploidy of individual 
chromosome was determined in 1,000 cells by conventional FISH and 20,000 cells 
by image cytometry. Importantly, monosomy and trisomy rates obtained by image 
cytometry were in good agreement with those scored by conventional FISH (figure 
6.1e; R2=0.9816). 
There are currently no centromeric probes available for six chromosomes which 
have high centromere sequence similarity to each other; chromosomes 5, 13, 14, 
19, 21 and 22. Unfortunately, I were unable to optimise the commercially available 
telomere probes for these chromosomes for image cytometry analysis. In some of 
the experiments below, the aforementioned chromosomes were analysed using 
traditional telomeric FISH; these data are highlighted throughout this chapter. 
These data demonstrate that I have a robust experimental workflow to systematically 
determine the aneuploidy rates for most human chromosomes in many thousands 
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of cells per experiment. I are therefore able to assess chromosome copy number 
alterations, with high accuracy, to determine if certain chromosomes are more 
vulnerable to missegregation. This is an important question as determining the 
missegregation rates of individual chromosomes may help elucidate the basis for 
the recurrent aneuploidy patterns observed in human diseases – do aneuploidy 
patterns arise mainly through selection pressure or is there also continual 









Figure 6.1. Aneuploidy can be accurately detected by image cytometry. (a) 
Human chromosome attribute map. Chromosomes display heterogeneity in physical 
characteristics, composition and interphase nuclear arrangement. (b) Centromere 
enumeration probes can be detected by image cytometry. (c & d) Overlapping 
centromere signals can be resolved by population-based histogram fluorescence 
quantification. (e) Aneuploidy rates scored by image cytometry are in good 
agreement with those by traditional scoring methods for a range of chromosomes 
within the 95 % confidence limits (CL; R2 = 0.9816). Scale bars: 20 µm. 
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6.2. Aneuploidy rates following nocodazole wash-out 
 
Chromosome missegregation can arise because of chromosome spindle 
malorientation occurring during mitosis265,392. To mimic spindle orientation defects, 
cell were arrested in mitosis for 8 hours with nocodazole. Nocodazole depolymerises 
microtubules which can reassemble upon wash-out, leading to chromosomes that 
are not correctly bioriented on the spindle, due to an increased frequency of 
merotelic attachments, as previously described in chapter 4 (figure 4.2a) After an 
8-hour mitotic arrest, nocodazole was washed out for 12 hours to allow cells to 
complete mitosis, after which the of ploidy of single cells was analysed, before 
significant cell death (and therefore selection) has occurred339.  
Here, I characterise the aneuploidy rates for individual human chromosomes 
following nocodazole wash-out in cell lines of different tissue origin, ploidy and 
tumorigenic status. Addressing the issue of chromosome missegregation following 
nocodazole wash-out is a fundamental priority for two reasons; firstly, the rate of 
merotelic attachments are known to be increased in human cancers and therefore 
patterns of aneuploidy might arise from the chromosomes most prone to orientation 
defects234,248,393. Secondly, nocodazole wash-out is a popular strategy for increasing 
chromosome missegregation in cell biology studies346,394–396. Therefore, it is 
important to interrogate whether segregation error rates and aneuploidy observed in 
vitro support the prevailing assumption that chromosomes missegregate with equal 
frequencies following nocodazole wash-out236. 
I chose to assess the rates of aneuploidy in RPE-1, BJ, HCT116 and RPE 12/3 (with 
a stable chromosome 12 trisomy) cells as these cell lines have been established in 





6.2.1. RPE-1 aneuploidy rates following nocodazole wash-out 
 
RPE-1 cells are a chromosomally stable, non-transformed cell line of epithelial origin 
which were used for my aneuploidy reporter strategy in chapters 4 and 5. It was 
anticipated that the rate of spontaneous chromosome missegregation would be low 
in this cell line, therefore elevated aneuploidy rates could be detected for individual 
chromosomes above this baseline. 
In untreated RPE-1 cells, basal levels of aneuploidy were low, as expected for a 
chromosomally stable cell line – and from the micronuclei formation rates already 
observed in untreated RPE-1 cells (figure 6.2; grey dots and figure 4.2c; chapter 
4). On average, chromosomes were lost at a frequency of 1.83 %. However, 
chromosome 8 was lost more frequently than the mean over triplicate experiments 
(3.49 %; p<0.05). The average chromosome gain rate was 1.03 % with no individual 
chromosomes varying significantly from the mean. 
I next determined aneuploidy rates following microtubule disruption with 8-hour 
nocodazole wash-out, to elevate merotely. Twelve hours post-nocodazole wash-out, 
an increase in chromosome missegregation was observed, as expected (figure 6.2; 
blue and red dots). The average rate of chromosome gain was 3.92 %. However, I 
did not observe uniform chromosome gains. Strikingly, chromosomes 1, 3, 4, 7 and 
10 were gained at significantly higher rates than all other chromosomes tested (3.59, 
3.97, 10.20, 5.48 and 5.09 %, respectively; *p<0.05).  
Chromosome loss also showed similar patterns, with chromosomes 1, 3, 4, 7, 10 
and 18 being lost at high rates (6.39, 10.95, 5.20, 5.56, 5.83 and 5.43 %, 
respectively; *p<0.05). Chromosome 2 loss rates appeared elevated above the 
mean, but marginally failed to reach significance (p=0.063). For chromosomes 3, 4, 
and 18 the loss rate was not equal to the gain rate. This was unexpected, given that 
the McClelland lab has not observed cell death following chromosome 
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missegregation at this time point. One explanation is that chromosomes trapped in 
micronuclei, which do not reincorporate into the main nucleus, are being lost during 
the FISH-IS sample preparation, as only the nuclear chromosome content is 
analysed. 
These data demonstrate that the contribution of each chromosome to the overall 
missegregation rate is unequal, with certain chromosomes being prone to 
aneuploidy following nocodazole wash-out. They further reveal that nocodazole, 
thought to increase global chromosome missegregation stochastically and equally 
for all chromosomes, is actually inducing the missegregation of a small subset of 
chromosomes. Moreover, these data highlight that recurrent patterns of aneuploidy 











Figure 6.2. RPE-1 aneuploidy rates following nocodazole wash-out. Aneuploidy 
rates were determined for a large panel of human chromosomes with commercially 
available centromere probes. Basal levels of aneuploidy were low in unperturbed 
cells (grey dots; 1.03 % gain, 1.83 % loss). Global chromosome missegregation was 
elevated following mitotic disruption with 16-hour nocodazole wash-out (blue dots; 
3.92 % gain, 4.00 % loss). Aneuploidy involving chromosomes 1, 3, 4, 7, 10 and 18 
were observed more frequently than the global average, suggesting they are prone 
to missegregation following mitotic insult (red dots). All dots represent independent 
experiments. Red dots represent significant aneuploidy deviation from the mean 








6.2.2. RPE-1 aneuploidy rates: single-cell sequencing validation 
 
To further validate the missegregation rates using an independent methodology, 
control and nocodazole-treated RPE-1 cells were analysed by single-cell 
sequencing. 
Single-cell sequencing is a recent technological development which allows the 
genomic content of single cells to be analysed. The advantages of single-cell 
sequencing over conventional sequencing approaches is that it allow genomic 
aberrations to be detected with exquisite resolution, providing highly-accurate 
determination of chromosome copy number alterations on a per-cell basis. Single 
cells were sorted by flow cytometry, to obtain a pure G1 cell fraction, and sequenced 
by a collaborator using proprietary AneuFinder software as previously 
described314,386. Samples were frozen and analysed 12 hours following nocodazole 
release, therefore the majority of cells sequenced were in G1 and were of sufficient 
DNA quality for analysis (data not shown). 
In untreated RPE-1 cells, basal levels of aneuploidy were low, in-line with the data 
obtained by image cytometry (figure 6.3; top panel). In all cells, I observed a gain 
of chromosome 10q, confirming the data from SNP array analysis of untreated RPE-
1 cells already observed in my hands (see chapter 5.2.1.1). One of the single cells 
sequenced harboured four copies of chromosome 10q, in addition to partial gains of 
chromosomes 6, 10p, 12 and X. Monosomy X was observed in a single cell; and 
partial trisomy of chromosome X in two single cells. These data validate basal levels 
of aneuploidy to be low in untreated RPE-1 cells, as observed by image cytometry. 
Following nocodazole wash-out aneuploidy was elevated, as expected (figure 6.3; 
bottom panel). The known chromosome 10q aberration in this cell line was observed 
in all cells, as for the untreated control. Importantly, chromosomes 1, 2, 3, 4, 7, 10 
and 18 were lost in between 10-30 % of cells, confirming the data obtained by image 
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cytometry. Additionally, chromosomes 5, 12 and 21 were observed to be lost in one 
single cell, out of the 12 analysed. In “cell 1”, the missegregation of six chromosomes 
was observed simultaneously, and accounted for a fraction of the chromosome loss 
rates not observed by image cytometry. This is likely a cell that underwent a 
multipolar division and would therefore be excluded, based on area and aspect ratio, 
by the ImageStreamX. 
Importantly, these data are in good agreement with the missegregation rates 
observed by image cytometry. Therefore, I conclude that the ImageStreamX is a 
robust system for determining the missegregation rates of individual human 
chromosomes in a high-throughput manner, which I have validated by two further 
independent methodologies (traditional FISH on glass slides and single-cell 
sequencing).  
Furthermore, these data confirm chromosome missegregation rates to be unequal 
following nocodazole wash-out, demonstrating that a subset of chromosomes are 
more vulnerable to merotely. If I exclude cell 1 from my analysis, which presumably 
went through a multipolar division, I do not see either the high gain or loss rates for 
chromosome 4 as observed by image cytometry. One explanation is that the CEP 
probe for chromosome 4 is subject to cross-hybridisation artefacts between 
centromeres, a possibility which is raised in the corresponding manufacturer data 
sheet for this probe, and may be exacerbated through unknown means following 
nocodazole wash-out. Finally, chromosome 2, which was borderline significant by 
image cytometry (p=0.063), was lost in 25 % of cells by SCS. One explanation is the 
experimental variance for chromosome 2 in a single experiment accounted for the 
failure to reach significance, as two of three experiments were above the mean and 




Figure 6.3. RPE-1 single cell sequencing following nocodazole wash-out. 
Aneuploidy rates for all chromosomes were determined by single cell sequencing in 
RPE-1 cells. Aneuploidy rates for control (top panel) and nocodazole wash-out 
(bottom panel) broadly reflected those observed by image cytometry. 
Representative DNA profiles for individual cells are shown. 
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6.2.3. BJ aneuploidy rates following nocodazole wash-out 
 
To determine if the patterns of aneuploidy observed in RPE-1 cells could be 
attributed to the intrinsic properties of a small subset chromosomes, or was a cell 
line-specific phenomenon, the nocodazole wash-out was repeated in BJ cells, a non-
transformed, immortalised cell line of fibroblast origin. 
Basal levels of aneuploidy in untreated BJ cells were low and uniform for both 
monosomy and trisomy (1.66 and 1.92 %, respectively; figure 6.4; grey dots). The 
only exception was chromosome 4 which was gained at nearly twice the mean rate 
for all other chromosomes (2.62 %), possibly as a result of probe cross-reactivity 
described in section 6.2.2. These findings are in agreement with preliminary data 
demonstrating low basal rates of anaphase errors in this cell line and the expectation 
that missegregation rates would be low in chromosomally-stable cells339. 
Following nocodazole wash-out, I observed an increase in the rate of chromosome 
gain and loss, as expected (3.75 and 4.32 %, respectively; figure 6.4; blue and red 
dots). Chromosomes 1, 3, 10, 18 and 20 were lost more frequently than the mean, 
in good agreement with the patterns observed in RPE-1 cells; demonstrating that a 
small subset of chromosomes are particularly vulnerable to missegregation (6.84, 
6.16, 6.48, 5.43 and 5.87 %, respectively; *p<0.05). Overall, rates of chromosome 
gain were more similar to the corresponding chromosome loss rates, in comparison 
to RPE-1 cells. Chromosome 4 was the only chromosome tested which was gained 
more frequently than the mean (17.79 %; *p<0.05). 
These data corroborate that the intrinsic properties of chromosomes 1, 2, 3, 4, 10 
and 18 make them vulnerable to missegregation following nocodazole wash-out. 
Moreover, patterns of aneuploidy in human disease may be influenced by the 
intrinsic properties of a select few chromosomes which are vulnerable to recurrent 
missegregation. This is a particularly important discovery as it highlights a 
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previously-uncharacterised requirement for individual chromosome-level resolution 
of aneuploidy mechanisms; the absence of which obfuscates the interplay between 

















Figure 6.4. BJ aneuploidy rates following nocodazole wash-out. Aneuploidy 
rates were investigated in a second cell line, BJ, of fibroblast origin. Basal levels of 
aneuploidy were low in unperturbed cells (grey dots; 1.92 % gain, 1.66 % loss). 
Global chromosome missegregation was elevated to similar levels following 
microtubule disruption with 8-hour nocodazole wash-out (blue dots; 3.75 % gain, 
4.32 % loss). Significantly elevated aneuploidies were similar to RPE-1 cells, 
involving chromosomes 1, 3, 4, 10, 18 and 20 (red dots). All dots represent 
independent experiments. Red dots represent significant aneuploidy deviation from 









6.2.4. HCT116 aneuploidy rates following nocodazole wash-out 
 
To elucidate if non-random missegregation could be observed in human cancers, I 
took advantage of a chromosomally-stable, transformed cell line HCT116, originally 
derived from male colon carcinoma tissue. Determining the rates of missegregation 
in a transformed cell line may provide additional insight into the intrinsic propensities 
of chromosomes to missegregate in cancer cells, with potentially important 
implications for tumourigenesis and cancer evolution. Additionally, this would allow 
us to investigate whether recurrent patterns of non-random aneuploidy occur for the 
same subset of chromosomes observed in RPE-1 and BJ cells. 
In untreated HCT116 cells, basal levels of chromosome gain were higher than 
expected for a chromosomally-stable cell line, and compared to RPE-1 cells (1.96 
%; figure 6.5, grey dots; *p<0.05). Particularly, chromosomes 6, 12 and 16 were 
being gained at rates approximately twice that of the mean for all other 
chromosomes tested (3.87, 3.37 and 4.57 %, respectively; *p<0.05). However, this 
could also represent a low level of previously-uncharacterised stable aneuploidy in 
the population as I cannot distinguish between these possibilities with this 
experiment. 
The average rate of basal chromosome loss was 1.83 % in untreated HCT116 cells. 
Of note, HCT116 cells are derived from the male colon and therefore monosomic 
for chromosome X. In my hands, I find that basal levels of chromosome X loss was 
zero (which is likely an artefact of the detection limit of the ImageStreamX), indicating 
that HCT116 cells with stable nullisomy X karyotype are extremely rare. Additionally, 
chromosome 12 was lost significantly less frequently than the mean (0.37 % loss; 
*p<0.05). For all other chromosomes tested, basal rates of chromosome loss were 
low and uniform, as expected. 
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Following nocodazole wash-out chromosome missegregation was elevated, as 
expected. The average rate of chromosome gain was 5.31 %, significantly higher 
than that observed for either RPE-1 or BJ cells following identical treatment 
(*p<0.05). Chromosomes 3, 4, 9, 15 and X were gained at significantly higher rates 
than the mean, representing a modest overlap in aneuploidy patterns compared to 
RPE-1 and BJ cells (7.37, 11.22, 10.04, 8.54 and 10.32 %, respectively; *p<0.05). 
Given that the mean trisomy rate was higher than both RPE-1 and BJ cells following 
nocodazole wash-out, there may be a greater degree of CIN or aneuploidy in this 
cell line than previously reported. 
The average chromosome loss rate following nocodazole wash-out was similar to 
the chromosome gain rate (5.81 vs. 5.31 %, respectively). Likewise, it was observed 
that the mean monosomy rate was significantly greater than both RPE-1 and BJ 
cells (5.81 vs. 4.00 and 4.32, respectively; *p<0.05). The loss of chromosomes 8 
and 17 were observed only at rates comparable to the untreated control cells (3.00 
and 2.14 %, respectively). Conversely, chromosome 18 and 20 were lost at 
significantly higher rates than the other chromosomes analysed (17.94 and 11.22 
%, respectively; *p<0.05). 
These data demonstrate that a small number chromosomes – 3, 4, 18 and 20 – are 
susceptible to missegregation in both transformed and non-transformed cell lines 
following errors that occur during mitosis. However, it is possible that there are 
several further features of HCT116 cells – such as tissue origin and transformation 
status – which influence chromosome missegregation rates for those chromosome 
which are distinctly vulnerable in HCT116 cells. The McClelland lab is trying to 
elucidate if the large translocation of one chromosome 18 allele, which I also report 






Figure 6.5. HCT116 aneuploidy rates following nocodazole wash-out. 
Aneuploidy rates were investigated in a transformed cell line, HCT116, of human 
colon carcinoma origin. Basal levels of aneuploidy were higher than RPE-1 and BJ 
cells in unperturbed cells (grey dots; 1.96 % gain, 1.83 % loss; *p<0.05). Global 
chromosome missegregation was elevated to higher levels than RPE-1 and BJ cells 
following microtubule disruption with 16-hour nocodazole wash-out (blue dots; 5.31 
% gain, 5.81 % loss; *p<0.05). The most frequently elevated aneuploidies were 
strikingly different to RPE-1 and BJ cells, involving chromosomes 3, 4, 9, 15, 18, 20 
and X (red dots). All dots represent independent experiments. Red dots represent 









6.2.5. RPE-1 12/3 aneuploidy rates following nocodazole wash-
out 
 
It has already been observed that the presence of extra chromosomes leads to 
genomic instability236,336. Specifically, RPE-1 cells harbouring a stable chromosome 
12 trisomy (RPE-1 12/3) are susceptible to an increased frequency of DNA damage 
and anaphase chromosome bridges336. In my hands, I have already confirmed the 
stable maintenance of a chromosome 12 trisomy by SNP array in this cell line (see 
chapter 5.2.1.1). Therefore, image cytometry was used to determine whether the 
presence of an extra chromosome generates recurrent patterns of missegregation 
for specific chromosomes in RPE-1 12/3 cells. This is an important question as it is 
currently unclear if aneuploidy itself influences patterns of pathological chromosome 
missegregation. Additionally, the missegregation rates for chromosomes 5, 13, 14, 
19, 21 and 22 were analysed by conventional telomeric FISH on glass slides 
(preliminary data shown). 
In untreated RPE-1 12/3 cells, basal levels of chromosome gain and loss were 
significantly higher (approximately twice) that observed for untreated, disomic RPE-
1 cells (figure 6.6; grey dots; 2.17 and 2.53 %, respectively; *p<0.05). The 
chromosome 12 trisomy was present in 82.4 % of cells, as expected from my SNP 
array observations (figure 6.6, bottom panel). No individual chromosomes loss rates 
in untreated cells varied significantly from the mean. Conversely, chromosomes 4, 
16, 20 and X were gained at significantly higher rates than the mean (4.02, 3.03, 
3.18 and 5.01 %, respectively; *p<0.05), highlighting that certain chromosomes may 
be vulnerable to missegregation in unperturbed aneuploid cells by the presence of 
a single extra copy of chromosome 12. 
In RPE-1 12/3 cells, following nocodazole wash-out, an increase in chromosome 
missegregation was observed (figure 6.5; blue and red dots). The mean 
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chromosome loss rate, but not gain rate, was significantly higher than that observed 
for diploid RPE-1 cells under the same conditions (4.00 vs. 5.27 %; *p<0.05). 
Chromosomes 1, 3 and 10 were lost at significantly higher rates than the other 
chromosomes tested, a pattern which was similar, but incomplete, to that observed 
for diploid RPE-1 and BJ cells (7.64, 7.41 and 8.01%, respectively; *p<0.05).  
These data demonstrate that basal chromosome missegregation is elevated in 
aneuploid cell lines by the presence of a single extra copy of chromosome 12, as 
previously reported336. Strikingly, this phenomenon is exaggerated following 
nocodazole wash-out where overall chromosome loss rates are ~ 25 % greater than 
diploid RPE-1 cells. Interestingly, patterns of chromosome missegregation following 
nocodazole wash-out were similar, but not identical, to those observed for diploid 
RPE-1 cells. This suggests that the presence of an extra chromosome influences 
patterns of aneuploidy, at least in this cell type. Further validation of other trisomies 












Figure 6.6. RPE-1 12/3 aneuploidy rates following nocodazole wash-out. 
Aneuploidy rates were investigated in a sub-clone of RPE-1 cells containing a stable 
chromosome 12 trisomy. Basal levels of aneuploidy were higher than RPE-1 cells in 
unperturbed cells (grey dots; 2.17 % gain, 2.53 % loss; two-tailed t-test *p<0.05). 
Global chromosome gain was elevated to a similar rate as diploid RPE-1 cells, but 
chromosome loss was greater, following microtubule disruption with 8-hour 
nocodazole (blue dots; 5.31 % gain, 5.81 % loss; two-tailed t-test *p<0.05). The most 
frequently-elevated aneuploidies were broadly similar to RPE-1 and BJ cells, 
involving chromosomes 1, 3, 4 and 10 (red dots). Chromosomes 5, 13, 14, 19, 21 
and 22 were scored in at least 200 cells from independent experiments using 
traditional manual scoring with telomeric probes. All dots represent independent 
experiments. Red dots represent significant aneuploidy deviation from the mean 






6.3. Aneuploidy rates following DNA replication stress 
 
DNA replication stress can induce chromosome missegregation through the 
formation of dicentric chromosomes and chromosome bridges226. It is also known 
that replication stress is increased in aging cells and human colorectal 
carcinomas397,398. However, the mechanisms underlying pathological aneuploidy 
patterns observed in conditions of high replication stress are currently unknown and 
therefore of high therapeutic interest.  
Moreover, it is known that one major mechanism generating replication stress is 
collisions between the replication and transcription machinery399–401.  I therefore 
hypothesised that gene-dense chromosomes, where replication-transcription 
collisions may be elevated402, may be more prone to structural aberrations which 
could generate aneuploidy-prone chromosomes. To interrogate these important 
questions, patterns of aneuploidy were determined by image cytometry following 
replication stress induced for 24 hours, with low-dose DNA polymerase II inhibition, 
using aphidicolin403. This treatment length was chosen to allow the majority of cells 











6.3.1. RPE-1 aneuploidy rates following DNA replication stress 
 
As expected, replication stress-induced chromosome missegregation was elevated 
in RPE-1 cells at 24 hours post-aphidicolin treatment (figure 6.7; blue and red dots). 
The mean gain and loss rates were not significantly different to the rates following 
nocodazole wash-out, demonstrating that global aneuploidy is similar under different 
cellular stresses (3.79 and 4.73 %, respectively). However, chromosomes 2, 4 and 
20 were gained at significantly higher rates than the mean (10.56, 5.37 and 7.25 %, 
respectively; *p<0.05). 
Additionally, chromosomes 3, 4, 6, 16 and 18 were lost significantly more frequently 
than the mean following the induction of DNA replication stress (5.83, 5.69, 5.98, 
6.82 and 9.27 % respectively; *p<0.05). I have therefore discovered that high 
aneuploidy rates can be observed for chromosomes that were not elevated following 
nocodazole wash-out, namely for chromosomes 6 and 16. One important 
consideration is that these data only reflect changes in centromere number. 
Therefore, structural aberrations which result in centromere duplication or loss 
following DNA replication stress cannot be differentiated in this experiment and may 
lead to a false discovery rate. 
These data demonstrate that similar patterns of chromosome loss can be observed 
in the same cell type (RPE-1) under different cellular stresses (nocodazole wash-
out vs. replication stress). Importantly, they also highlight that some patterns of 
chromosome missegregation, for example chromosomes 6 and 16, are induced by 
different mechanisms. Moreover, the lack of high chromosome 1 missegregation 
following replication stress, observed after nocodazole wash-out, raises the 
possibility that there are multiple routes to aneuploidy which may be chromosome 





Figure 6.7. RPE-1 aneuploidy rates following DNA replication stress. 
Aneuploidy rates were investigated in RPE-1 cells following 24 hours of replication 
stress induced by aphidicolin. Global chromosome missegregation was elevated to 
a similar rate as RPE-1 cells following mitotic stress (blue dots; 3.79 % gain, 4.73 % 
loss). The most frequently elevated aneuploidies were those involving 
chromosomes 2, 3, 4, 6, 16, 18 and 20 (red dots). All dots represent independent 
experiments. Red dots represent significant aneuploidy deviation from the mean 










6.3.2. BJ aneuploidy rates following DNA replication stress 
 
To determine if the patterns of aneuploidy observed following DNA replication stress 
in RPE-1 cells was intrinsic missegregation behaviour of these few chromosomes, 
or a cell line-specific phenomenon, I treated BJ cells with low-dose aphidicolin for 
24 hours. 
As expected, chromosome missegregation was elevated in BJ cells induced with 
replication stress (figure 6.8; blue and red dots). The mean rate of chromosome 
loss was 3.70 %. However, some individual chromosomes were significantly less 
frequently monosomic in the population, with chromosomes 1 and 8 being lost at a 
rate approximately half that of the mean (1.66 and 1.82 %, respectively; *p<0.05). 
Conversely, chromosomes 3 and 18 were monosomic at rates significantly higher 
than the mean, an interesting observation given that these chromosomes were also 
lost at high rates following replication stress in RPE-1 cells  (5.84 and 10.86 %, 
respectively; *p<0.05). Of further interest, chromosomes 6 and 16 which displayed 
high monosomy in RPE-1 cells were not missegregating above the mean in BJ cells, 
highlighting that there may be cell-line specific difference for particular 
chromosomes following DNA replication stress. 
The mean rate of chromosome gain was elevated, and similar to the loss rate, 
following DNA replication stress (3.44 vs. 3.77 %, respectively). Chromosomes 2, 4 
and 20 were all gained at significantly higher rates than the mean, representing a 
complete overlap in trisomy pattern with RPE-1 cells (6.18, 12.57 and 6.84 %, 
respectively; *p<0.05). All other chromosomes tested were gained at similar rates. 
Taken together, these data demonstrate that patterns of aneuploidy following DNA 
replication stress are recurrent between cell types with different tissues of origin. 
Moreover, there are individual chromosomes which are prone to missegregation 
only following nocodazole wash-out (1 and 10), DNA replication stress (6 and 16) or 
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both (2, 3, 4, 18 and 20). The underlying mechanistic basis for these recurrent 
patterns and differences are still unclear, as chromosome-specific rates of 
aneuploidy are likely to reflect a range of individual chromosome characteristics and 

















Figure 6.8. BJ aneuploidy rates following DNA replication stress. Aneuploidy 
rates were investigated in BJ cells following 24 hours of replication stress induced 
by aphidicolin. Global chromosome missegregation was gain was elevated to a 
similar rate as RPE-1 cells, but chromosome loss was marginally reduced (blue dots; 
3.44 % gain, 3.70 % loss). The most frequently elevated aneuploidies were broadly 
similar to RPE-1 cells, involving chromosomes 2, 3, 4, 18 and 20 (red dots). All dots 
represent independent experiments. Red dots represent significant aneuploidy 










6.3.3. HCT116 aneuploidy rates following DNA replication stress 
 
It is known that DNA replication stress is increased in colorectal carcinomas 
(CRC)398. I wanted to test the effect of replication stress in a cancer cell line, 
particularly colorectal cancer as it is known that CIN+ CRCs are associated with 
replication stress226. Importantly, HCT116 are CIN- and therefore a good tissue-type 
and cancer-specific control to determine patterns of aneuploidy following replication 
stress-induced chromosome missegregation. Additionally, the karyotype of HCT116 
cells had already been extensively characterised by SNP array, and patterns of 
aneuploidy following nocodazole wash-out elucidated for this cell line (see chapter 
5.2.1.1 and chapter 6.2.4, respectively).  The missegregation rates for 
chromosomes 5, 13, 14, 19, 21 and 22 were also analysed by conventional telomeric 
FISH on glass slides (preliminary data shown). 
HCT116 cells were treated with low-dose aphidicolin for 24 hours, as for RPE-1 and 
BJ cells. As expected, chromosome missegregation was elevated following DNA 
replication stress (figure 6.9; blue and red dots). The mean rate of chromosome 
gain and loss were significantly higher than that observed for either RPE-1 or BJ 
cells under the same conditions (4.07 and 8.26 %, respectively; *p<0.05), implying 
that there are unique characteristics of HCT116 cells which predispose to replication 
stress-induced chromosome missegregation.  
Overall, there was a wide range of chromosome gain rates following replication 
stress from individual experiments (0.46 to 10.66 %). Of note, chromosomes 4, 7 
and 15 were being gained at a rate significantly above all other chromosomes (6.47, 
6.29 and 8.06 %, respectively; *p<0.05).  
Similarly, there was a wide range of chromosome loss rates across all chromosomes 
tested from independent experiments (0.46 to 29.4 %). Chromosomes 6, 18, 21 and 
X were lost at significantly higher rates than the mean (13.11, 14.91, 13.77 and 27.90 
183 
 
%, respectively; *p<0.05). The loss of chromosome X in HCT116 cells (27.90 %) 
was the highest rate of chromosome missegregation I observed for any cell line 
under any cellular stress, which is interesting as HCT116 cells are of male origin and 
therefore monosomy X in untreated cell; the loss of chromosome X therefore 
represents an extraordinary nullisomy population following DNA replication stress. 
Given that basal levels of monosomy X in HCT116 cells are undetectable in this 
assay, it is likely that this population will undergo apoptosis. 
These data demonstrate that HCT116 cells missegregate chromosomes more 
frequently than non-transformed RPE-1 and BJ cells following DNA replication 
stress. They also reveal differences in chromosome missegregation patterns 
compared to RPE-1 and BJ cells, implying that there may be characteristics of 
transformed cells which promote instability of a different subset of chromosomes. 
One key observation is that there was a modest overlap between HCT116 cells 
following nocodazole wash-out and replication stress, suggesting that certain 
chromosomes are intrinsically vulnerable and others depend on the underlying 
mechanism in this cell line. 
It is important to reiterate that only changes in centromere number for each 
chromosome are quantified. Furthermore, I have not formally validated these results 
by single-cell sequencing. These data therefore form the basis for further 






Figure 6.9. HCT116 aneuploidy rates following replication stress. Aneuploidy 
rates were investigated in HCT116 cells following 24 hours of replication stress 
induced by aphidicolin. Global chromosome missegregation was gain was elevated 
to a similar rate as RPE-1 and BJ cells, but chromosome loss was significantly 
increased (blue dots; 4.07 % gain, 8.26 % loss; *p<0.05). Significant chromosome 
gain was observed for chromosomes 4, 7 and 15; significant chromosome loss was 
observed for chromosomes 6, 18, 21 and X (red dots). Acrocentric chromosomes 
were scored manually in at least 200 cells from independent experiments using 
traditional manual scoring. All dots represent independent experiments. Red dots 









6.3.4. RPE-1 12/3 aneuploidy rates following DNA replication 
stress 
 
Following the observation of recurrent patterns of missegregation in diploid and 
aneuploid RPE-1 cells after nocodazole wash-out, I wondered if similar patterns 
could be observed, and whether missegregation rates would be exaggerated in a 
similar way, following DNA replication stress in the trisomic RPE-1 cell line already 
discussed in this chapter – RPE-1 12/3 (section 6.2.5). One hypothesis is that the 
presence of an extra chromosome may increase chromosomal aberrations, 
following replication stress, by increasing the frequency of novel translocation 
involving the trisomic chromosome 12. Additionally, the missegregation rates for 
chromosomes 5, 13, 14, 19, 21 and 22 by were analysed by conventional telomeric 
FISH on glass slides (preliminary data shown). 
RPE-1- 12/3 cells were treated with low-dose aphidicolin for 24 hours. Chromosome 
missegregation was elevated following DNA replication stress, as expected (figure 
6.10; blue and red dots). The mean rates of chromosome gain and losses were 
comparable to HCT116 cells, but significantly higher than that observed for both 
diploid RPE-1 and BJ cells (4.37 and 6.31 %, respectively; *p<0.05). This is 
interesting as it suggests that the presence of a single extra chromosome is sufficient 
to increase aneuploidy globally following replication stress versus diploid RPE-1 
cells. 
Chromosomes 2, 4, 7 and 14 were gained at significantly higher rates than the mean, 
indicating that aneuploid cells also become frequently trisomic for a small subset of 
chromosomes following replication stress (4.64, 6.87, 9.15 and 11.58 %, 
respectively; *p<0.05). Interestingly, chromosomes 2 and 4 were also gained at high 
rates in diploid RPE-1 cells under the same conditions (chromosome 7 failed 
significance p=0.64 and chromosome 14 was not analysed in diploid RPE-1 cells), 
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confirming that patterns of chromosome gain are similar, but not identical, between 
diploid and aneuploid cells induced by DNA replication stress. 
Furthermore, chromosomes 3, 13, 16, 18 and X were lost at high rates, which is in 
good agreement with the majority of significant monosomies in diploid RPE-1 cells 
(8.00, 13.02, 10.78, 10.51 and 13.95 %, respectively; *p<0.05). Chromosome 4 
marginally failed significance (p=0.064) due to a large variation between 
experiments.  Of note, chromosomes 8 and 15 were very stable and lost at rates 
comparable to that of untreated control cells (3.41 and 3.46%, respectively). 
These data support the hypothesis that patterns of aneuploidy arising following DNA 
replication stress in diploid and aneuploid populations, derived from the same cell 
type, are recurrent and may be caused by inherent of properties of individual 
chromosomes. Additionally, the rates of aneuploidy following cellular stress were 
elevated by the presence of an additional chromosome 12, corroborating a similar 













Figure 6.10. RPE-1 12/3 aneuploidy rates following DNA replication stress. 
Aneuploidy rates were investigated in a sub-clone of RPE-1 cells containing a 
chromosome 12 trisomy. Global chromosome gain and loss rates were marginally 
elevated compared to diploid RPE-1 cells (blue dots; 4.37 % gain, 6.31 % loss). The 
most frequently elevated aneuploidies were broadly similar to RPE-1 and BJ cells, 
involving chromosomes 2, 3, 4, 7, 13, 14, 16, 18 and X (red dots). Acrocentric 
chromosomes were scored manually in at least 200 cells from independent 
experiments using traditional manual scoring. All dots represent independent 
experiments. Red dots represent significant aneuploidy deviation from the mean 









6.4. Aneuploidy rates following centromere protein A 
depletion 
 
The centromere protein A (CENP-A), a specialised histone H3 variant, is known to 
play a role in specifying the centromere of human chromosomes, is important for 
down-stream assembly of kinetochore components and therefore important for the 
faithful segregation of chromosomes (figure 6.11a)404. It is currently unclear whether 
certain chromosomes are more vulnerable to the loss of centromere specification 
and fidelity. One important concept here is the idea of centromere strength – the 
notion that stability of chromosome attachment to the mitotic spindle is proportional 
to the recruitment of kinetochore components291. A critical limiting factor for 
kinetochore recruitment to centromeres is CENP-A, as CENP-A levels determine 
CENP-B recruitment which in-turn acts as a scaffold for the inner centromere 
complex405–407. Moreover, CENP-A levels are proportional to chromosome size. 
Therefore, I wanted to ask whether patterns of chromosome missegregation could 











6.4.1. An inducible CENP-A depletion system 
 
To assess the role of CENP-A, and therefore centromere size and strength, in faithful 
chromosome segregation, I obtained cell lines with an inducible degradation motif-
tagged CENP-A from a collaborator which were previously characterised409. These 
cell lines were derived from diploid RPE-1 cells, already described in this chapter 
(section 6.2.1); and DLD1 cells, a human colorectal carcinoma cell line. In each cell 
line, both alleles of CENP-A had been replaced with CENP-A mutants tagged with 
an auxin-inducible degradation (AID) domain and a GFP fluorophore (figure 6.11b). 
It was previously shown that CENP-A degradation following addition of auxin was 
rapid, with a half-life of 16 minutes409. However, CENP-A already established at 
centromeres was protected from degradation until the next cell cycle when CENP-A 
is unloaded from the centromere. Therefore to completely remove all CENP-A, a 
total auxin treatment time of 48 hours was necessary to allow cells to proceed 
through one complete round of cell division in the absence of CENP-A. 
To test whether I could observe complete CENP-A degradation in my hands, RPE-
1-CENPA-AID-GFP and DLD1-CENPA-AID-GFP cells were treated with auxin for 
48 hours. CENP-A-GFP was easily visualised in untreated cells by fluorescence 
microscopy and could be observed as punctate GFP spots (figure 6.11c; control). 
As expected, CENP-A was completely depleted by 48 hours in the presence of auxin 
in both RPE-1 and DLD1 cell lines (figure 6.11c; +48h IAA). These data 
demonstrate that these cell lines are capable of a complete and expeditious 
degradation of the CENP-A protein and can therefore be used to determine the rates 








Figure 6.11. An inducible CENP-A degradation system. (a) CENP-A is 
incorporated at centromeric DNA sequences and helps assembly of down-stream 
kinetochore components which are required for chromosome biorientation. (b) 
CENP-A tagged with an auxin-inducible degradation (AID) domain and a GFP 
fluorophore is degraded by the proteasome following addition of auxin. (c) CENP-A 
is completely degraded following 48 hours auxin treatment in RPE-1 and DLD1 cells. 





6.4.2. RPE-1 aneuploidy rates following CENP-A depletion 
 
RPE-1-CENP-A-AID cells were used to determine whether differences in 
centromeric CENP-A generates aneuploidy patterns following CENP-A depletion. 
First, the mean rate of chromosome gain and loss were determined in unperturbed 
cells and found to be marginally lower in control RPE-1-CENP-A-AID cells compared 
to control parental RPE-1 cells, although this did not reach significance (figure 6.12; 
grey dots; 0.82% vs. 1.03 % and 1.26 % vs. 1.83 %, respectively). 
RPE-1-CENP-A-AID cells were treated with auxin for 48 hours to remove CENP-A. 
As expected, chromosome missegregation was elevated following CENP-A removal 
(figure 6.12; blue and red dots). There was a range of chromosome loss rates 
across all chromosomes tested. However, chromosomes 4, 9, 15, 16 and X were 
missegregating significantly more frequently than the mean (8.85, 6.61, 7.97, 7.90 
and 8.21 %, respectively; *p<0.05). Additionally, global chromosome gain (1.29 %) 
was not as high as would be expected given the monosomy rates across the 
population (4.68 %). Across all chromosomes, trisomy rates higher than the mean 
of the untreated control cells was not observed, suggesting that trisomic cells may 
undergo apoptosis before 48 hours and are therefore undetectable. One way to test 
this would be to assess cell death at this time point. 
These data suggest that the loss of CENP-A at the centromere, which is an indirect 
measure of centromere strength, generates chromosome-specific missegregation 
patterns. Furthermore, variations in centromere length, and thus CENP-A, between 
chromosomes may determine the rates of chromosome missegregation when the 





Figure 6.12. RPE-1 aneuploidy rates following CENP-A depletion. Aneuploidy 
rates were investigated in RPE-1 cells following 48 hours of CENP-A depletion 
induced by auxin (IAA). Basal levels of aneuploidy were low in untreated cells (grey 
dots; 0.82 % gain, 1.26 % loss). Global chromosome missegregation was elevated 
following removal of CENP-A for at least one cell cycle (blue dots; 1.29 % gain, 4.68 
% loss). No chromosomes with significantly elevated trisomy rates were detected. 
The most frequently elevated chromosome losses were for chromosomes 4, 9, 15, 
16 and X (red dots). All dots represent independent experiments. Red dots represent 









6.4.3. DLD1 aneuploidy rates following CENP-A depletion 
 
A transformed, chromosomally-stable colorectal carcinoma cell line, DLD1, was 
used to determine whether the patterns of chromosome loss observed following 
CENP-A depletion in RPE-1 cells were cell line-specific. Similarly to RPE-1 cells, 
DLD1 cells had both endogenous alleles of CENP-A replaced with AID-tagged 
mutants.   
First, the mean rate of chromosome gain and loss were determined and found to be 
marginally higher in untreated DLD1-CENPA-AID cells compared to untreated RPE-
1-CENPA-AID cells, but this did not reach significance (figure 6.13; grey dots; 1.10 
% vs. 0.82% and 1.97 % vs. 1.26 %, respectively). 
DLD1-1-CENP-A-AID cells were treated with auxin for 48 hours to remove CENP-
A. As expected, chromosome missegregation was elevated following CENP-A 
removal (figure 6.13; blue and red dots). Mean chromosome loss rates were similar 
to those observed in RPE-1 cells following CENP-A removal (4.61 % vs. 4.68 %), 
however average chromosome gain rates were significantly greater (1.82 % vs. 1.29 
%; *p<0.05). Strikingly, chromosomes 1, 6, 7 and 18 were missegregating above the 
mean across independent experiments which corresponded to a complete non-
overlapping of aneuploidy-prone chromosomes between the cell lines (figure 6.13; 
red dots; 5.77, 6.97, 8.32 and 5.45 %, respectively; *p<0.05). Additionally, global 
chromosome gain was also not as high as would be expected given the monosomy 
rates across the population in DLD1 cells, similarly to RPE-1 cells (1.82 %).  
These data suggest that chromosome missegregation rates following a 
destabilisation of the centromere and/or kinetochore are cell line dependent. 
Alternatively, they may highlight intrinsic differences in centromere fidelity between 





Figure 6.13. DLD1 aneuploidy rates following CENP-A depletion. Aneuploidy 
rates were investigated in DLD1 cells following 48 hours of CENP-A depletion 
induced by auxin (IAA). Basal levels of aneuploidy were low in untreated cells (grey 
dots; 1.10 % gain, 1.97 % loss). Global chromosome missegregation was elevated 
following removal of CENP-A for at least one cell cycle (blue dots; 1.82 % gain, 4.61 
% loss). No significantly-elevated chromosome gain rates were detected. The most 
frequently elevated chromosome losses were strikingly different to RPE-1 cells 
following CENP-A depletion, involving chromosomes 1, 6, 7 and 18 (red dots). All 
dots represent independent experiments. Red dots represent significant aneuploidy 










I have implemented a high-throughput approach to determine individual-
chromosome aneuploidy rates in unperturbed cells and reported how these rates 
change in response to a variety of cellular stresses. The discovery that individual 
chromosomes missegregate with different frequencies following nocodazole wash-
out is a novel observation with high biological significance due to the importance of 
merotely in human disease and the ubiquitous nature of nocodazole in the study of 
aneuploidy. Importantly, this phenomenon was not cell-line specific, as a small 
subset of chromosomes behaved similarly in cell lines derived from different tissues 
of origin. 
Moreover, individual chromosomes were missegregated with significantly elevated 
frequencies following replication stress, revealing that particular chromosomes are 
intrinsically vulnerable and others are contingent on the underlying mechanism 
inducing aneuploidy. 
Furthermore, I have demonstrated that CENP-A-dependent centromere 
specification sensitises a small number of chromosomes to CENP-A depletion. 
Strikingly, aneuploidy patterns observed in the absence of CENP-A were not 
recurrent between RPE-1 and DLD1 cells, exposing a previously-unrecognised 


































It is widely reported in the literature that conditions which elevate aneuploidy 
often generate segregation errors at anaphase410–412. Indeed, it is possible to stratify 
segregation errors into a variety of sub-categories in an attempt to refine the 
underlying mechanism and impact on chromosomal instability phenotypes. 
Segregation errors are broadly split into two categories: lagging chromosomes 
(caught at the centre of dividing mitotic figures) and chromosomes bridges (thin DNA 
strands which span between the dividing mitotic figures)226,413. A prominent gap in 
my current understanding, based on the available literature, is the lack of data 
concerning chromosome-level resolution of segregation errors and therefore the 
contribution of individual chromosomes to the overall error rate. 
My data from chapter 6 highlighted that a subset of chromosomes account for a 
disproportionate amount of the population-wide aneuploidy following cellular stress 
in multiple cell lines, induced through different mechanisms. Therefore, it is clear 
that there is a burgeoning requirement to elucidate if there are differences between 
individual chromosome segregation errors at anaphase, and their contribution to the 
overall error rate. I hypothesised that aneuploidy-prone chromosomes may account 
for a significant proportion of segregation errors observed at anaphase following 
nocodazole wash-out.  
Here, I quantify lagging chromosome rates at anaphase with single chromosome-
level resolution. Strikingly, I reveal that individual chromosomes undergo different 
routes to aneuploidy, even under the same cellular stress. Moreover, I expose the 
phenomenon of ‘premature sister chromatid separation’ (PSCS) for particular 
aneuploidy-prone chromosomes following nocodazole wash-out414,415. 
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7.1.1. RPE-1 individual chromosome segregation error rates   
 
RPE-1 cells were arrested in mitosis with nocodazole for eight hours followed by a 
release for one hour to allow cells to proceed through to anaphase. The 8-hour 
nocodazole arrest length was the same as for chapter 6, so a fair comparison 
between aneuploidy rates and segregation errors could be made. A panel of highly-
aneuploid (1, 2, 3, 4, 7 and 10) and relatively stable (6 and 17) chromosomes were 
marked with two-colour FISH with centromeric α-satellite probes to determine the 
lagging rates for each chromosome at anaphase (figure 7.1a). 
Strikingly, at least one chromosome 1 allele was observed lagging between the 
mitotic figures in ~ 50% of anaphases (figure 7.1b). Staining simultaneously for 
chromosome 1 and an all-centromere mark, and scoring missegregation as a 
function of all lagging chromosomes per cell, revealed that chromosome 1 
accounted for 43 % of all lagging chromosomes at anaphase.  Chromosomes 2 and 
10 accounted for a further 22 % and 12 % of all laggards, respectively. These data 
demonstrate that over three-quarters of all lagging chromosome at anaphase are 
accounted for by just three aneuploidy-prone chromosomes following nocodazole 
wash-out in RPE-1 cells. 
Conversely, I did not observe a significant increase in the lagging rates for 
chromosomes 3, 4 and 7, despite the observation that these chromosomes are 
frequently aneuploid under these conditions (chapter 6.2.1). However, it is possible 
that these chromosomes undergo cryptic non-disjunction, where chromosome 
missegregation occurs without a lagging intermediate. 
To test the hypothesis that chromosomes 3, 4 and 7 may undergo cryptic non-
disjunction, the percentage of monosomy/trisomy was scored following nocodazole 
wash-out in cells without lagging chromosomes (figure 7.1b). Importantly, 
chromosomes 3, 4 and 7 displayed non-disjunction at rates which were comparable 
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to the aneuploidy rates obtained by flow cytometry (4.67 %, 6.00 % 5.00 %, 
respectively), demonstrating that chromosomes undergo different routes to 
aneuploidy, even under the same cellular stress.  
I next wondered if individual chromosomes take longer to align at metaphase, and if 
this may provide indications as to the underlying chromosome biology causing the 
striking differences in segregation error rate. Given that the McClelland laboratory 
has observed chromosome alignment to take approximately 45 minutes following 
nocodazole wash-out, the percentage of unaligned chromosomes was determined 
at this time point339. Interestingly, the frequency that individual chromosomes were 
unaligned at 45 minutes post-nocodazole wash-out displayed high heterogeneity. 
Chromosome 1 unalignment was highest, occurring in 37 % of prometaphase cells 
(figure 7.1c and 7.1d). All other chromosomes tested were unaligned in between 
12 % and 22 % of prometaphase cells. 
These data may reflect the disparity in the distances chromosomes have to congress 
to align at metaphase – chromosomes residing in the interphase nuclear core will 
require less time to congress to the spindle equator than those occupying the 
interphase nuclear periphery. 
To assess whether unalignment for individual chromosomes was eventually 
resolved given extra time, cells were prevented from entering mitosis by inhibiting 
proteasome-dependent securin breakdown with MG132 for a further 2 hours, 
immediately following nocodazole wash-out. Despite the inhibition of securin 
cleavage, some sister chromatids were observed on opposing sides of the 
metaphase plate, suggesting cohesion failure and premature sister chromatid 
separation (figure 7.1e, PSCS). Strikingly, chromosome 1 displayed PSCS in 
46.06% of prometaphase cells (figure 7.1f). PSCS was also observed for 
chromosome 2 (30.2 %) and to a lesser extent for the other chromosome analysed 
(5.59 to 15.34 %). These data suggest that there may be chromosome 1 and 2 -
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specific sister chromatid cohesion fatigue following mitotic arrest. Moreover, PSCS 
was not observed for chromosome 1 in metaphase spreads following 8 hours 
nocodazole treatment alone, suggesting that microtubule pulling forces are required 
for this phenotype (figure 7.1g and 7.1h). 
These data demonstrate that the chromosome missegregation rates, determined in 
chapter 6, likely reflect the intrinsic properties of individual chromosomes. 
Furthermore, the vulnerability of subsets of chromosomes following nocodazole 
wash-out may influence pathological aneuploidy patterns observed in human 
disease, through multiple routes to aneuploidy. Importantly, I have shown that routes 
to aneuploidy are not homogenous for individual chromosomes, even under the 
same cellular stress, highlighting a previously-uncharacterised need for 
chromosome-level characterisation of molecular mechanisms which generate CIN. 
A further unexpected consequence of nocodazole arrest was the elevated rate of 
PSCS for chromosomes 1 and 2, demonstrating that there may be chromosome-
level differences in cohesin establishment or maintenance, exposing a potentially 








Figure 7.1. Characterising RPE-1 segregation errors following nocodazole 
wash-out. (a & b) Lagging and non-disjunction rates for a panel of chromosomes. 
(c & d) Chromosome 1 is frequently misaligned at late prometaphase; n=1. (e & f) 
Chromosome 1 and 2 are vulnerable to premature sister chromatid separation 
(PSCS). (g & h) PSCS is not observed at metaphase in the absence of microtubule 
pulling forces. Inset: non-separated chromosome 1 chromatids. Data by Dr. Sarah 




7.2. Metaphase chromosome territories 
 
Preface 
It is known that chromosomes occupy well-defined territories in the 
interphase nucleus67,416. What is less clear, is whether the spatial arrangement of 
chromosomes during interphase gives rise to similar patterns in the metaphase plate 
as cells proceed to sister chromatid alignment at the spindle equator. Early work 
demonstrated the potential for non-random arrangement of chromosomes in 
metaphase spreads417,418. However, this approach is subject to significant artefacts 
due to experimental reproducibility and subtle fluid mechanic disturbances as 
chromosomes settle onto the solid glass support – thus obscuring the true 
arrangement. Moreover, assessing the arrangement of chromosomes in the 
unperturbed metaphase plate has the additional advantage of enabling the 
elucidation of sister chromatid geometry. 
I hypothesised that if patterns of chromosome alignment at metaphase were 
observed, they may be able to explain chromosome missegregation behaviour – it 
is possible that there are regions of the metaphase plate which are more prone to 
chromosome missegregation. 
The geometry of individual metaphase sister chromatid pairs (including relative 
metaphase position, inter-centromere distance, inter-homologue distance and inter-
centromere angle) are currently unknown. Determining these parameters at 
metaphase may reveal differences in underlying chromosome biology which could 






7.2.1. The geometry of metaphase chromosomes 
 
Given that interphase chromosome territories are subtle, I anticipated the same 
would be true at metaphase64,419. Determining the geometry of sister chromatid pairs 
in the metaphase plate would therefore necessitate the precise analysis of hundreds 
of metaphase chromosomes stained for specific centromeres by FISH with α-
satellite probes. Manual geometric measurements of such large image sets using 
the image analysis program, ImageJ, can be labour-intensive and prone to analysis 
artefacts introduced by human error. To circumvent the issues associated with 
manual measurements, I developed a macro plugin for ImageJ which elucidates 
chromatid geometry, regardless of the orientation of the metaphase plate in the 
image (chapter 10.1.2). Using this novel approach, I undertook the first systematic 
and high-throughput assessment of metaphase chromosome arrangement to test 
whether specific chromosomes occupy preferred domains.  
The metaphase plate region was defined by best-fit ellipse analysis of DAPI-stained 
DNA. The metaphase measurements defined both the major and minor axis length 
as well as the rotation of the plate around the ellipse centre from 0 to 180 degrees 
(figure 7.2a). The ellipse centre served an important function as a reference to which 
the normalised positions of sister chromatids could be radially mapped. Coordinates 
for the centre of individual centromere signals were expressed as the distance from 
the ellipse centre in both x and y dimensions (∆x and ∆y, respectively). 
To calculate the relative metaphase position, chromatids were mapped as the radial 
distance from the ellipse centre when aligned on the major axis, to standardise the 
positions in the plate (figure 7.2b). To achieve this, standard trigonometric functions 
were applied to the ∆x and ∆y coordinates (for proofs, see Materials and Methods, 
chapter 3.8). These formulae accounted for the positioning of sister chromatids 
relative to the major and minor axes, as well as the orientation of the metaphase 
204 
 
plate ellipse. To further account for metaphase orientation and length variation, 
relative chromatid positions were expressed as the normalised radial distance from 
the centre of the ellipse (figure 7.2b). 
The angle (θ1) between sister chromatids pairs was calculated as the deviation from 
parallel to the major axis, where [θ1 = 0] represents parallel chromatid alignment 
(figure 7.2c). Furthermore, inter-centromere distance and inter-homologue distance 
were calculated from the hypotenuse length between centromere pairs and relative 












Figure 7.2. The geometry of metaphase chromosomes. (a) The coordinates of 
metaphase chromatids relative to the centre of the metaphase plate ellipse. (b) The 
relative metaphase plate position of individual chromatids can be determined by 
trigonometry in any metaphase orientation. (c) The perpendicular angle deviation 
between sister chromatid pairs. (d) Representative images illustrating chromatid 





7.2.2. RPE-1 metaphase chromosome geometry 
 
7.2.2.1. Radial metaphase chromosome positioning 
 
The normalised radial positioning of metaphase chromosomes in unperturbed RPE-
1 cells, relative to the centre of the metaphase plate, were calculated as described 
(figure 7.3a and section 7.2.1). Radial metaphase chromosome positions were 
graphed on a cumulative frequency plot, to reveal average positional trends. 
Strikingly, radial distance from the metaphase centre showed a positive correlation 
with chromosome size – larger chromosomes at the metaphase periphery and 
smaller chromosome at the metaphase centre (figure 7.3b and 7.3c; R2= 0.3783). 
Average chromosome position was defined at 50 % cumulative frequency:  
15>18>17>3>11>16>8>X>6>20>10>7>4>2>9>1 (central to peripheral; figure 
7.3d). 
Of particular interest: chromosomes 1, 2, 4, 7, 10 and 18, which were frequently 
missegregated following nocodazole wash-out (see chapter 6.2.1), occupied 
average positions in two contiguous regions of the metaphase plate (figure 7.3d; 
aneuploidy-prone regions, *p<0.05). This suggests that chromosome arrangement 
at metaphase may predispose to aneuploidy, particularly at the metaphase 
periphery following nocodazole wash-out. Replication stress-induced aneuploidy-
prone chromosomes were not found to be located in the aneuploidy prone regions, 
indicating this phenomenon may be related to microtubule dynamics (p=0.3173). 
To determine if homologous chromosome pairs had preferred territories at 
metaphase, individual chromatid positions were graphed as a normalised density 
plot (figure 7.3e). Interestingly, although chromosomes showed broad size-related 
positioning, homologous chromosomes were infrequently confined to strict 





Figure 7.3. The radial positioning of metaphase chromosomes in RPE-1 cells. 
(a) Radial metaphase position can be expressed in metaphase length. (b) 
Cumulative frequency of metaphase positions reveals a size-dependent positioning 
phenomenon. (c) Chromosome size is correllated with radial metaphase position 
(R2=0.3783). (d) Average chromosome position with aneuploidy-prone regions. 
Nocodazole-induced aneuploidy-prone significance by chi-squared *p<0.05 (0. 
0117). (e) Individual chromsomes occupy a range of positions at metaphase. Blue 
boxes: example of chromosome 4 territories. Red arrows: significantly elevated 
aneuploidy in nocodazole wash-out. n=2820 from three independent experiments. 
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7.2.2.2. Inter-homologue distance 
 
Given that chromosomes broadly exhibited size-dependent positioning at 
metaphase, I hypothesised that there may be a tendency for homologous 
chromosomes pairs to be spatially separated from one another by a regular 
distance, and this could contribute to the positioning phenomenon (figure 7.4a). To 
test this hypothesis, the distance between homologous chromosome pairs along the 
major metaphase axis was enumerated as a function of total metaphase distance, 
to account for variability in overall metaphase plate length. Strikingly, most 
homologous chromosomes were usually found within 25 % of the metaphase plate 
length from one another, irrespective of overall position (figure 7.4b). This was not 
true for chromosomes 1, 2 and 17 where chromosomes were frequently found 
beyond this distance. Excluding these three chromosomes, it was rare to find 
homologous chromosomes separated by greater than 50 % of the metaphase plate 
length. 
The chromosome spacing phenomenon is most easily conceptualised using 
chromosome 4 as an example. The distribution of chromosome 4 at metaphase was 
broadly restricted to two readily-identifiable metaphase regions, [0.13-0.17] and 
[0.46-0.54], of the normalised radial distance from the metaphase centre (figure 
7.3e; blue boxes). However, the spacing of chromosome 4 homologs was 
infrequently greater than 0.08 (8 %) of the metaphase plate length (figure 7.4b, 
chromosome 4). This suggests that chromosome 4 homologs congress to the same 
region of the spindle equator, thereby establishing territories in one of two regions 
in the majority of instances. 
These data demonstrate that there may be mechanisms which govern the relative 
spacing of homologous chromosomes pairs – possibly as a result of interphase 
chromosome territory preservation through to metaphase.  
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7.2.2.3. Inter-centromere distance 
 
The distance between centromeric signals of sister chromatid pairs can be used as 
a surrogate measure of cohesion. To investigate if particular chromosomes were 
more vulnerable to cohesion weakening (but not complete PSCS, described in 
chapter 7.1.1) at metaphase, and therefore increased missegregation at anaphase, 
inter-centromere distance was measured as described above (chapter 7.2.1). The 
mean inter-centromeric distance in untreated RPE-1 cells was 1.84 µm – less than 
the 2 µm limit defined for faithful sister chromatid cohesion (figure 7.4c) 256. 
Conversely, the inter-centromeric distance for chromosomes 3, 9 and 18 were 
significantly greater than the mean, suggesting that some chromosomes may be 
more prone to weakened cohesion at metaphase (*p<0.05). This is interesting as 
chromosomes 3 and 18 were observed missegregating at significantly higher 
frequencies in this cell line following nocodazole wash-out, suggesting that cohesion 
weakening at metaphase may be compounded by a global increase in merotely after 
nocodazole wash-out.   
Moreover, the average position of chromosomes 9 and 18 were found in the 
peripheral, aneuploidy-prone regions at metaphase. It is therefore a possibility that, 
in addition to the intrinsic properties of individual chromosomes, sister chromatid 
cohesin strength is influenced by the relative position occupied at metaphase.  For 
chromosome X, no chromatids were separated by a large enough distance to be 
analysed, because of sister centromere signal overlapping. 
One important consideration for the experiments described above is that, in my 
hands, the FISH signals of centromeric α-satellite probes are not as accurate for 
determining cohesion as immunofluorescent inter-kinetochore distances analysis. 
One explanation is that there may be incomplete probe binding or subtle differences 
between signals on sister chromatid pairs, even within the same metaphase plate. 
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Therefore, my data may be prone to artefacts introduced by differences in probe 
hybridisation. My image analysis tool finds the Gaussian-fitted centre point of 
fluorescent signals and measures the distance between non-overlapping signals. In 
this way, the inter-centromere distances defined here are more useful for inferring 
general weakening of centromeric cohesion rather than the de facto distance 








Figure 7.4. The separation of sister chromatids and homologous 
chromosomes in RPE-1 cells. (a) The distance between homologous chromomes 
can be expressed relative to metaphase plate length. Intercentromere distance was 
calculated between sister chromatid pairs; n=722. (b) Homologous chromosomes 
are rarely separated by greater than 50 % of the total metaphase length. (c) Sister 
chromatids 3, 9 and 18 are frequently separated by greater than 2 µm. Whiskers 
inclusive of 90 % to 10 % minimum and maximum values; n=325 from three 
independent experiments. Asterisks represent significant difference from the mean 
using a two-tailed t-test (*p<0.05). 
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7.2.2.4. Inter-centromere angle 
 
It is currently unknown if there are differences in the angle between sister chromatid 
pairs at metaphase. This is interesting to determine, as gross irregularities in sister 
chromatid orientation may proclude faithful kinetochore-microtubule attachments 
and therefore segregation behaviour. It has already been demonstrated that the 
outer-kinetochore components are rotationally felxible, thereby increasing 
attachment to K-fibers at the metaphase periphery420. I wanted to ask a similar 
question of the individual chromatids themselves. To test this, deviation from 
perpendicular to the angle of the major axis of the metaphase plate between sister 
centromeres was calculated by trigonometry. I find that the vast majority of human 
metaphase sister chromatid pairs align within 0º – 6º of perpendicular to the major 
axis in untreated RPE-1 cells (figure 7.5). Occasionally, angles larger than 6º were 
observed for all chromosomes except 3, 4, 11 and 15. For chromosome X, no 
chromatids were separated by a large enough distance to calculate the angular 
deviation. 
These data suggest that sister chromatid arrangement is tightly controlled to 
maintain near-perpendicularity with the major axis of the metaphase plate, as is 
expected for properly bioriented chromosomes at metaphase421–423. To examine this 
further, tracking with high temporal resolution of individual centromeres, marked by 
fluorescent centromere proteins, could be used to detect whether chromosomes 
which ultimately lag at anaphase first exhibit positioning or geometric defects. 
A further consideration is that my data are determined from images projected from 
3D, thus increasing the chance that my data are misrepresentative of the true 
chromatid geometry, as has been shown for inner and outer kinetochore 
components420. However, as my data reflect a larger-scale observation they are 






Figure 7.5. The rotation of sister chromatids at metaphase in RPE-1 cells. 
Rose plot frequency histograms of the angular rotation between sister chromatids. 
Inner and outer circles are 0.5 and 1 frequency markers, respectively. Sister 
chromatids rarely rotate greater than 6 º from perpendicular to the major axis for 
most chromosomes. n=350 from three independent experiments. 
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7.2.3. BJ metaphase chromosome geometry 
 
7.2.3.1. Radial metaphase chromosome positioning 
 
To determine if size-dependent chromosome positioning applied broadly across 
multiple cell lines, BJ metaphase chromosome positions were determined as 
previously described (chapter 7.2.1). Similarly to the observation in RPE-1 cells, the 
average chromosome position at metaphase correlated with chromosome size 
(figure 7.6b and 7.6c; R2=0.7537). The average chromosome position was defined 
at 50 % cumulative frequency, with chromosomes ordered as follows (central to 
peripheral): 18>20>16>15>11>10>8>17>X>6>4>7>3>9>2>1(figure 7.6a). 
The most notable differences in chromosome positioning between cell lines was for 
chromosomes 3 and 20, found predominantly at the metaphase centre and 
periphery, respectively, in RPE-1 cells. This is important because chromosomes 18 
and 20 were highly aneuploid following nocodazole in BJ cells (chapter 6.2.2), 
suggesting that central metaphase positioning may also contribute to the propensity 
of chromosomes to missegregate in addition to metaphase periphery vulnerabilities 
(figure 7.6b; aneuploidy-prone regions). In both nocodazole wash-out and 
replication stress, aneuploidy-prone chromosomes were found significantly more 
frequently in the aneuploidy-prone metaphase regions, confirming that regions of 
the metaphase plate are vulnerable to missegregation across cell lines (*p<0.05).  
Analysis of individual chromosomes revealed a distribution throughout the 
metaphase plate which correlated with chromosome size but not individual 
chromosome territories (figure 7.6c). Chromosome positions were similar to, but not 
indistinguishable from, those observed in RPE-1 cells. For example, chromosome 
16 positioning was discreet in RPE-1 cells but continuous in BJ cells. Additionally, 
chromosome 4 was more evenly distributed than in RPE-1 cells. 
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These data therefore highlight that chromosome arrangement at metaphase is 
broadly size-dependent but individual chromosomes are not restricted to particular 
domains. Furthermore, chromosome positioning at metaphase may predispose to 
aneuploidy of particular chromosomes, potentially by compounding the effects of 












Figure 7.6. The radial positioning of metaphase chromosomes in BJ cells. (a) 
The cumulative frequency of metaphase plate positions reveals a size-dependent 
positioning phenomenon which was similar to that observed in RPE-1 cells. (b) 
Chromosome size is correllated with radial metaphase position (R2=0.7537). (c) 
Comparison of average chromosome positions with aneuploidy-prone regions 
highlighted. Aneuploidy-prone significance by chi-squared *p<0.05 (0.0389; 
nocodazole wash-out and replication stress) (d) Chromatids occupy a range of 
positions and territories at metaphase to a lesser degree than RPE-1 cells. Red 
arrows: significantly elevated aneuploidy in nocodazole wash-out. n=3206 from 
three independent experiments. 
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7.2.3.2. Inter-homologue distance 
 
Overall, homologous chromosome pairs were infrequently separated by greater than 
50 % of the total metaphase length, similarly to RPE-1 cells (figure 7.7a). However, 
there were notable differences for some chromosomes. For example, chromosomes 
3 and 11 were less-regularly spaced in BJ cells compared to RPE-1 cells, although 
there was no clear association between positioning of homologous chromosomes 
and differences in the missegregation rates of individual chromosomes. 
These data suggest that whilst homologous chromosomes broadly appear to be 
found less than 50 % of the metaphase away from one another, there may be cell 
line-dependent variation in the regulation of homologous chromosome spacing. One 
explanation is that subtle difference in chromosome territories between cell lines is 
exacerbated in homologous chromosome positions at metaphase. As BJ cells are 
male and possess only one X chromosome it was not possible to obtain homologous 
distance data for this chromosome. 
7.2.3.3. Inter-centromere distance 
 
Similarly to RPE-1 cells, there was a range of inter-centromere distances in 
untreated BJ cells. The average inter-centromeric distance was 1.71 µm (figure 
7.7b). Interestingly, the inter-centromeric distance for chromosome 1, 2, 7 and 9 was 
significantly above the mean, which correlated with their average position at the 
periphery of the metaphase plate, in the aneuploidy-prone regions. Indeed, these 
represent four out the five chromosomes furthest from the metaphase centre.  
These data support the hypothesis that metaphase positioning may influence inter-
centromeric distance. One way to test this hypothesis would be to analyse the inter-





Figure 7.7. The separation of sister chromatids and homologous 
chromosomes in BJ cells. (a) Homologous chromosomes are rarely separated by 
greater than 50 % of the total metaphase length. Similar patterns are observed 
between BJ and RPE-1 cells; n=821. (b) Sister chromatids 1, 2, 7 and 9 are 
frequently separated by greater than 2 µm. Whiskers inclusive of 90 % to 10 % 
minimum and maximum values.  n=463 from three independent experiments. 







7.2.3.4. Inter-centromere angle 
 
The angle between sister chromatid pairs were similar to those observed in RPE-1 
cells, with the majority of chromatid pairs exhibiting an angular deviation of less than 
6º (figure 7.8). There was no obvious correlation between inter-centromere distance 
and the angular deviation, suggesting that sister chromatid alignment is tightly 
coordinated regardless of centromeric cohesion. However, angles greater than 6 º 
were not observed for chromosomes 16, 18 and 20 which, on average, occupy the 
most central metaphase positions in BJ cells. Of particular note, angles greater than 


















Figure 7.8. The rotation of sister chromatids at metaphase in BJ cells. 
Rose plot frequency histograms of the angular rotation between sister chromatids. 
Inner and outer circles are 0.5 and 1 frequency markers, respectively. Sister 
chromatids rarely rotate greater than 6 º from perpendicular to the major axis for 
most chromosomes. n=479 from three independent experiments. 
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7.2.4. RPE-1 metaphase chromosome geometry post-nocodazole 
 
Condensed chromosomes congress to the spindle equator during prometaphase by 
microtubule-dependent translocation424–426. It is currently unknown how metaphase 
positioning might be affected by an 8 hour period in the absence of microtubules, as 
is the case for nocodazole wash-out. One hypothesis is that chromosome position 
may be altered by Brownian motion of chromosomes during this period of 
microtubule absence. Additionally, I wanted to determine whether aneuploidy-prone 
chromosomes remained clustered at discrete metaphase regions, as previously 
observed in unperturbed RPE-1 and BJ cells. To answer these questions, the 
position of metaphase chromosome were analysed 45 minutes after release from 
an 8-hour nocodazole arrest, to allow time for chromosomes to congress to the 
spindle equator. 
7.2.4.1. Radial metaphase chromosome positioning 
 
The radial positioning of metaphase chromosomes in RPE-1 cells post-nocodazole 
arrest, relative to the centre of the metaphase plate, were calculated as described 
above. The relative chromosome positions were plotted as cumulative frequency 
along the metaphase axis, to reveal general positional preferences. Interestingly, 
size-dependent chromosome position at metaphase was observed, with 
chromosome order being similar to that reported in untreated RPE-1 and BJ cells 
(figure 7.9a and 7.9b). Chromosomes of intermediate size were arranged in 
accordance with their size throughout the plate. Average chromosomes 
arrangements were defined centrally to peripherally in the following order: 
18>16>15>17>11>8>6>X>10>20>4>9>7>2>3>1 (figure 7.9c). In agreement with 
the data without nocodazole arrest, aneuploidy-prone chromosome are located 
significantly more frequently in the aneuploidy-prone metaphase regions (*p<0.05). 
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Furthermore, the position of individual chromatids was plotted as a density plot and 
revealed similar patterns to those observed for untreated RPE-1 and BJ cells (figure 
7.9d). Of special interest, chromosome 1 – highly missegregated following 
nocodazole wash-out – was observed in a diffuse pattern relative that observed in 
untreated RPE-1 cells (figure 7.9d; blue boxes cf. figure 7.3e; chromosome 1). It is 
possible that the premature loss of sister chromatid cohesion (PSCS; chapter 7.1.1) 
may result in two phenotypes: one in which the sister chromatids are separated and 
remain uncongressed; the other where PSCS still occurs but individual sisters 
congress to a number of metaphase geographies in a stochastic manner. This could 
account for the diffuse pattern of chromosome 1 positions observed at metaphase 









Figure 7.9. The relative position of metaphase chromosomes post-nocodazole 
wash-out in RPE-1 cells. (a) Radial metaphase plate positions reveals size-
dependent chromosome positioning, similar to that observed in untreated RPE-1 
cells. (b) Chromosome size is correllated with radial metaphase position 
(R2=0.5991). (c) Average chromosome positions with aneuploidy-prone regions. 
Aneuploidy-prone significance by chi-squared *p<0.05 (0.0117). (d) Chromatids 
occupy a range of positions at metaphase. Red arrows: significantly elevated 
aneuploidy in nocodazole wash-out. Blue boxes: example of diffuse chromosome 1 
territories n=3436 from three independent experiments.  
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7.2.4.2. Inter-homologue distance 
 
The distance between homologous chromosome pairs along the major metaphase 
axis was enumerated as a function of total metaphase length, to account for 
variability in overall metaphase plate length. Interestingly, chromosomes 1, 3, 6, 7, 
9 and 16 were rarely found more than 8% of total metaphase length apart (figure 
7.10a). Additionally, for all chromosomes analysed, it was rare to find homologous 
chromosomes greater than 50% of the metaphase length apart. These data suggest 
that homologous chromosomes with well-defined metaphase territories tend to 
congress next to each other. They also suggest that homologous chromosome 
positioning is largely unaffected by microtubule disruption and therefore Brownian 
motion. 
7.2.4.3. Inter-centromere distance 
 
To investigate if particular chromosomes were more vulnerable to cohesion loss at 
metaphase following microtubule disruption, and therefore increased 
missegregation at anaphase, inter-centromere distance was measured as described 
above. The mean inter-centromeric distance was low and uniform compared to 
untreated RPE-1 cells (0.77 µm), which was not anticipated given my observation 
that chromosomes display PSCS following nocodazole wash-out (figure 7.10b).  
One important consideration is that only chromosomes which are aligned in the plate 
are analysed, therefore unaligned chromosomes displaying PSCS are excluded. 
Additionally, the low and uniform inter-KT distance could represent unattached 




Figure 7.10. The separation of sister chromatids and homologous 
chromosomes in RPE-1 cells post-nococodazole wash-out. (a) Homologous 
chromosomes are rarely separated by greater than 50 % of the total metaphase 
length. Similar patterns are observed between treated and untreated RPE-1 cells; 
n=663. (b) Average sister chromatid separation did not exceed 1 µm for any 
chromosome. Whiskers inclusive of 90 % to 10 % minimum and maximum values. 
No significant deviation from the mean was observed with a two-tailed t-test. n=1335 





7.2.4.4. Inter-centromere angle 
 
The deviation from perpendicular to the angle of the major axis of the metaphase 
plate was calculated by trigonometry as previously described. I find that most human 
metaphase sister chromatid pairs align within 0º – 6º of perpendicular to the major 
axis in RPE-1 cells following nocodazole wash-out, in-line with those aboserved for 
both untreated RPE-1 and BJ cells (figure 7.11). Occasionally, angles larger than 
6º were observed for all chromosomes except 6, 17 and 20. Suprisngly, 
chromosomes 3, 4, 8 and 16 had an increased number of chromosomes which 
deviated by more than 6º, and chromosome 1 infrequently had sister chromatids that 
deviated by as much as 36º. These data suggest that sister chromatid arrangement 















Figure 7.11. The rotation of sister chromatids at metaphase in RPE-1 cells 
post-nocodazole wash-out. Rose plot frequency histograms of the angular rotation 
between sister chromatids. Inner and outer circles are 0.5 and 1 frequency markers, 
respectively. Sister chromatids rarely rotate greater than 6 º from perpendicular to 






Chromosome missegregation rates are not equal across the human genome. The 
most frequently aneuploid chromosomes following mitotic insult are display recurrent 
patterns across cell lines of different origin (figure 7.12a). Additionally, patterns of 
aneuploidy can be observed under different cellular stresses, highlighting the intrinic 
instability of a small number of chromosomes. I  have shown that aneuploidy-prone 
chromosomes are missegregated via different mechanisms following nocodazole 
wash-out (PCSC and non-disjunction). Strikingly, chromosomes 1, 2 and 10 
accounted for three-quaters of lagging chromosomes at anaphase. Chromosome 3, 
4 and 7 missegregated without a lagging intermediate (cryptic non-disjunction), 
demonstrating that individual chromosomes missegregate through different 
mechanisms, even under the same cellular stress.  Furthermore, chromosome 
arrangement at metaphase is size-dependent (figure 7.12c). I reveal a trend 
whereby chromosomes which are aneuploidy-prone following nocodazole wash-out 
are clustered at the metaphase centre and periphery (figure 7.12b). Taken together, 
these data highlight the importance of chromatid geometry and stability of the 











Figure 7.12. Chromosome missegregation and positioning summary. (a) There 
are recurrent patterns of aneuploidy across cell lines and cellular stresses. (b) 
Anupoidy-prone chromosomes are frequently found in discreet metaphase 
territories. (c) Overview of size-dependent metaphase chromosome positioning 

























The early responses to aneuploidy in human cells, and the missegregation rates of 
individual human chromosomes, are poorly characterised. In part, these important 
questions have remained unanswered due to technical limitations obscuring the 
resolution of early aneuploidy responses, and the lack of appropriate technologies 
to accurately assess de novo aneuploidy rates for single chromosomes.  
In this thesis, I have demonstrated it is possible to isolate aneuploid cells as early 
as 12 hours following the missegregation of a single chromosome using a novel 
strategy. Isolation of monosomic cells with this system has revealed some of the 
transcriptional responses that occur immediately following chromosome 
missegregation in human cells. Most notably, the expression of the pro-apoptotic 
BCL2-family proteins and up-stream p53-interacting proteins, MDM2 and p300, are 
significantly upregulated. 
Additionally, I have implemented an image cytometry-based method for determining 
the missegregation rates of individual human chromosomes in a high-throughput 
manner. Using this system I have shown that certain chromosomes are more prone 
to missegregation, across multiple cell lines and stresses. Furthermore, I have 
started to elucidate the important contribution of centromere integrity to chromosome 
missegregation rates. 
Finally I have, for the first time, shown that chromosome arrangement in the 
unperturbed metaphase plate is non-random, with certain chromosomes having a 
preference for alignment in average territories at the spindle equator. This has 
revealed the existence of aneuploidy-prone regions which are subject to high rates 
of chromosome missegregation. Taken together, these data have important 




Following the development of a drug-inducible chromosome missegregation 
strategy and aneuploidy reporter cell line I was able to isolate a population of cells 
enriched for monosomic cells. However, there are some important issues which are 
likely obscuring the aneuploidy responses. Firstly, the monosomy 6 rate in the 
EGFP-negative population after FACS was only 74.9 %, implying that I have a ~ 25 
% contamination of non-monosomic cells which may be cloaking some of the earliest 
responses. Moreover, the preparation of samples by FISH following FACS is a harsh 
procedure which may be introducing artefacts, as a 75 % monosomy should be have 
detectable by SNP array. 
Furthermore, it is a possibility that some cells transiently dysregulate the dsEGFP 
gene following mitotic arrest, thus appearing EGFP-negative, despite remaining 
diploid. This is supported by the observation in the literature that gene transcription 
is down-regulated globally as cells enter mitosis427–429. Therefore, a fraction of the 
EGFP-negative population, which are in-fact diploid, may simply not have started to 
express dsEGFP in the subsequent G1. 
Additionally, the presence of EGFP-negative cells arrested in G1, but still alive (and 
not in apoptosis) at 24 hours post-nocodazole, suggests that some cells in this 
population may have arrested for aneuploidy-independent reasons. One such 
possibility may be as a result of unavoidable FACS-induced cellular stress. This is 
supported by the observation that the percentage of EGFP-negative diploid cells is 
similar to that percentage of cells not in apoptosis at the 24 hour time-point (~ 32 % 
alive vs. ~ 20 % diploid). 
An alternative strategy to elevate chromosome missegregation, which is currently 
under development in the McClelland laboratory, is to induce the specific 
missegregation of single chromosomes without the need for a mitotic arrest. One 
advantage of such system would abrogate any effects of nocodazole wash-out 
which are not manifesting solely as DNA damage. This would more faithfully 
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recapitulate the missegregation of chromosomes following merotely and therefore a 
fairer comparison of the early transcriptional responses to aneuploidy. 
Interestingly, at 12 hours following EGFP loss, I did not detect a change in the 
expression of p53. This suggests that p53-mediated cell cycle arrest in the earliest 
stages of the aneuploidy response is entirely due to translocation of p53 into the 
nucleus rather than an increase in p53 transcription, resembling a global DNA 
damage response phenotype430–432. In support of this, I observed the transcriptional 
upregulation of MDM2, a known repressor of p53 activity. This is important as it is 
known that stabilisation of p53 in the nucleus activates transcription of MDM2, 
thereby providing a regulatory negative-feedback loop on p53 activity; the greater 
the p53 stabilisation in the nucleus, the higher MDM2 transcription and, in-turn, p53 
inhibition433,434. 
There was also significant upregulation of the DNA-damage response protein ATM. 
This is important as it is known that ATM activates p53 by phosphorylation on serine 
15, causing translocation to the nucleus435,436. ATM also phosphorylates Chk2, 
which together form the ATM-Chk2 DNA damage response pathway172,197. 
Interestingly, I did not observe an increase in transcription of CHK2, suggesting that 
ATM acts independently of the ATM/ATR DNA damage response pathway in 
response to aneuploidy. These data demonstrate that nascent aneuploid cells 
stabilise p53 in the nucleus through ATM-dependent phosphorylation; in agreement 
the p53-mediated cell cycle arrest observed in the literature176,177,431. 
It has already been shown that apoptosis induction is increased when the expression 
of two regulators of apoptosis are perturbed, namely BCL6 and BCL2437. Confirming 
the literature, I also observed a significant increase in expression of the pro-
apoptotic protein Bcl6 and downregulation of Bcl2. Additionally, Bcl2 has been 
shown to inhibit the pro-apoptotic Bax/Bak1 complex, and therefore downregulation 
of Bcl2 would expect to increase the fidelity of Bax/Bak1-mediated apoptosis438. 
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Finally, I observed an upregulation of BCL2L11, encoding the protein BIM, which 
diminishes the activity of Bcl-xL, an anti-apoptotic protein which inhibits p53438,439. 
These data suggest that chromosome missegregation leads to apoptosis through 
transcriptional upregulation of pro-apoptotic proteins, and simultaneously 
upregulating proteins that inhibit pro-survival Bcl2-family members (fig. 8.1c). 
 
Following nocodazole wash-out, I observed unequal rates of individual 
chromosome missegregation between transformed and untransformed cell lines 
(Table 8.1). It is already known that chromosome 1 has a large region of 
pericentromeric heterochromatin and is frequently missegregated following 
hypomethylating treatments440,441. This suggests that changes in centromeric and/or 
pericentromeric integrity may influence chromosome missegregation rates. This is 
supported by my observation that chromosome 1 was frequently observed with 
premature sister chromatid separation (PSCS) at metaphase which suggests that 
chromosome 1 is vulnerable to the disruption of centromeric cohesin following a 
prolonged mitotic arrest. This phenomenon has been previously reported in the 
literature, however it has not been associated with specific chromosomes442. 
This raises an important question: do individual chromosomes displaying PSCS 
evade the spindle assembly checkpoint (SAC)? If so, they may be frequently 
missegregated and contribute to the high aneuploidy rate observed for particular 
chromosomes. In support of this hypothesis, it has recently been shown that 
premature sister chromatid separation does not elicit a robust SAC response, 
followed by abnormal mitotic exit after a short delay443. Moreover, there is mounting 
evidence that aneuploidy in human disease is linked to cohesin complex 
malfunction, in some instances443,444. The mechanistic basis for chromosome-
specific cohesion loss is still unclear, given that there is little evidence of a correlation 
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between chromosome length and centromere size, which would dictate levels of 
centromeric cohesin. 
The idea that cohesion defects may predispose to aneuploidy of individual 
chromosomes is supported by the observation that weakened sister chromatid 
cohesion is prevalent in ageing oocytes, indicating that age-related pathological 
aneuploidies may be caused by intrinsic properties of individual chromosomes445. 
Further supporting this hypothesis, it has been observed that nearly two-thirds of 
failed-fertilised oocytes display chromatid abnormalities, with the most frequent 
aneuploidies involving chromosome 1, 4, 16 and 22446,447. Strikingly, chromosome 1 
aneuploidy in oocytes is common (15.8 %) but not related to maternal age, indicating 
that chromosome 1 is particularly vulnerable to missegregation in meiosis I, 
independent of age-related replication stress448. 
A further explanation for the non-random lagging chromosome and PSCS rates is 
related to centromeric Aurora B levels. It is known that Aurora B is recruited to 
centromeres where it participates in the removal of the cohesin complex and 
destabilises merotelic kinetochore-microtubule attachments449–454. Therefore, 
reduced centromeric cohesin on vulnerable chromosomes would reduce the 
capacity for Aurora B-dependent erroneous attachment correction. This may 
promote elevated rates of merotely for subsets of chromosomes with weakened 
cohesion, thereby generating high rates of lagging chromosomes at anaphase. In 
some cases, where biorientation is achieved, microtubule tension in the absence of 
merotely may overwhelm centromeric cohesin forces for particular chromosomes, 
especially chromosomes 1 and 2, promoting the PSCS phenotype (fig. 8.1a). This 
is important because it highlights how chromosome-level differences in intrinsic 
routes to aneuploidy  may obscure the conventional assessment of segregation error 
rates, depending upon whether the observer is scoring lagging, bridges or non-
disjunction rates, and for which chromosome(s). 
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Remarkably, when RPE-1 cells are released from nocodazole following p53 
knockdown, there is significant chromothripsis for chromosomes 1, 2, 3, 4, 9, 16, 18 
and 20 which are trapped in micronuclei455. The only chromosome subject to loss in 
micronuclei following p53 knock-down alone was chromosome 1. These data are in 
striking agreement with the unequal missegregation, and segregation error, rates 
observed in both RPE-1 and BJ cells in my hands. Taken together, this implies that 
the increased merotely present in cancer cells may perpetuate the instability of a 
select few chromosomes through illicit chromothripsis in micronuclei. 
Additionally, I observed chromosome-level differences between merotely and 
replication stress. For example, chromosome 16 was missegregated at high rates 
following replication stress, but not in nocodazole wash-out. This is in support of the 
literature in which the replication stress fragile sites, FRA3B and FRA16D have been 
shown to predispose chromosomes 3 and 16 to high rates of non-disjunction 
following replication stress456,457. Furthermore, previous data have described age-
related chromosome-specific aneuploidies arising in the ageing mouse brain457. Of 
particular interest, chromosome 18 was missegregated at high frequency, 
suggesting that chromosome 18 may be particularly vulnerable to age-related 
replication stress and contributes to CIN in ageing cells.  
One possibility linking the similar patterns between stresses is that structural 
rearrangements which perturb faithful attachment to the mitotic spindle, such as 
those which disrupt centromeric integrity, may account for some of the observed 
aneuploidy rates. Moreover, it has been shown that replication stress-induced DNA 
bridges are subject to down-stream DNA damage through breakage-fusion-bridge 
(BFB) cycles410,458,459. Patterns of aneuploidy following replication stress may 
therefore represent a subset of chromosomes which are most vulnerable to 




The data in this thesis therefore contradicts the conventional wisdom in which 
conditions thought to elevate chromosome missegregation uniformly across the 
genome are actually inducing the missegregation of a small subset of chromosomes. 
This has consequences for the design of experimental mouse models trying to 
recapitulate tumour karyotypic complexity, where aneuploidy induced using certain 
strategies may predispose particular chromosomes to missegregation. It is therefore 
unclear whether the current literature describing recurrent patterns of aneuploidy in 
vivo are faithfully recapitulating those observed in human disease. 
 
Cell line Aneuploidies 
RPE1 nocodazole w/o 1, 3, 4, 7, 10, 18    (Fig. 6.2) 
RPE1 replication stress 2, 3, 4, 6, 16, 18, 20  (Fig.6.7) 
RPE1 CENP-A depletion 4, 9, 15, 16, X    (Fig.6.12) 
RPE1 12/3 nocodazole w/o 1, 3, 4, 10   (Fig. 6.6) 
RPE1 12/3 replication stress 2, 3, 4, 7, 13, 14, 16, 18, X  (Fig.6.10) 
BJ nocodazole w/o 1, 3, 4, 10, 18, 20   (Fig. 6.4) 
BJ replication stress 2, 3, 4, 18, 20   (Fig. 6.8) 
HCT116 nocodazole w/o 3, 4, 9, 15, 18, 20, X   (Fig. 6.5) 
HCT116 replication stress 4, 6, 7, 15, 18, 21, X   (Fig. 6.9) 
DLD1 CENPA depletion 1, 6, 7, 18    (Fig.6.13) 
 
Table 8.1. Significantly elevated aneuploidies display recurrent biases. 
Patterns of aneuploidy are observed between cell lines and stresses of different 
tissue origin and tumorigenic status. Chromosomes shown are missegregated 
significantly more frequently than the mean of all other chromosomes (p<0.05).  Red 
= gain rate greater than loss rate. Blue = loss rate greater than gain rate. Black = 





The highly-repetitive α-satellite DNA of human centromeres contains an 
element which is important for centromere integrity, the CENP-B box. CENP-B 
boxes, together with the N-terminal domains of CENP-A, recruit CENP-B to 
centromeres. In humans, it has already been shown that CENP-B fulfils at least two 
roles at the centromere including establishing neocentromeres and inhibiting 
multiple centromere formation460. In agreement with these data, abolition of CENP-
A reduces centromeric CENP-B levels by >50 %461. CENP-A is also known to be 
important for the stability of the centromere and faithful segregation of 
chromosomes. In this way, CENP-A can be used as a surrogate measure of 
centromere strength. 
Following CENP-A depletion I revealed distinct patterns of aneuploidy in RPE-1 and 
DLD1 cells, suggesting that certain chromosomes are more contingent on 
centromere viability for faithful segregation behaviour. In support of this hypothesis, 
recent data have described the role of CENP-A in protecting against illegitimate 
centromere rearrangements462. This suggests that patterns of chromosome 
missegregation in the absence of CENP-A are, in-part, reflected by the intrinsic 
susceptibility of individual centromeres to structural aberrations. Furthermore, 
super-resolution microscopy of α-satellite DNA has revealed the existence of a 
CENP-A-dependent mechanism for preventing promiscuous α-satellite 
rearrangements34,462. It is therefore likely that patterns of aneuploidy in CENP-A 
depleted cells are also defined by the integrity of the base pair sequence in addition 
to down-stream assembly of kinetochore components. One important consideration 
is that CENP-A might not be totally depleted, leaving just enough to assemble a 
functional kinetochore. This would explain why global aneuploidy is not as high as 
would be expected following complete CENP-A removal. 
Chromosome missegregation in the absence of CENP-A was variable between 
RPE-1 and DLD1 cells, which is surprising as α-satellite array length polymorphisms 
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have not been shown to be significantly different between cell types. It is known, 
however, that CENP-A levels are proportional to chromosome size408. 
Surprisingly, I did not observe size-dependent patterns of chromosome loss 
following CENP-A depletion in either cell line, suggesting that the maintenance of 
chromatin architecture, described above, are likely the primary driver of 
chromosome missegregation in the absence of CENP-A. In agreement with this 
hypothesis, under-condensation of centromeric chromatin and high rates of 
aneuploidy have been observed following hypomethylation treatment with 5-
azacytidine, specifically for chromosomes 1, 9, 15 and 16463,464. Importantly, I also 
observed elevated rates of missegregation for chromosomes 9, 15 and 16 when 
CENP-A is depleted in RPE-1 cells, suggesting that CENP-A may dictate 
centromeric chromatin environments which are required for faithful segregation of a 
subset of chromosomes. I had already observed high rates of chromosome 1 
missegregation under other cellular stresses (nocodazole and replication stress) but 
did not report a similar phenotype in the absence of CENP-A. Therefore, 
chromosome 1 may be less susceptible to centromere integrity defects than aberrant 
kinetochore-microtubule attachments and structural rearrangements. 
Given that centromeric α-satellite sequence length is likely to vary at each 
centromere, it is plausible that less aneuploidy-prone chromosomes have reduced 
dependence on CENP-A-mediated centromere specification. The pattern of 
chromosome missegregation in DLD1 cells depleted of CENP-A is surprising, given 
the absence of shared aneuploidy-prone chromosomes compared to RPE-1 cells. 
To understand these data more fully would require further karyotype analysis and 
characterisation of CENP-A levels in DLD1 cells to ask if there are differences in 
centromeric CENP-A establishment, maintenance or function between RPE-1 and 





It is pertinent that I observed a size-dependent chromosome positioning 
phenomenon at metaphase. Strikingly, large chromosomes congressed to the 
periphery of the spindle equator whereas smaller chromosome were generally 
located towards to centre of the spindle equator. This phenotype had already been 
reported in human interphase and prophase cells and therefore highlights the 
maintenance of chromosome arrangement during congression to the spindle 
equator465,466. 
Importantly, I observed similar positioning patterns for both RPE-1 and BJ cells, 
indicating that metaphase chromosome positioning is conserved and may influence 
pathological aneuploidy patterns observed in human disease. Indeed, the average 
position of chromosomes at metaphase correlated with their likelihood to 
missegregate under cellular stress.  
This suggests that chromosomes may missegregate depending on where they are 
located in the metaphase plate, possibly due to a transient deviation from bipolar 
spindle geometry, and complexity of kinetochore-microtubule dynamics, which has 
been observed to generate CIN in cancer cells242,467. This is supported by the recent 
discovery that peripherally-located sister kinetochores are rotationally flexible420. 
Although kinetochore flexibility was shown to broadly aid attachment to microtubule 
K-fibres, it is plausible the metaphase periphery represents a region of elevated 
instability following microtubule disruption with nocodazole. These data are further 
supported by the notion that centrally-located chromosomes are captured by 
microtubules in early prophase, therefore achieving rapid biorientation in most 
cases, while chromosomes at either pole display increased propensity to become 
mono-oriented and merotelically attached to microtubules468–470. My data are in 
agreement with this observation given that size-dependent chromosome positioning 
at metaphase increases the mass of DNA at the spindle equator poles, therefore 
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potentially shielding kinetochores from erroneous microtubule reorganisation and 
correction. 
Early work characterising the territories of metaphase chromosomes in cultured 
Indian deer cells has also established a size-dependent positioning phenomenon471. 
Here, the authors additionally describe homologous chromosomes as being 
significantly closer to each other than would be expected if there were no 
mechanisms regulating the spacing between chromosomes pairs at metaphase. 
This is in good agreement with my data in which homologous chromosomes were 
most frequently within 25 %, and rarely greater than 50 %, of the metaphase axis 
length apart in RPE-1 and BJ cells. 
Taken together, these data suggest that the arrangement of homologous 
chromosomes at metaphase is both tightly coordinated and conserved across 
species. It is currently unclear whether there is homologue-specific missegregation 
of vulnerable chromosomes, and the McClelland laboratory is currently trying to 
optimise fluorescent live-cell-based approaches to determine this. It is already 
known that homologous chromosomes display recurrent patterns of differential 
chromatin condensation472,473. It is therefore plausible that there are homologue-
specific chromatin differences which may influence missegregation rates.   
Sister chromatid geometry also displayed recurrent patterns which may further 
perpetuate differential missegregation rates. For example, I observed an increase in 
inter-centromere distance for chromosomes 1, 2, 7 and 9 which correlated with their 
geography at the metaphase periphery in BJ cells. This further supports the 
hypothesis that, although there are mechanisms to promote microtubule stability at 
the spindle periphery, chromosomes may be vulnerable to microtubule pulling forces 




8.5. Conclusions and models 
 
Interpreting the data presented in this thesis, I propose three models for aneuploidy 
mechanisms and responses in human cells. 
Firstly, the unequal missegregation rates for a small number of chromosomes are 
influenced by their intrinsic properties and premature loss of sister chromatid 
cohesion, in some cases. This is most apparent for chromosomes 1 and 2, which 
display high rates of lagging at anaphase and precocious separation of sister 
chromatids in late prometaphase. One explanation is that reduced centromeric 
cohesin for some chromosomes causes a reduced Aurora-B localisation to the inner 
kinetochore, preventing the efficient destabilisation of merotelic kinetochore-
microtubule attachments (figure 8.1a, upper pathway). Occasionally, under 
microtubule tension, sister chromatids with weakened cohesion (or complete loss) 
are frequently separated despite biorientation (figure 8.1a, lower pathway). 
Secondly, chromosome alignment at metaphase is non-random, which is in 
agreement with the early observation that chromosomes occupy size-dependent 
positions in interphase. I propose that, in addition to the intrinsic chromosome 
vulnerabilities described above, regions of the spindle equator are more prone to 
missegregation (figure 8.1b). This is supported by >85 % of significantly aneuploidy-
vulnerable chromosomes occupying average positions in these ’aneuploidy prone’ 
regions following nocodazole wash-out.  
Finally, I have started to elucidate the transcriptome responses to chromosome 
missegregation in nascent aneuploid cells. These data have highlighted the potential 
for expeditious, ATM-activated nuclear stabilisation of p53 in aneuploid cells (figure 
8.1c). The subsequent onset of cell-cycle arrest and apoptosis may be mediated by 






Figure 8.1. Models for aneuploidy mechanisms and responses in human cells. 
(a) Model for how lower cohesin levels at centromeres of chromosomes 1 and 2 may 
promote both the failure to destabliise merotelic attachments by deregulation of the 
ICS (upper pathway) and complete separation of sisters during artificially extended 
metaphase (lower pathway). (b) Model for how chromosome position at metaphase 
elevates missegregation of aneuploidy-prone chromosomes in particular regions of 
the spindle equator. (c) Cell cycle arrest and apoptosis in nascent aneuploid cells 
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10.1. Macros and programming scripts  
 
10.1.1. Fluorescence intensity within the nucleus – ImageJ macro 
 
{ 
dir = getDirectory("image"); 
processedDir=dir + "\Text Data\\"; 
File.makeDirectory(processedDir); 
title = getTitle(); 
dotIndex = indexOf(title, ".");  
title1 = substring(title, 0, dotIndex);  
setBatchMode('false'); 
run("Set Measurements...", "mean redirect=None decimal=3"); 
selectWindow(title); 
run("Z Project...", "start=1 stop=50 projection=[Max Intensity]"); 
selectWindow(title); 
run("Z Project...", "start=51 stop=100 projection=[Max Intensity]"); 
selectWindow(title); 




run("Analyze Particles...", "size=100-Infinity add"); 
name = title + " - Cell Identification"; 




run("Input/Output...", "jpeg=85 gif=-1 file=.txt use_file save_column"); 
name = title + " p21" + ".txt"; 






run("Input/Output...", "jpeg=85 gif=-1 file=.txt use_file save_column"); 
name = title + " p53" + ".txt"; 
saveAs("Results", processedDir +name); 
selectWindow("Results");  
run("Close");  




















10.1.2. Metaphase plate positioning – ImageJ macro 
 
{ 
title = getTitle(); 
dotIndex = indexOf(title, ".");  
title1 = substring(title, 0, dotIndex); 
run("Set Measurements...", "centroid fit invert redirect=None decimal=3"); 
selectWindow(title); 





run("Convert to Mask"); 
run("Analyze Particles...", "size=50-Infinity pixel circularity=0.00-1.00 show=Overlay 




run("Convert to Mask"); 
roiManager("Select", 0); 
run("Find Maxima...", "noise=10 output=[Point Selection] light"); 
roiManager("Add"); 
array1 = newArray("0");;  
for (i=1;i<roiManager("count");i++){  
        array1 = Array.concat(array1,i);      
}  









run("Find Maxima...", "noise=10 output=[Point Selection] light"); 
roiManager("Add"); 
array2 = newArray("0");;  
for (i=1;i<roiManager("count");i++){  
        array2 = Array.concat(array2,i);         
}         
























setwd("   ")   # set working directory for analysis file 
df <- read.table("    ",  # point to analysis file (.txt) 
   header = TRUE, fill = TRUE) 
ggplot(df, aes(x = chromosome, y = angle)) + geom_bin2d() + 
  scale_fill_gradient(low = "white", high = "red") 
 




setwd("   ")   # set working directory for analysis file 
df <- read.table("    ",  # point to analysis file (.txt) 
   header = TRUE, fill = TRUE) 
ggplot(df, aes(x = angle, y = frequency)) + 
   coord_polar(theta = "x", direction = 1) + 
   geom_bar(stat = "identity", width=1, fill="slategray3", colour="black") + 
   scale_x_continuous(limits = c(0,45), breaks = seq(0, 360, 60)) + 
   scale_y_sqrt(breaks = seq(0,6)) + 
   theme(panel.grid.major = element_blank()) 
 




setwd("   ")   # set working directory for analysis file 
df <- read.table("    ",  # point to analysis file (.txt) 
   header = TRUE, fill = TRUE) 
ggplot(df, aes(x = chromosome, y = distance)) + geom_bin2d(bins=23) +ylim(0,1) + 
   scale_fill_gradient(low = "light grey", high = "green") 
298 
 
10.1.6. Chromatid geometry – Microsoft Excel function macro 
 
10.1.6.1. Cell definitions  
 
C2  ellipse centre raw x position 
D2  ellipse centre raw y position 
E2  major axis length 
F2  minor axis length 
G2  metaphase rotation angle 
C3  sister chromatid raw x position 
D3  sister chromatid raw y position 
H3  Δ x 
I3  Δ y 
J3  Hypotenuse of Δ x Δ y  
K3  Angle between Δ x Δ y and x-axis (radians) 
L3  Angle between Δ x Δ y and x-axis (degrees) 
M3  Chromatid quadrant check 
N3  Angle between Δ x Δ y and the metaphase major axis (degrees) 
O3  Chromatid position  
P3  Chromatid position normalised to metaphase plate length 
P3:P6  All chromatid positions normalised to metaphase plate length 
Q3  Number of individual chromatid signals 
R3  Number of resolved sister chromatid pairs 
S3  Inter-centromere distance between sister chromatid pairs 
T3  Inter-centromere angle (radians) 
U3  Inter-centromere angle (degrees) 
V3  Inter-centromere angle sister chromatid qualifier 







10.1.6.2. Cell functions 
 





M3 =IF(G2<0, (G2+180), G2) 
N3 =IF(M3>90, (IF((180-M3-L3)<0, ABS(180-M3-L3), (IF(AND((H3>=0), 





























V3 =IF(AND(Q3>=3, U3>0),(90-U3),0) 
W3 =IF(Q3=2, (ABS(P3-P4)), 0) 
 
